var title_f30_59_31664="Annular ligament displacement in nursemaids elbow";
var content_f30_59_31664=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52710&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52710&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 539px\">",
"   <div class=\"ttl\">",
"    Annular ligament displacement",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 519px; height: 371px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    With sudden traction on the distal radius, the annular ligament partially slips over the head of the radius and slides into the radiohumeral joint, where it becomes trapped.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_59_31664=[""].join("\n");
var outline_f30_59_31664=null;
var title_f30_59_31665="Severe pulmonary paracocci";
var content_f30_59_31665=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F74974&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F74974&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    Severe pulmonary paracoccidioidomycosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 252px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAD8AeADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6c1rVbPRdMm1DU5jDaQ43uEZ8ZYKOFBPUjtXKD4q+DSPl1dz9LOc/+yU344xCf4W63GzOoYQjKHB/10dfOHgXwNP4g1k2FtqU0AETTPK7nbGoHU49yB+NAH0cfi14KHXWH4/6crj/AOIq6nxG8LPEsiak7I3Qi0mP/slfInjnwzPZahd28s80d3aStBKUkOGwcbvx/rXJWl7f6NcqslzcvbN1XzD+Y5oA+19T+MHgbTHCX2tmJyM7fsc7ED3wnFZ//C+/hr/0Mg/8Abn/AON18n6pbRyWS38JaeOQjcxJJ6d64rWNPO03doDj+Je4oA+5f+F9fDbP/Iyf+SNz/wDG6D8efhsP+ZkH/gDc/wDxuvz93nNG9vWgD9Af+F9/DX/oZR/4A3P/AMbpR8evhqTj/hJB/wCANz/8br8/fMb1q5bwuQrHIzQB98x/HX4cyfc8RZ/7cbn/AON1MPjZ8PjjGv8AX/pyuP8A43Xw/o9m+8ErwRxnua6W2s8HlfzHSgD7Ct/jD4FuC3k65u28n/Q5x/7JVuH4oeD5gxj1jO0ZP+jTDj/vivkywgggUlomD9dyng/hXTabp63m1xMYz12kUAfSkfxF8KyDKarke9vKP/Zabc/EnwnbECbVduRu/wCPeU8fgteEafYp5mPPY7iR06f0rL17TlaUyRzyY+6e+AKAPoe3+J3hC4IEOrbs8D/Rph/NKnf4ieFkZlbVMEckfZ5f/ia+btD0pQwaO4zsweauXz+S7KAXPfj9aAPcX+MXgRHZG1whl6j7Hcf/ABFMb4z+AQMnXj/4B3H/AMbr5Zu4DNcSMUxznGKozWquCMEH2FAH1i3xt+Hy9fEH/klcf/G6rSfHn4bRttfxJg/9eNz/APG6+Qr+0MSllB47Y6VyOrRNITJGOV649KAPun/hfvw0/wChlH/gDc//ABul/wCF+fDT/oZR/wCANz/8br8/iSOM8UhJoA/QL/hfnw05/wCKlHHP/Hjc/wDxuj/hfnw0x/yMo/8AAG5/+N1+fxclQOOM81YsreS9uUiiHJ4z6CgD79h+O3w4mJEXiLdj/pxuf/jdWI/jT4Akk2JrxLen2K4/+N18cw6OLOBIoky2B271Uvbg6SjRRHN5Jwx/uCgD7OuPjd8PLd9s3iJVb0FncE/pHVvw38XPBHiTXrXRtF1v7TqV1u8qH7JOm7ahc/MyBR8qk8ntXw3pumPcuJJixLnqep969c+CtpDbfF/wisKBdrXJ4HX/AEWbrQB9F+KPiv4K8La5Jo+va0LTUo0V2h+yzPgMMjlUI6e9Zn/C9fhxn/kZF/8AAO4/+N181/tO21xP8ctSFvaec32W3I+Yjjyxz1+v5U7xL8EdS0bSNUu4tY0u5udPt1u57XyZozsYDhXI2k8jABoA+kv+F7fDf/oZF/8AAO4/+N0n/C9/hv8A9DIv/gFcf/G6+IrHS9WuEZraytjtHzKx5/ImoP7K1TcX+zQ5HBXJ4P0zQB9y/wDC9fhx/wBDIv8A4B3H/wAbo/4Xt8OP+hkX/wAA7j/43XwNNdSxt5UsKKy9RjBqP7Sz7QFVT6qOf50Affv/AAvb4cd/Ei/+AVx/8bo/4Xr8OP8AoZF/8A7j/wCN18BKZSeTge/alZ9o/wBY1AH36nx0+HL/AHfEYP8A25XH/wAbqQfG74eHp4hH/gHcf/G6+CdKcSTMu85I4GK3o4m5xQB9vQ/GTwHP/qte3f8AbpOP/ZKsj4reCym8a0CvtbTf/EV8Xac0kUZUoGBPbrXXaHatdwSfKUwO44oA+o3+K3gtCA2s4z/06T//ABFH/C1vBf8A0GT1x/x6T/8AxFfNUUDGDI+YoMHOOarSxeXDljjIyQTigD6ab4u+B1kCHXBuPGPss/8A8RUr/FXwYiF21jCjv9lm/wDiK+VrLTRcK7K3zA8A/wAxUlzay+XsbJUUAfTJ+M/gEEg6/wAj/pzuP/iKYfjZ8Ph18Qf+Sdx/8br45vIWW4f5SMmq0sDEnt04xQB9mN8cfh2vXxEB/wBuVx/8bpv/AAvX4cf9DGv/AIB3H/xuvhrWQ0Qz049KxBO3qe9AH6Af8Lz+HI6+Ixz/ANOdx/8AG6UfHL4dHp4jX/wDuP8A43X5/faWzn9KVbh85LYAoA/QMfG74enp4hB/7c7j/wCN1Gfjp8OVOG8RAH3srj/43XwEt3Ly2859Sac128inPUd80AffX/C9fhx/0MY/8Arj/wCN0f8AC9fhx/0MY/8AAK4/+N18AGdxnBORVqCK7uWBRCF9WFAH3r/wvX4cf9DGP/AK4/8AjdKPjp8OT08Rg/SyuP8A43Xw7b6YxbDlpJD2Xp+NOnhigO2SbBB/1cYyfxoA+4f+F5/DrP8AyMQ/8Arj/wCN13HhzXNO8R6Nb6rotx9psLjd5Uuxk3bWKnhgCOVI5FfnBGEyBFHJ7bq+6f2c8j4NeHt2Af8ASOn/AF8S0Aa3xgXd8OtXHqIv/RqV4j4O8RQeHNO1SF7CO4u7zZH++B2CMcspAIJJPv2Fe7fFGFrjwLqcSY3N5WP+/qGvn82yKR55BPTPpQBF8SNUh8RasdQgtjbzzwoJ17NIBglfbgV5drdorIyOMFeVOK9VuoIpISgZenDHpXF6howa4ZncM+O7UAcjp1zNp1vKu3zLdiN8fp71NNYHylubP95A45XrxXS2uhB2KlkCkYYE06w0S/0qdozG0ti54Zedue9AHlmv6I9uDdW6kwsfmA6qawQM19Fv4WeUFokRo3HzBuhFcrq3wjupJDdaXJGIc5dG6r9KAPKrG0MsgyCfaup03Q7i5I2x7Y88seK63T/DCaZHicpAq/fml4qw+uaPZ4jtfMun6bvujNADdI8ObZE3MuSAARyB9a6uLRFSFfMjTIx8wFcfP41gjlSKGxKqp5ZX6mtq28VrdKwjuHUnA2svH0oA2o9OWNRkR7M/1rZsLWOOMqIgGPUjtXGW88st6m9iy7s5zXd6dd7ViXyfMU4XnrQBYVljOxQpOM1z93fCUmJo1jK54ySDXYBoZphGtsVcZHtmsfVLSAys6W8akHBYdTigChp4AwQV45OO9T6sjYJGF3DG4dzVvT1QQDbbqrbuA3pVfWrhYoi07rgZIBOMGgDnotNBXfIIyCeSTmmXNlbIy+ZLFkLgBeg/GuY17XsFyrMSD8qLwK5e51/VLlGCP5SAnhR/WgD0W80txCz+UjKy9wMGuK1DRjlmNovP9w1hDUb/AMpkmmmaJuzOePcU2K4vrb5452K8cb80AUdR0Dlja5Vu8b8fkaxjYzKxV0KkcEEV2serCXat9GCDxvA6Vr2WgDXNqQfvEPAkTll/xoA80gsJZphGiEknHAr0Hw94bOnwI7qGnk7HtXc6R4Mj0GMtMEluD9xscCt5LNbRDdXW1sDKqR/KgDidbVNLsg7DdcsNqg+vrXCfZnmuGaU5djkk16JrsRvJmmmQE+3O0VlQ2tqrfNC+cetADbGFBIoGMIABjpivQ/g/DFF8VvDDYZpWe45PYfZpa5vSba1tFJUNvY52McgV2/wwWFvij4bf7rh5yqr0P+jyigCp8cLct8X7+RACTZ24PHs1dNrnxDs721voha6jIbyz+zC2uZ1a1j4A3qgXO4Yz161mfGS3aT4q3jLkn7JAP0auZe0kEZ2thT1FAHIXVm1tJ9rtgQ8X3gP4lpzW6TgXtooKt95T29jW1eW0rgpGmEGRkd6qaXbTWk7KyExOcOPSgDz74g6GIPIvbdRhx8y1x2RGPlJA/wA9K938R6M0w2OheF0Azt+7XjGv6NcaVePHIh8sn5SfSgDJdy2ccD2NNGPTJqRoiF3H0pYITI4AoAvaMrLOrdATiu0jtmyu7oa560t8LGBkYxmvSoNMZ4YGyPmUGgCDRligBDxhmPQ10+mQPKG8v5Vbhu3FZ1hYMtyo27gewrqLSIxKRt28/dx3oApPpiMkkRYqcjIXg1XvtGtPMQbMkL8xB5NbrRyux/dEZHJPGaxpINTb94ZLcjJKgk5oAbpOnoxdlLIVyBnmquqxzq7MASoBI4rW0SG6Jk8xUJzkBT0o1dvLbbIyjPGO4oA4Ka2MrM20bz7VUnsyqjK/kK6+WFSxMUZGfTnNVJbMlcFDz+tAHnXiO222rMF+7weK4nr2zn9K9f1/SpJtPnEceGMZyM15peaTdQNymT25oAy8Hn8qOaleGSI/vI2HvTT1Az06UANCnGB/KnLGXdVA+ZqfDE8zbYwT9K7/AMKeE8hbm6X94fuq3agDI0zw6I4hNcr82M4PatdLSPy2kkGyBR1PGa6m5slgUy3IIhU4AWucvA15Ng5WIH5E6fnQBTklmumENghRDxkDk0TeHLm3jErKrjHzbDkj611Oj2aQwhwBuOTn3q8UaNATwGP04oA4iGxPRUOfYV9pfAOJofhLoUbjDDz+P+28lfLqWpfDMODyB619W/Bldvw10dfTzv8A0c9AFv4ov5fgTU3JwB5XPp+9Svnh9SibImAkHIzXv/xgbb8OdXYdhF/6OSvl4sxUlc4PHFAHR209tONivszgAMf1zTdR0GWVNyrvYDh15BFY9puMgzg4/Gup0S6lhJUFgD2J4FAHN2+nuBk7hz0Nb+nQsnlruJX0POK6dIoLoeZsUMeNwHOferFtaqGBC8DqdooAqaXYOMAEtB6HtWnIEs4CwRTxwnWrbkW8IZ8gEYVf61yut+IYLJwLqRQCfmTOWI9vSgDkPG+gSeKpWkadbSZOFVj8p/D1ry650htLnkS+WQOvA44Jr6CljtLu2jntA21hk7xmsO70Ka8WSC5eOS2AyBsAZTjsaAPB0iRCCEY5PPOa6iGCLy8w4yQMr0zityz8AXMmoE2t2JoN2CAuSPYg1m6uJLDW5LEwRgoAccqaALuiQXMtwWVCY2XOSa9C8Ohp7FXRm8wMdyk8gCuc0SWGzhV512vtBAH8ga6+BRNcxyRExpKQRxyKAJriWaynVlRt4XecVj3mqG9RPLidDuO7HrXVXCyySKysX2qQazII5/Kcsu0jrmgCLTdxh8xQ5IX0PJrnPFMwWOWEqZLgZIT2rsphMmkttkERAI475rkJoyrSzTuXfZtHGTn3oA89bSmmDfaMoWO+smeGJNwAxGucuT+tdLr1xNHLJLbRbvlyxbt68VxFzb3l3O7FMg/N1wKAKlzLDtdQzPnoR3qvYSo9u/mGTC9MYq9Ho945KrAWYdQCDXZ6F4BjktoJL/fG7fM0SNz7D2oA47R7CXUbhYoHKg9S68Ae9ey+A4YdKQQRhZnYAPIhyP8A61Zp0aKGIQQ2xiQ84Q54+tWYrmx8OugQ77tgDsB/n6UAemC0iWIyzEsrDO2sbU7QzSHf9wD5B2qn4d8Xi6lCX64R8AOowF+orp7m2WWImNtwPP8A9egDiLzTQFIHTpWYvh5yxdUO0dD2zXahMMQUGQcYx1NQX7hGHmMNw7f3f/r0AcuulrbhnuHQN1AyDWz8L7i1/wCFr+GYoVd3Z7jMh6H/AEeXpWFqjGQkk46/jU/wmyPjL4W9PMuR/wCSs1AHY/FxlHxLuxkA/ZYecZzw1c+keejqcdOetb3xcQt8TbzHP+iwDH/fVYUUbqAf4gKAKl7BKi5XdtPb0qmkZ/iPPXGa6SGRgmHO/tg0slsjkfu1XnPA4oAp2a/aYfJc/OB8tZWu+EYdWtjFdxqGHKvjOK6q3gk+UEY9xWkbcTR7TkP70AfKniTw/faVfPBcwuEB+VgMhh2qCw099xPlt+VfTeqeHotThMFxGCw5WT0rlJPBH2Ob5kMsfUsTgCgDzXRNJZn3TqQvYZ616notn51nChXGFxyOKmsbC0iyQ9vGi9SWFbljcwJAqh427gIQx+tAGUNMdZSyle5yeKuWds8cygnPck0uo6gif6liAOpZaXS7lplPmNuX72V7UAX7ncqOxIKqO3esKW9hJYkEOORgcV0wFtNBKCx2Bax7Wzs0Dkx+YvTJb1oAraOf3+SR8wODmpNRt1YqRGCBz61NYW1vBP5aRkd85yQKm1FpFc7flQDnFAGStsufm2gkenNQXbW8KK7lWYdcnhfWsjWtR8vcVZhGT8pB69q4rWL66vBsMrrCV+6D796AOr1nVtIa1dVuQZMfcTnP0rhr7UNKncrLbSj33isa5iyCELsaqLczXC7PKUOh5JHX60AaMsFjLIBBMyA9A3NWLTwZJqUgMagAjO6M5z+FVdM0e7vJEdmhEefvM3H/ANevW/BSm1C26RwlSMGQnBagDA0LwIumAPOommzgbRwtdjaWEdgN9ztLnAVV7e1dZHbxKhaM7zjG04yKxNSsy7GTDNjsexoA5LW7KSW5Lk5j7BePwqgIQrbWi+bHTua69rdpEwxww/HJqk9sGb5uT0+YUAZNuEQhQpU9sHIrQ+ywXZ3iZlI4+bnJ9KnSwjJyce+ORV0wQJGAFYBem7v70AZY0+RHyMPj7pB4r6R+EalPh7pSsMEeb/6OevnsXYViAML3JNfRXwux/wAIJpm05U+aR/39egCv8YAT8OdXA5OIv/RqV8ypA7ZByT6Yr6g+KwDeAdUBIA/dcn/rqlfPVtbxM+C65+v6UAVLK1YbOeSeCK6PTLYqeRnJwfb0p0FkQwCqSewFaVhbnfkcAfrQBeso2XaCBz2xWu5jtITJIVVR82W6CqoaCwtTdXjBVH3Qe/pXHa3rk2qxNHEp8snG1RyPegCj408ZrE8gtzt2jCv3P09K5HTtuqrNeXYd8t16AHtk1duPD637RzXO6RUyPKj7+5qnJLb6dJ9lvk8u15VFQ/ebtxQBu6fNLZ27XfmO5VguxORtFdfouv2+pKoiQJc5wVbow+teU6drotkniRdvykfvD1P0rNhvrp7hZo5pmj3biwbCjH0oA9nliuYLh3QeUjE/Iq4OfWs17GDV5hNqFmlxj5fNZcECuY0jxPLI7xXbedbj7oHLKMetdB4Y864maKzu98YORG3JX2IoA3ZvDUFxYhLQiF88My54p2l6ZcRxiNpEZYyQBnkVMmq3NtfuksamJRywGK2bNI5Jj5fKt82RQA1bd0aQGPjZjPXNYqpetdSRmEKmc78YyP8AGuu2lmCqR+XtVaaEswkB+YjFAHP6xG62XlxpmV1G30zXNzaVcpa7ZGU7mJY4HJPb8K7qa23OrEfMvOazNTeO3gYsOgyaAPN9U0pNziKNdx+Uh3+8PpWLe6Fp6wx/2heLbu5ICAHg+ntWzqMl3em6kiIi2sCpPUDFZuoaJc6tbQySuCUAzI33R9TQBFopsLadrWN5BjkELlnHpk1ux3kUNw0jtJDbgjO/BxXN2t3aaGQ1yjXlwjbR5X3R/wAC71geJb+8vLtmkWZYs5CKML+VAHbXviuERyDSLiJiMq8jrtyP9muakcXU0cxiIdxtMynIJrkY5ZyGQKFBHQjqalsb9rU5Sd1cfdC/dP1oA7TSorpbxVWVZ40bgA4YivSdD1iSBwlxv8s9iPmH0ryXw/rsXnFr2I/Kc+dCAD+Vei6beW9ykbwkXMJ/jzyv19KAO7ukR4jNbkGRhwVFctfqQ+5cjnmp9J1B7a78tstZOcEnqp9aua3a/J5iA7T97HY+tAHF3DbSSejH0FXvhSP+LxeFvlGA9xyP+vaWo54MHkD8Aav/AAxgZfi74ZYABRJcH3/49paAOo+K0W74kXbdR9mg4I/3qw44ty9Dn3rpPidHu+It0cdbaH+RrMgiKg5HzcdaAKTRkcDGGPHrWjZQNt2y5I/rUiwjdyB68irtvHyNp4oAREB54Az6VNFbsxDZIHb3qzFCCo+WluZRBGc43YwM9BQA1vLRdrYZuwqhfwrdJ5Uo/dnPy9qxL7WITOT5xBHZO341Fb+I4pnMMq7SOBITxn3oAxvE/hu2WIi0mmZVJZkQCuOkmXTgzK0mB90eleg6neT27CbamwDG7bkHNcZ4hvYLnastqrszEFouGx60AQab4inniiSS3L7jtPf6V1OjzMbpUQFNx5BGa5C3091nBsRvVRyhOCPSus0UTwpGbyJ03cLxkj60AddHF+5kQxDIPUelctFq8tnqk9ottJPExOPl6YPaut0RZEQ5Y47KetYN7a3KayxV2XD7gV9KAFsZbp7h5JrZow2T0x+FXbuH/Rd8qk5BwO5rTjgaVFkLsCVyQajvbVWjGc7eeKAPLdft/NmYHKxr2HGK4m/unKMh+RM4HrivTPE9pGsMrSySIzHACjOBXBXFvYWsplNq0wAxmV88/SgDn0Fxc4W2GB0Mh4rqdA0O3t4vNuVF1OedpHyj/GoNJkl1G6EUUaJGhzwmAB6Ve1TUbTTwPtN2vmDny0OSaANAhsDKrFGucbVAC1nXniWOItHZqWdeDMwwPwFc5qfiH7Y+0SMIwMqqj+dQ214jH/XoNw+668UAdx4X8R3cd2GW4JHBcPyDXpGmatbaigjmKpLjkdj9DXkejpFLE0pSJyTgGMjNblq0aMSkkkTjnD9KAO9vbMw7iPuevcVnyx/vAxGMfpU3hvVHuVEF5tO4YjfOcexrQu7UJ91Rjt7e1AGakQRSxUYPT3qvMN+c5zWjPGMBSPur2FVJYsjgY9h2oAx7iPk/MT745r6N+EBJ+HekZP8Az1H/AJFevny4QE8HGevFfQnwiAHw80kDOP3vX/rq9AEXxmJHw11jHX9z/wCjkr5hEkm8FTgjv619QfGNd3w31cDv5P8A6OSvmuCAjBAOR6GgDr/C120sYhnYMTwp7iuz0+zCjfJjC8nNcl4O09pLuN2BCqcniuz1mcWunNkZZ/uqO9AHBeNLiTU7sCd2gsI/lBPf3Hqar6IpW2B8hre3GcSyj5pO1VvEF/JbxOtxJHNcNyltjgem49vpWFb6hqdjbmed5HE+BucfJEvoAf6UATeLdbm0+VYLRWtbRhgEj5pG/oK5q5liksdzxSJfB8/vv+Wi44I+ld1YyadqEsSS7bgq3Msq5UHsADUPihrTU5YbZ7i2guEJMTbhh19Pb6GgDloLWPUoy1/GkZxhjGPvH1q+1nYadZyxfZGjEu0KxYnd789qdYzfZtKW8aASxQyGOY9Cvpge9ZV1rNzq11NBa24IALRAgnGOvfmgC7pbQWEzhIlZymHLDqfQVcspzGs1zDFJbc5Yx8HPqK57R9WmjvfLvljV5BgMVGMfjW3BqN1bwTQyQQSAdJgPlIoA9H8OSyXVqIdRIuTKMpJjBx7+9dHpVr5WBHkgZGSea5rwtqcJitgIzv24Yg5Art4NhHycFewoAUFg5GDkd6HQ5wB05walCEOT1zUmzjigCnKmY8gdawdY0xru1aP7obqwrpZULsCDwDVe4XMZGM0AeU69ZJpFq7G2mkiC/PtOc/j2FeearrV1qEhiX93arwIl+VQP6/jXvupoZLZkwF3DknmvBPHukrZX7XEUcjQO2CvPHvxQBnS3gjtFX7QAQeobkflSXs8clkB9v5H7z94pBPtWXHaSOUNnC8smf9Uwrb1vwxqtvptvd3cRKNg4HYdv8KAFicLHCYJILlJEyCxwQfTBqK40e2uTEVUWxztb5cfyqhFYzhkZ4pIwD+7AGcetdHpzSxXIDAxLDHvLP0c0AUItChstKkaC689nPQ8YpNKvL7SrhGtxJA+fmJ6Eelal7sjt0ZngkgL5PkHD5Pcjvit2wit/LSWKWG5jC8pty2en3T0/CgCz4a1JLx1e7KQ3LZAQn5ZP8D7V6Dbul3Yh1U4T93IhzwMV5Zf6VCebFgJT8xjZu/t6V2Pw41eSc3Fne5E64Cs3VuvBoAg18mxidFxvzwex96x/hNPK/wAbvCokYnL3PU/9Os1dh4104z2iSoMKuQw9K4/4VxhPjf4T9pLn/wBJZqAPVPiLFv8AiBdZPH2eHj86zY4uR69eDW54+QN45uieggi7+xrKDqm0AZJoAWJMuc4IHbFXbaM7goxt7iktl8wZUc1LdzrbrtTqM7jigBt5eRWYIJG/0ride1GWeUq8hRSeBnAxirl4Ly/Z5IMCMZJLN0rGuvsj2siTuHlHTzBgCgDnL5riOYNGFaBcEsTxVGe6jE7Euzqx55wBVfWdTtw22I+ZIONingVyd/qk0m9SnlEdCvJoA9CsNbeyh8rb9ptjncrcg59PSopL9XuM2iKFIOIsAMD/AFry9b64YjNxKVzk/MeKdNcupRS7hlO5TvORQB6rbXEM1wGeLysgA54robeCRr6EKcALuAzwR9K8u8OeKb43SwXeLqPGMnh1Hse/416LZ+I7WG6gR5d7kDGFwV+v/wBagD0LTkEkkOGB4+b1qC8sHluW/eJuPA46U7QZluXd9yscZHsK1DHunBPagCrbWjQxbGfJXjOM1Hcj5hGDz6mtN04B7mqV86W5Dtzx0oA8y8fvHCIYQCJCSSO9ebaxf6fZIUab7RcZyY15wfc11Xjqa/vdUlMORBtKkjhhn37V53daXFE25mbaCeNvP40AVpdfmeErCfJGc8dcVm3Vwso8z5mJ68GreVRiVjG0e2arSSgoUMoVeuKAK6+ZkeWjZ+lTIJw20xnkjkioReqjMwlc+g29RV6K8h+VpJGzjuOBQBbFwsaosRZFXv0yfWtaz165gZVLech/hk5GKxo7yJmXE0TZ6BuK0ILZWAaS2BQ87oz2/CgD0XwprFvPIvP2eXsrnKN7Z7fjXqKr9pgjkAG5lG4f1rwnTLBptptpsFjgo57V6/4RvWtRFZ3OdhG1S3agC06fOPUiqk8Y24YYOPSt/ULXB3xryDzjmse7ZE+8wBNAGPdoADkZOMgjvXvnwpGPAOlj/rr/AOjXrxKSEbcnHPIP+Fe4/C9QvgbTVHbzf/Rr0AQfF0A/DzVgf+mX/o1K+fdMtTNLGFBxmvof4qJ5ngLVE9fKH/kVK8e8NacBIvBz2z60AdT4fslt4iVGBgc+prO8X30scCx2WDeNwgPO38PWt64f7LZkoCX6KB3NcXf+bFI1wxVpecyk4EY78+tAHB3Wnvb3Hn3DNJcg5MIbO4nu1Z2ta/btDJDqa75VG2KKDG1f96pvEmqC681tKlKCTIlmHWU+3oK8/uV+xynOWc87SeSf60AaC6lftIqAGG3BGFjPT3+tLfTOpDSK0SrySwxuFPs4Jrm3aZzHAB837xgCMeg71d1SzEypdFftKgfMHOe3pQBLo+qG1t7q3nVriGYAlG5/HNS2bT2FzayJbMjFsE7gMoeh9K54+X5DGSQIjMcAnG32ro9I1DTZAsM2ob7dk2MhQkhu2DQB1t/4VtdUaFluUWTGS24HH0/GpLTRt6NYOryRsgUYbqT3qjp6NZ2txdyLcSwwMDiNfvDPXrziuy06W11O2nIkaMyKro2Np6ZGaAG+ENBNnO1sfN2qOMnOw16FZ2vkIVJJz3rmfDMwMqgyI0mMdeSK7OMHFAEQzu6Din4IHToaeAB9DQQD15oAiccdKrtFkk5Oepq6eRjioXUbcGgDJvIlYElQfb1rz34kW/n6bIkSvuAyFjOB616PeSeWCFUk4ryn4wyas1lElikphkwpMfQH3xQB5z4bjjgvEmvpQiKSPmIzmvQ11NNU0yERGMwDKMzOMk+1co/hCeOCxllAczgbkKYI9fxrZksLvT4biFbZLaJUCp/E2O5PvQBoWfh/y5BuZpt4Aj2MAw9uak8TRtbQxpBppnaQ7HL84H+RWBeMbGa2nW/eSZAqJE7cI3rV3UJdWRbVfP8AOMsZkUZ3EsKALdp4Ug1WSRLq3+zyKuVaI9ceorFuNFmtbmMNgcEJIp27cdK2/DXiubT4bhdXt3lJTG9BgbvTNZ1zKuuRiRHuFl3/ACq3BXnp7igDJi1yM3It7nZHJnBnXo3+96fWu10m2ZijFRFcKQwkH8Q/r9awr3wpCGT7eu26HPAxn610+kT3VjCLfUFhXTwAkTDqv0oA7CdRe2YEi7TInI964XwDaGD41eFiQOJbjp2/0aYV3tgC9muCGwfkYc5FZvh2wVPi14fuAuMSzn65gk/xoA3/AIgADxjctnH7mP8AkawolaRhkHBrf+IPPi+dQOTFH29jVCzhLbePpQBbiHkQEgZIGBkd6wNQuXjfzGBdieFHauiuQEj+ZgoAyWNeYePtauI5Y7ayDJCfvlPvMT6+1AGt4p1yz062glhkE8pHMMbYH4n+lee6xq0OsQiVZClyesOcAc+nrWXNHNHORfSlIw25Yxy2f6VS1OeK1uCREsCMv3icsaAK1xFPIDIUVGAIJBwWHr9azMQiFpUV2kTG5c0h1oLJ+7Td6g9GFUZNTl3yiILH5nDAr1oA0LX7P5bs8RXuB1q1NIXXzRbruXAfK5+lcwZpU3MZW9MZxTnvbh8P50gb03UAdnooBvo53iEZTkMqgZzxXomjQ6bfzpIYszAbVZ+p49K8UtdRu1AKztsyM9+ld14c1K9muLOcMAFkCkqOvNAHuHhu1W3WRkJVSMY7VtJEPM+9355qLSdr2cLjady56d6uhQTkfXNAEc6jaASSelZWsW8su5YU3Pjg1uyRnqM0x4/lBI5oA8R8UeHdVjDyRGMgkuVL815RrtxcW1wYp0cSDu3C/hX1VqmmrMNxAJ9DXmfjrwfBfW+6RSwVTgg/dNAHz1eXE8pPzHGOQhqGG3kfdhG9QK1rm1uLeeSFQyvGxUgd60NJFrHcMbh1RQp3Ac0Ac5HauNu4qC38NSeUWJRihPt/D9amubiCS6YxF2TJAOKfDNDG5znCjBBA+Y+lABHYSEqy7SO3vVywjvbeZGjEokP9wnn8qba3tu8hEsb57bT0roNMFu22SGfMn3fn4INAG74c1PyrgLqUSyP/AHl4Zf6E/WvS9Kkt540MUi3Ea8kqeVPpivNRDHEv+lxsecb8YP51v+H4pop0l0yVtoP3Sef/AK9AHsjfPbI+c7k5PviuM1QMRk9BnNdbpd0t3aYA2uvDJWHrVpsL9SGO4fSgDL0i5EsbW0p+ZRlfcele+fDddvgvThjGPM/9GNXzZNIbO7jnQ8qcnPpX0t8OyG8G6ay/dYOw/F2oAh+J5x4H1HHXMX/o1K8/0GEKqkYzjPSvQPidz4I1DnHzQ/8Ao1K4zRIyLcMRyeBQA/VGEaIDtUBdzMei+teN+LPFP2tJbO1gP9n7jk9C7ep9vavSfHRnudPNtabi+cuF7j0rzddOhimLrh5m4JYZVfp60AchJDJdW6r5fkQkZ4yOfSoY7a3W0ZYxhlO5pn5OPQelT+JL1LC6aPzBLLn7q9Afc1x9/qMsxKySYUnoKALF9NELr92zzEDAweKSTVL97cRLcbEJwFBxgVnI0hcC357Zq6miXFwPMzsAHJoAZaRMJdkiCQuSCRWlp+l3STkiImNG3lgucVf0vRl8xRCGaTIyV5rudMtr8xyXSo22BctG4AVv8aAG6dPcCACNChmG7anRvUEf0rptCS4u7GASJ5MsZIPy4GKwl1JbuJAiqJ4JA4RMAgHqDXoNlsexjkbA3/N8xzigDV0GygSMNgbxznFdDFuwc8iqul24jhOcfMOcCr8Yx2I+tADTgn6UYyeeTT9vPFKAPQce1AETLyDnionT5ckk+wqw4B7Z9feoXOAc5AoAzbqFnbrXO+ILZPKUzHcFcFR6Gutk2kHJA+tcX42urOxiiku7kxljgADmgCK7vYVhVjzxlGbswrA1HUrXXZIrHY6IrDzyQQXA5/IcVW1jxTYCzs7SBJJ5Gf5c8E4HX3qwdSvorWSQ6VZRyxqEbzGIJU8nPrQBxN5odjP4jktZpHjQy7kO7IY9v/1Vc1CO7+1wRzPtlgJWIhOQv4VsJr+nXUwWfT4IpmRtkiZyp9a6HTtKP2G3lnLy8FyH4Yg0AcVNZ3UiJZNJJIqsZC6cbfUGkix9n3xwvDOJMRys2TtHf0FdJLLa3N5EyywwyjKeUj5bJHU1DcWVpZxIbxnlZnLbpFxx9fSgCZ9eFz5Z1DyXlTCLcxkHHuR3qaWNJFW3kYywEZ8xTnP0rA1nR4bw/a7W4DKg4jU7TWn4Ki/s+OQSv9pjlcFkc58v0x70Adt4ZX7NZpas5cYJjc962NCgA8eaFIOfml9v+WT1StdpkjdAvljG0jtW1oSf8VfpRP8ADLIfziegCp46yfHFz1wIIv5GlsIwFz+XtR41Yf8ACd3ikceRFn8jU8KhYAOg24oAwtelkuGEUOQP0Hua4zVPKsI5bmV/KVfvTyDOfZRXaa5dW2nWrTXHJI+WMdWP+FeF+MdYvL65b7UT5Y4jjUfKg9AKAMvX9Zaadm01PKJPMr8s4+nQVyk8rySb5nLN0JPNXmt5XUs/7pc/x9fypbdLeGR2EQcsMBn5/SgDBZJTvMCMQD2HFSJG0qAySIHzgqetWbi5SKQh3Gw9EX0qnLcRNtKRYPqxoAsRpEvyzLlZB1HUGpIrGJmccluig96baXboERRGGBysm3pW7J589kZ55gkySBVkUAZOKAI9IsIrsmMxqhGeT/F+Fd/4MsYYrqOKJQW3AMM5Bz3rz2G/voZkYFXZgf4Ac16F8MtRuL3XWMsETJ8pO0YwRQB7jaW5t4Y1ycY6HvV1Uw3WnLiUqyjAA6YqYKM9DQAzZkcE0jpnvjP51YAyAQMjPSkkXOP738qAM6eMY5z9a53XxAlpJ5g3HGQvauouF4I9RXJeM7G6uNHlWz4lHr3FAHzB46n+0eIbkodiA42IMD/69YsAbepQ4X7rfT3rr7rwpqEq3c91H+88zAZuOKSLwu9pbRGXy0aTLYY9VoA4SeMIz7Mkg8nGalgx5WySM5H8WM11N9ZWzwTGOJizNtXHTjvVC1tmSJjGpPHINAGbb+XCTkMcnjC81qi5+zRpFGE3E5HPT60rqQUVTh2GCSOg9qQWx3qLhA+ccgZNAFjTdTvbMhRIXQnmNxuX8q9P8C39rd3AEo+zSoOxwjHsB7/WvPdOtUkm2gtDxjJ5/HFdbpNlLaIpk2vFngqeT+H9aAPYrMsLhGVSjggnP8Q75qzrkIa2Y4zsOQPr/kVyfhTxCjziyuFLRY+SUnJU/wCFd3qETPZOSAWCYPvxwaAPLtddY0DEYGeSR0r6G+EEwuPh1o8gORiVQc56SuP6V8y+L7rNykIPGSzDHYV9F/AP/kk2hf8Abf8A9KJKANj4mkjwVf4GTvgAHv5yVykGIbUYHKqAPrXYfEJPM8J3S4z+8gPPtMhrjoT5ltvHXP60AUJ4iVK43O2c15D8RNY+yTPbaR94fLLMB+e3/GvSvF1+1lYvBAC0rD5z3APYV5FqWk3V0zXF0jIhP3APmx9KAPPJwZWkYZaXOAPSo4rJGcK8gLnjGMgV2R8MXk8bSQQmKHOQ7HC4rDmeKy+S1g82UNguwyM0AVLhTpZ8shWfqGxgAe1KussQVjBf5SMZwKq3kshkIvG3OQcc8D6Vb8N2MTTqbhSQ+SuD1oAtaXeX04OybZEvUJ8uPx61t2s7uYoIrttzZbaSSGPpTbvSJbe0KxQvsdgitjAJPb61p+EvDV+b4STRND2UMuc9qANPQ9FmS48+0tQt0y5mYnC4z29K9H00AadFHMqtz26H6Vq+GtDjtNMaGTEjsxLH2PQVbj0mKBgIzmEHoxoA1bBTHaxbc42jr1q+hOOait1AiXb90DipwvJ9R6UAJj0pD1xipCoH86bjIGKAGMOMDIqCUEr8vSrLdqa6g+vtQBmyo2NxyPT3ryX4v2kkslsXRijAgY4AYc17Q0YI5rG1yzt7m0kW4VGODjdQB4V4XgnvbyD7UqQw20ZBZhjC+1dtAnmBBO7XMONq89QevNMuBYwZW+tnj2sAJV+6QO1bjaxZS2KXFi9urg4CHjFAHNTeH7a01W3eK38sSOCZGGSo/wAK1pvEMSSMsUheWOP5YlXBK5rZkvtsYeJd5OAwZawZorWbUbiVIkEqr/rE7geooAwJU01r46gkEsM8a+btbgbvT3qlrOueZeQpqrrLAygrGnVc+prtNU0u21WyjS3QxADkkZP41yN5pNlA5jgRpbj1+8F9KAJ7Ox07UI2bTmdAhG5Ax/rXRWVglnHvDBgwzt28H25rntG02S0mt7i7E+VOWVVKqT6e9dPdXtvLF5qBgpGDH0P5elAGjol/CT5CrtDHv2auv0JP+Ko0xjjIZ/8A0W1cNbrFcmOaADeMHJ7iu48MSebrmlN33OD/AN8NQBm+MDv+IV6mScQQ8fgasyusUO5sYHb1rN8TOR8VdWJJ2LaQcZ6HBqxqGWIXPyKvzY60Acd4ptJ9Tl85GIRQdxI7e1ef6nZCIEWkeXUHdNJ2+p6CvUdfuILKzaW6m8uPoig8v7D/ABrxfxfrMt68kcBEFt/zzHT8fegDm9WnghdwWM82eq9K56S5keZQcrg+tWGjlkZmVcRjqxOBVdoAZDn5h1IBwKAIZrcsxHVgeQOaiSxndeFwO2euavW6yQHMZCK3v2qR9QVGUswPptHNAFGG3eNNszbepHHpWxYw3DrCvmBoyNp3DP506HUI5JNwhQiNcnzDnP4VbtdR1AK32e3g2j5sbcgUAatnpT6LfWzsY3DEgdSv09+tex/D/QrW2tnlggEZlfIK5ryKx1i4msi72kDAHcflzhvavbPhfdvN4XilmXnzCBigDt7eEoqjBPNWGVt3UYJ6023ZJMkH5iKnx6cUANUY4OTQ4yvIp54pCOPp0oApypx0qjdYCHd39a05G+U1m3YVlJZuQM0AeOeJRCz3aSLJK5kJUJwAM15xr9xfvua3iMUI/dMVGcjt9K9FudagOsXEKos1wXLIq9/8iuSa6vL0XkjqLe35+VcAnsAAaAPPbgzCN0m3Bgc5Oaotv80FHIY8jnGa6CUy3EhTzgWJ+bPH6Ui6X5sJkjYmTpgL0/GgDJhLouBIDnB3NkYNXLa6OAhkJPHJ5qZ7ML8pYAgd+oNRxWcgGQgYZ+8D39KANyxv4oXVnVJO/TBNdXp+piV1e1UHGOCPmUe/tXBBoxCVMZUjg7u341asmKSRtaTtuB6jigD2HSLGO7niurcFZHJ3gHqM132iXq3VlJE7ZkgPP+7/APWrgvAt/BKogIC3KD5gTwxPPy1s2F8lvr6ITtF3mFx6Ejg0AcN4wgaLWbwn/VqMIfVT0NfSHwGGPhPoX/bf/wBHyV4Z43tcxwuflKho2OOhX/8AXXuvwKwPhXogHT9//wCj5KAN7x1/yK93/vRf+jFri4CI7U7uwyPrXb+Nl3+Grpc4y0X/AKMWuCv2xZZBx844HegDn7xPKZbq4Zi8hJCYGB71mX+owaUIp7xW+dt/l4BZgPX0FS+LtWttEt4Lq4xLdSEiGIngf7R9q8+/toahqTi5ie5lP3SM4PqBQB22p6Jd67bPc6bceRbTx5jhPAB/CvLT4O1g3siQ2bBEfDuzYX8K9j8O299Z2i5kdmPKxZ+RR6ZrcNu9y4aXDdPlYZoA81tfh9p9xpyT3hkklL8qqbcDv/KpxpunRN/ZsdjIEyBG0agH3JNepyCG1i3yR4x049azpUtZ38y3tQbnpzx19aAKOl6RZnSYbcxh4lk3bio4NXYtKtxqjThmIONqgcLjvUwtnVkeZ1YRjcI1PAqbzUS4GEEbEZwDQBPDLFCX82by9vJGOoqBdTikikaJXlCk8jFVddd5o0hljzHuxgen1p9vYRwxJFBAwRsHcTz+PrQB0do2+FW2lQRnmrQPftVO2DLGoPQcCranj+tAC/xY/CkIx9B6UAgeuaU9cjjFADT0GOgpp605jwTk0xgV+lADWPt1rNuwZFkUhRkHlhmtE9MnrVKT7744oA4/VLKee0ntmZEjfIJKZ2+hFcfq+ky6Xp8EkUiNHEQGBQAv3OK9QubcSK7ZwxrndW06G8tpFZj5SjkA8mgDhLzxNfmGKKIxywMvIKjeD6nFb+g6nbyWJjYbbkjdvyM7e4rlNU0W70tZZbYo8fDOpznn3+naucvbm9Gpwm0HlrCw3Er972oA9Y0+9W5nuLe3MoaQ8SKPlYY96kZhog89GR4X6zEZwQOlZmiNINNt7iIfZ4JAzGSTqWPtUWq6kbfT2tb/AGSAkFOc7mJ6/TFAGgl1JfXJuy7m0T7o3YDcelc9NqU1veRzwQoMP1cZx7c1LeakwihTTvuKAcBe9Vtetmv7O3t4JNlxneuT83PY+1AHcaBdpe2i3kagE/IynqpHauu8HnHiKxQn+NmH08tq808N3slhdQ2d2qoJMK5A43+teieE2P8Awl+mp0w0mff921AFfxYg/wCFj6o3GWt7cfoaW9mjto5JZztjiTLHPU9hUnioD/hZF5kZH2eJj+ANch8SLiT7XYWIcx27/vJ39M8L/WgDh/FOp3mrXryAbkXhR2jH9K4q+iRctJIJpM44+79Peun1+7URmGEi3tYBh3Y9T7nua861PWQs22wZsDPzt1/AdqAE1KQMP3/ydgin+nasia7VFxCgZ+uTUcszOd0rksO1QYdzvRenpQAyWV5DhmyO4FRrjnpUy2rsck4z+tTC3jCju3egCaB0dAo+761rWDtAd0ZOwnuetVLS3RkCYJbrW3bWqyRYUKCDgFjwaANrwxp80E3moymCUZIJyOa+gfBNgLfw9bIyqrHLHb0FeeeFdOutMsYxdRRhJAGUnkAZ5r1XQJhLYKVkVsEj5aANOGPZ2H1qx601OeDyalGMEUAMP5j60EYWnDkdQKUjjOc0AVZV3L0zWddW3mwumduUIzWvJjHOARzVC5mSIHJJHPIGaAPmq932muSiC0L3KOVMjdq6WTTpbzR4nkeIyyDbuZACPqao/EeyuzqssljNIBNl2RV249jiuLttbuoJfsi+YjbNsm5s4bsRQBU8R2Tabqiu80ezO0+XziqJ1ZoZXhhum8vk/KvU1ovMuozvaXiZ5BEmMZxWDOPJuJFQALzt46UAP86O4nwDhs5zzzTobl7dwsUuQDyTzVVRHsZmPQbgAOahRDcRh4jgDqtAGqsyMSCSRuy5B4arIgUMPs7MvHAHIrIiuCkbDCoD0JGc1qaVdMXLFxnoFPQigDasLyfTSA26Jxkhgep9a6zwzrC61qNrfiZzJauqTRAYPPRsehrj7+6Wa0aNnXLdOOc/Wj4bzvpfjizt5j+5vGFu/owP3T+BxQB7L45hDWkx4+WXP5ivYfgaMfC3RRjHM/8A6PkryXx5Gxsd3QNtUjtx3r1z4JDb8MdGGMYM/wD6PkoA3/GXHhy6PvH/AOjFrz3UZ4bbTjLdMBEmWb3r0HxmM+G7rPTMf/oxa8e8fI17p0FjE21s+ax7cetAHKahbx+LdU2RghgNhJ+6grodP8E2ek26ok371TkuwyDS+HdNgtvKwjIFGcn+M9ya0da1Bp4/KttqpghnJ6fSgB9hcQ2jRwTTI2GxkmtS9vFtm5C/NwrEd64vVQgSDZJboyAOpYd+3Ipl5qlxPoYkknUS5+U47g9vWgDtlkM7ol0QvGc44NVL2eeOeVtOaF2TqrDBP/1qwdO1R28sX6urlSV461t2sTLKt5E++3K8r6/hQBHbaddvE09ySszEZCnP5VtQxQwhUuFZsHKlutJDMbtFBbyRjIXGKgu9Vitp/IkEbM3Ayck0AX1nZ7lo0C7MAkMO1W41UHeSAD2rFMqBnlkSTfjCBeRirljOs6leN64J9qANeNVU8ZINSEY4zxjpiooiNoIOfept2QSOT6UAA6cn3oIyTg8UfUketBI6dMUANx/dx60hAzTuP8eKYevHPvQAh9+lQlUBzgE1IW49aZvB6AUAMePchHBz7VQuNNt5G+bKnvjvWiWIU4AA9ajO1cn+KgDnpdKgNpNbkERsSxPU5rynU4rjTrm5ure3iWLzPlhlOSxHfOOvBr2m5bEg7KOCcV574409LqSPY42lix7AHtQBxR168S8V5Y99vIv3EJAU+gXtTb/Xre6nRzBF8gwkX3ix/wBr3pCklyslveSxxvCSfkUZPcc066k0vULoTWcCG4jzIQFwrNgZBoAZe635RhubUbI41UeWD1b3rXj1GwudRhuozuuMDK7uh/wrm9Zv0h1eRZbIPbvEF+UnAyOefrXNxyjTb1PJ3ZRhgH09KAPVdTQs32oBVK43D2PRq9K+Hk32zXNFuyQWdHzgd9jCvJtM1OPVLZZYiTEBskTOdpx0PtXovwUmL3drDICHgu5Yxn08tjQBt+KEB+ImpNzuNtAP0Ncf8VYR9iW5mYRW0CAyN/Ie9dp4iUn4iaiewgg/ka8m/aB1F/s9rZRfPAhzKAerdvyoA8l8V6zJrU/yAQ2icxxjv7n1NcyIS5wBj3NdJY6fazw+Zcu8Z/hQDJP19Ks/2fa4L3L7YADsYDG09uKAOTjtAZDnDH17VPFDlSWIABxVy7RFkEcZ4PRjxzVWaFkPlhy2DhjjjNACTiNfuvuAHIFJZIZZPKjh8xmzjHWkIjSMHdlsdhwat2N5HAQQWWQEYwMYHrQAkVrdLbG4ad4QSVCbSDitbRrAajqdraRXLSLM+0nnj1q3cR32uWVrBakzpGSpGMYr0z4eeHrKwtkF3b/NyN5GDv8A8KAOs0vQEttIiUyjEceBv54re8MlIrMwROCQc49BXN2s17NHcrdSJDHuCwljgbfX61s+GIorSSWQXAuJJG5btQB10KsDluKmJ4x3zxUUZLZ9e1S9+OlACjn/AOtRt+v50q460tAELKM8Dnp0rPvlyhGDk+lajdKqXC5BGP0oA898WaA1zaTtAMSuuM9x9K8fk8O3RaaaOBjcR5V92OfQ/lX0hcKXVhtGcZ5FYstku9iiRHeMdMEUAfMjJ9m1C6hnjlDqAwQ/nxWfdg3Erv5TBQeAOSK9M8f6CzXc11Esa3KYGXkGD9K4Y2/2aIG5CRSkk7QeQB3oA5tlwFEcOcHJz6VEW/eeWqFYx1GOT+NdJfG3SNJYmjYsM7cZCmmxQQ3oZkCJLsyV6A0AYCRxsCrrtHTJpVKpkxyYx8oBFW57aJmkHzZXpmqEkDRwuxw5P8XpQBMb5yyxy7tnXce1dbodubmWC4hyZ7MidGXvjtXnzyEqiMAAowCO/vXZ/DK9I1UadK5H2k4ibP8AH2X8aAPoXxYyzadCyjgkOufRhmvV/g4Nvw50oYxgz8f9t5K8n8Uwk6WFUYVYUYV6t8GSx+G2kbyS2Zsk9f8AXSUAbHjg48L3h94//Ri15XqDubhlXG4+o7elereNF3eG7sE8Zj/9GLXlM8i7J5nPOSAKAMTxD4rs9GgW38t5bgjGU4Arltb8RRT2SxWXInxG/wDeX1PtXK+N2e61CNYZC3kMSqqcnFRwRWcKi4llDMycRg4APuaAJp31i5M1nabmGQwlJ5VR6V0OiIRoM/2yd2aMFkd+pPoK5PRNfurLUVhQqqyEgdyc0ajqd3DNOkRnBHCgITnPbFAHa22toJLS6uJCuwFBk4Htmtfw549idLhLraY1B2MeFYexrxhbu9lslt/sN2/Jfc0bf4VHYm48iYSW1w0KHrtIwaAPcdL8ajUHmLotraDhZSc81Tj120s9SVSWmiBOZXPyDr+deeNiTTRBLMyMQGbaMYHpVrSbiyudLaOU7hFJ8rkEn8aAPSLTxVaxtNJDLuAOWUqcBT0xXU+Hp/MaRkPL8sM5rzCW0bUYLX7OkUOTuwOrDsTXX+A5ZbfUb1LmbepUYDeo7YoA9Kt2O1cDAqyMYxyeKpWb7uD19aug8Y9elAB169qPpxR260MRnp+VACEcc4pjYBPepCOmKjfv/nFAETkcYGKjHyknJA7/AFpxOTnrQy//AKqAGGQ85P04pu7PLEf1NLIoCjBOfpUbKcdcUAU75GaNgDgnuK4jxRYzG1dogS4wR7V3V0C3HOPaub1dJhHLEG4IJ44/GgDwC61WWHVLgScOwMZ4yVq/pd19mRZRtBPBU8Fh3qn40syPFMzAbTLg9Mc45xWctzJFMY7iTKLkqG6rQB6LLYWs9hczyt5ikYVXONpx1zXmetCWFgwOdvVgcmt9tbIs1tyzHzB87HrWTPbyJI5LCRWXgHnIoAseCdWa11dI5mxb3WInHbJ6H86+kfhfai01yzHO4ysrD1Iifn9a+W7a3eCXeo4HT/ZNfVvwwuvtx8P3bD95Kp8zHdxG4P8AKgDR8TFY/Hl6x6mGJj9AprxXxQEvElurjDlnZo1P1PJr1/xwf+Kx1M9NtmmSOo4NeFeKb9be1kuJiRk/Inr7UAcbcSxWoa5dsBmyi9STWFqOpz37iSc/IvRBwB+FVtQu5Lm6aWU9TwOw+lVwSx+UEkenFAE8YMjloyAAA2D2pgSeeVlXOTz1qUIzAGR/LA4wO/1q9YM8V0qLyScbSPve2KAKkdhIy8MqqO4yc+1dJoumW6L5sqhmjiLNu5zx09qfNPJ5nlxwpaWO3CgdOepyetT2MGnr5MUt/KbRsGVgm3J7AZoAj0i4kupUitzsUMASDt2j8K9ntyul6Wk164dBg/eyWJryny4pr02ujRhrbdhpWIyPriuwt1gj0s213JcXFx5m9VGdikdqALepXtvql0YNL82TO0MkxK7TnHQfyrt/D8Bs0S3h2sqAZ+Xoa8r8Prc2vi3ZdxuW3GQso6Z6V69o9uYmLSszStyWbj8KAOlsi/8AHgfSrhGOlU7Ffl6k5q6aAADrRxjg5oAxQcigBrDJOOtU5+T94irjZxxVObnI6jpQBk3yMx3HgdOtUby1jhHmIS24YJPGK25UJXj8hUU8O+MBl6GgDzDx5oCXw2KwVnBYZ714Vq0RszJFJ/rEBXnr14r6o1aya5tj8pEq/dNeUeP9GZVa6bT2dR/y0Azg+lAHjsKyMoVu+CFzzV2KaW1lMewCRjznjAqnOXiuGaNmRiTweDS3shuYVZgfNXjOepFAGzq21rSGeJ8uuY5Bjv61hMMQbjllz096rfb5TG8YfanBPuaYs58kFGO1Sdw96AI5olmmOMfhVzTvMtr6CRG2SROsisPUHNQrIkzgljkVo2q+YFTHfr3FAH1De3Eeq+GLa/jHyzQh+DwMjJ/XNep/B8AfDvSgCCMzdP8Ars9eF/De6a78B3FrIQz2rtGuf7pAYfhnNe6fB47vh1pR95//AEdJQBs+MOPDt19U/wDQ1r59utfz4mvLAwloo2MYIPfufzr6C8YEL4du2PRdh/J1r5FimnGui4UF7m6n+6RnPzcCgCS78P3Euv3FvapJtZsliOeRW7ZfC4X0gn1KSS2tM/6pW+Y/4CvStB0z7NEZLmNRPKd7kDue1bBiEhBxgUActo/hTRNLMZs9Oi8xDxM43Nn6muhSAORIIo1fnnAq9FbgdBgfSrCQjAyKAM+O3Oegzkn7tW4LZUUiRI3DdioIq2seCcUoGOKAOf1XwroWpeb9u0u3kEn3mQbD+lYVz8ONKNk9rYN9nRuQHAYD6V3ZUk5/yaaU59h+NAHlF94Q1SznieD/AEuKIcLEwTkeufwq1oFnfRag0k9jLFj5TnnOTXprR56DHHpUQh6kjOaAGafkg5Bz05rQAOB61HCuxT3P0qX14oAQ9++KMCikJ574oAMdKZJnGRmnHGe9Ml+7gGgCBn2nIAqIStyc9T0pXYMMZzmoiTtAzn60AP8AM54UCkZwM5xUIDFuKHSQr8qnHrxQAkrERgkgis26YMuXAc4wAasPbXDA8ADsM1CmnSAEztkDoBQB4Z8VrTyNUjeMAL0Le/WvPdSlYTRZX5WHDE9TXvfxE8K2uoQRyzXTQ4bDhVzu54rkNd8CG/0+2g0543MYJXaeR9c8mgDy5JXbf8wLnoSelWbS6OI45sYJxn0pdW8L65o0ha9sLjyRz5qruH44qBPLnQJGf3wbIGO1AHfaBYQTuBJtCEcj19DXtXwcEsV9aWsxGYLmTGP7pib/AArwTw3rCL5dvtCnsScEH0r3n4SkLr2ngFvmLZz/ANc3IoA1fH4LeK9TUcb4IUz6DBya+VfGWo/btVmSNi8UblYvcev419H/ABwvmsL3XJkbDi1hRDnoWyP5Zr5faPYzMy/M3IJPQUAU/sw5aXrx8vWnRJtlCscg9Oaslx5T5AUgcHHJFUJblcBYEJf1OKAOi0SLT5754ru4EAIypIzkioTMtpczS211C0hOyNQvzfUZ6VzKTyrjz2GRyBnpUkMiW7bgmW4xnsaANNzNJOEuZ2Rf+eZPWup8LWU2oXCRPbW6aaGw8s8gVvwri45pJDmbBOcqD1FWYA93nzGO3ooY4GaAO9vp9J0y6e0syYroH/XRtuVh+FdBo+m6pJG7O0S284DR5bJX3IrzuxFvZJHJdSRwnouP4vet3TfF4S5Szt0ZwMlmwFDDHc0AejS32m2GrxGWbfcHbHvVAAvue9d1aTJdIk4BwxxkcV84X2sXEt1JJF5e/I+YruYD8a9c+F+tzajo+J51eRWyRxkEUAeqWYPljnmrXOPX3rN02XeuSQfpWiM4PrQA8fSk/pQPqfyooARvYEVUYYJ44q0/pVJ2yx5oAQkD/OaJCCjEnHemHoACaY3+tPTB4NAFa4ZQDlsZ4Ga53xAm+HYCrRr1U9+OtbtyvytnOM9BXPeILVrnT3IO0jqc4NAHzj4u06az1qRGfeX+YE9zXPoSA2zIYHtXT/ENZbaaCViW8uTbyc9a5TzEkDAnAyCPY0AMvLUKizQYKnlgeuaoKVBGcgH8jWtG/wArF9ocAgA9CKy7qMq21ufm/OgCP7nKNzyDWjY3u2VPMx1FZ8iMGyMhTTY+oPHtQB9H/CuQHQbsLkljuAz2Havor4Tx+V4C05Oflefr/wBd5K+TvgnrAKPplww348xM/wAS9xX1x8NE8vwXYL6NN/6NegC342G7wvfAdwo/8fWvHdL8OWsN+L6SMMyHKA84NeyeMv8AkXLv/gH/AKGtcDbR7mBzwOoAoAmg3SAyN0bkCrkShhyKZGBkYxjpjFW1GMYFADkGOe9SAdMD8Kb9aeuNvGPegBAvH1FLjGf8KcMdyKQ9cj6UAIBgZH8qUjJ6Z9KPX1ozz60AJt45pAv15708df8A61H8qAExkigjoB70AYoOM59OtADR35z70nJHoacRz70hHIwaAEHXFRy5wfSnkfnTGGePWgCi4ZpMBT+AqZIMEGQ59hVjHHH50xlLZBoAjZ0iBwOlUZ70KpySBVt7bd0Jx7VVk05G67h60AZ9xqrIP4ansb4XMR/vgYK5z+NEmhI45c0yz0MWsxdZCRQBzHj6a6Fj5emxq0rNuDMu7gdfpXHaPq89vFuvo0Mi5+ZFxg16ZrelSyRFo3wR0rh9W0PaxcDl/fuBQBip4v1GKd7e6kjmjU4BdRyPeq994f0fxRua0QadrHUPGflf8Kw/E1vNbCOSWBl3AYYd/pT9JnZrKMxsd6tkHuPxoA5DUtOvNH1J7S8UxXCnKyAZWQA9Qa+jvgfdG+k0S9CYDyywOeOWWJj/AFrlIdMh8W6I5u4w92gID45I/vD3rS+BTPo/je10K5yWZpZoz0BIjfJ/EH9KANP4+W4utS1KHttgkbHcKDXzl4ikWOUZwABk4r6Z+MJUeJ9Q8wgR+REXOO2DXyrr0on1GcZzGGIU+o9aAMu5uXkLbTg4xVaJpGcEuQ2eCadNmKQqw6cAdTSNHuAeQ454FAF6Pyxtec7ueOPvVOQqO0rBcuMgYrPSQKg3jPoak+0bz8x6DjNADDcbn+YcA1dm1AzW8UYCRKh4I6/jVKRR5e9wdzHgYqud24L1XpQBfhZZJd06tIOcDPOK17KVBJuI+aX92pzzWFGjs4xnOPyrcgihjkDzsDHGoAAPJPtQBOJAtzL5bMR/EM11/wAPtUNhqTRBmVLkhQPU1xc2I3aSL7pPNTG7nitLOW2fbLHIWHbBBoA+wdIhSC1hQnL4yxNalYPhm8F9othdMvzyQI7D3IGa3VI56CgB/wCNBz7flSew4peeaAGnpgjpxVKZQD1z+FXG71SkyRyOaAINwHzHHFI3XK8CnP0xjrUbjHagCKT7pDdOtY+oAmIx9mOCa1Sww4IJJ9KyNQbIxjDZyKAPCviZYK1nOCD5itu/KvLdr+TuQfKp6+or2X4pSgxz8YJGd3qDXjUjAJtHHFACXEhjdGXkMOarySmU5fDEcDio3YlcHnBOKiLHJ5x3oAmZiduck4xQELEAYJJqLOAuDzmpIm+YPxQB0XhnVX0rWbO9jPNvIpYeq55H4iv0B+HGP+EN08qcoTKVPqDK+P0r864wGyRwT+tfoF8FJzc/C3w/KzbiYWGfo7D+lAG94xIXw5dk9Bs/9DWvP9Pc7TnPXtXeeODjwvefWP8A9GLXA2GcEkfjQBqQKEyAeSc1ZU9Ofbiq0THjrjNToc4PNAEymlUjvUanPQ0/POB1oAf8uaUnOaaDilzxwaAF4wecZoJwOOtJnnJpTnHt2xQAuR1x+NJnk5zmgkepIpvOD/OgBc4P+c0BhluaMdc9PzpvI6CgBcgDg+3NGfWk96TPJ5oACO3SkB9xS5waY3TIGBQAo+8B6UA9OtH90E9KMnnnPrQAfTmmj1ByKceevekzjGPr9aAG8+3Wmso7dDSn2PWjuBQBDJGCpyfY1i3umxlixUEc8EcVvN0znviq8wBB4yPegDzLxJoP9tNLbMoQKcRM2ePeo7HwWYbZI4iInQfMSuQRXbXS+VMXAGSehpRcOcbgAD1INAGN4Z01tOldjtAYYGO1W/D+kqnxV0DUIxgAzK3tmCQVPt8mcuCTu6itLwyd3i/SCSCd8h+h8p6AOJ/aMuHgv9WWLhpYIIx+IJP8q+ZLhVfbs4wcDnrX0X+0vI48QXaI3ASB2/75NfOcXDEyD/d+lAFWeFd7OTliew6VTZ9r4Jq7esRnGMGqfltOdka5agCN5d5AAojkCsODure03wxKwR58kt91QOtekeGPh55sKSTRDLdyO1AHkizM3zFW2r/s0+2j81yUUkqQT7V9MaZ4It02ZhU44HHGK238D6NPZrFNYR726sBg/jigD5TEwRSqffJ5OK1LeHzbdXk4AYDP4V9Jr8LPDzxlTZque/enD4WeGkgWMRXXXnbJjNAHzrAojRlC9W6HnitOztI5VRZcE7/uoCSR7V73B8MfDkAIFm8nqZJSc/0rd03wvo2nxAWthDFg5yF5/OgBfB0LpoViHR49qAbWGOK6ZR/nNNQAIqgAAccU7jGe1ADh1JHU9KXIzx1puSOaOcdKAEfn2qjdZVdw5GautyOOvTmqM6nymAGcjpmgDPW7O7OBj0o+1Ak5BqqLa4wPlP5002V+wby0TPYs1AD5Z4wrMXI+tZ97cqInKyAkDJ71M+iajLw0kMaY55zVWXw2phkS51AgnoEUCgDxb4u30YtBA64kncEccjHevJp02y7Q2MD+I1734++H9je6lazyapLHAq7SZGH14rlb74Z2N/Jv0bWVmwBujYc59PagDyCUlSQwxmm569OPWu21r4e6tZzsItkirwR3FctdaZd2eRPC4APpxQBRHJPGcninL1I/D8KOMY/nzTkBAPzDAxQBbsZMXCKRxmvv74BEN8I/D5XoUmP/AJGkr8/IxsYMG5HrX33+zo274M+HD/sz/wDo+SgDqPHvHhS++sf/AKMWuBsm+XZzXfeP/wDkUr71zH/6MWvN7OcYGeM8YoA20YE9/wAatI2R9KoQkcdqtRn5hz+FAFoH5SQMU4Hiogef1p4Y0ASA/N3p1Qg84FOUgDFAD89OCRSioYnDKCCTnjJGKeG/nQA7ofSjP5dcU3OemcUueKAF6UrfrTDS5xkH0zQAfSkPakJCg0hbIPYAZoAUng7frSepzyabnkYpCeMnigB4xwKMjPWmAjpmgHnmgBxzn096QHJpueecUmec9unNADiPQUmeOOabu54Bz0pobngEcd6AHMecGoj0pznPc9KjY5PPQUAULlF34Gfx6VUMgjUA8AD8q0pUBLHqDxVC6RAnYDgmgCjPIX5Xg5q54Nlz4w0hG+8Gk/8ART1SbaOhI/Wk8IOR8QtEXdu3SS59v3MlAHE/tEuz+Pb6A/6preANj/dNfP11G0czIBkoSPrX0H8eFE/j/wAQLjLQ2tt+qn/Gvnu+mfzSE/1hO0gdzQBSSGW/uhb26FpM9B2969N8HeBLhlEtwqfKP4uaZ4E8NmwEcs6755QGbI+77V7poViqxQqFAwMnAoAxvD3hOCDDyIpb0I6V2Npp0UUYVVwF6AVftrdVUZGPwqwiKOnSgCCOHaAP6VOkQAGAB9akRQT9PapMcGgBgQd6RoxjP6Gpu3pikxQBAy8gUm3pnH41OAOfSmbMH39TQA+PGBnHpxTs/wD1qaD19j6Up6cGgBy00k5HPFJ70fjQAucDPaq8gyeOlTduOajbGMnsaAI1Ud6cTx9KQngE9c0E9+1AEUytICN2DWfNpbyE/OM9ua1M/iKSgDktY8JHVIjHNcKuCCpI6VyZ+FMsFz9ptNXMMy85RTz6d69YYDbzUJX1agDjX0eRrSNZyGuI1wzhcBq5bxB4VgvAX8kK2OR/er1SSIMcnPHt1rKvbQHJGPegD5h8W+BJrYSXOngkpktHj7w9q4QoVYqwKkHkHtX1vqWmq0m1l4GcZHevIfiB4MiS48+3UL5vPA4DdxQB5XGOmMmvvj9nDj4L+HM+lx/6USV8HyW8sExSRCCGweK+8f2cf+SMeHfpcf8ApRLQB1/jKyudR8N3lrZR+bcSbNq5Azh1J5PHQGuBs/Ceuxt+8svl95U/+Kr1iigDz6Pw9qgHNryP+mif41ZTQtRXA+z8f76/413FFAHGDRdQwP3GD0++v+NO/sbUOP3HT/bX/GuxooA4/wDsa/8A+eH/AI+v+NB0fUMf6jn/AH1/xrsKKAOObRtQP/LDn13r/jQNH1ALj7P+br/jXY0UAcgukahnmD/x9f8AGnf2Pff88eP99f8AGutooA5E6PfkYMH471/xoOkX+OIORyPnX/GuuooA486PqB/5dx/32v8AjQ2j35/5Yf8Aj6/412FFAHHHR9Q7QD8XX/Gj+xb/AKeRkeu9f8a7GigDjTo2oE/6j/x9f8ab/Y2pf8++R6b1/wAa7SigDi/7E1ADAt+399f8aP7F1EjP2fnP99f8a7SigDiv7E1HP+oOO3zr/jSf2HqWP9R/4+v+NdtRQBxH9h6lx/owwP8AbX/Gm/2FqeP+Pbn/AH1/xruaKAPPjoGrnP8Aop/7+p/jVK58Ma1IrbbUc9vMT/GvTqKAPI38Ja+qkrY72HT99GP/AGaneGPCGt2fjPSL+6svLtbdpC7+bGcAxOvQNnqRXrVFAHz78V/APivWvHOuaho+lG5srq2gjjf7REm5lXDcMwIx7ivNdA+BfjddaiudS0RUhDbmBu4G5/BzX2ZRQB4Vpnw21uEL59kAT9796n+NdbYeF9Tgj2m1x/20T/GvSKKAOIj0PUtvNtg/76/41INF1DJ/0fr/ALa/412dFAHHDRtQ7wf+Pr/jR/Y1+OkGP+Br/jXY0UAccNG1DjMOcf7a/wCNH9jah3g/8fX/ABrsaKAOP/se/wD+eH/j6/40f2Pf/wDPv/4+v+NdhRQBxv8AY1/g/wCj/hvX/Gj+xtR/54A/8DX/ABrsqKAOMGjaiD/x7jH++v8AjSf2NqO3At+f99f8a7SigDijomoY/wCPb/yIv+NN/sTUQP8Aj2/8fX/Gu3ooA4f+w9S/59//AB9f8aP7C1H/AJ9//Ii/413FFAHD/wBhaj/z7/8Aj6/40f2FqWf+Pf8A8fX/ABruKKAOF/sHUv8An2/Dev8AjTW0DUySfs3/AI+v+Nd5RQBwDeHtUIP+jflIv+NQTeGdUbJW15/66Jz+tejUUAeV3PhDV5B/x5hvrKn+NYOp/D7XLmGSL+zlkU9Myxjn/vqvcqKAPkrxH8DPFF1cebY6YhDDLA3EQOf++q9/+DGhah4a+Guj6TrMH2e/t/O8yPer43TOw5Ukchgeveu2ooA//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Chest radiograph at diagnosis showing severe mixed-type infiltrative lesions in a 65 year-old patient with paracoccidioidomycosis. (B) Radiograph for the same patient at the end of the post-therapy follow-up period (12 months) showing extensive fibrosis and basal bullae.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Tobon, AM, Agudelo, CA, Osorio, ML, et al. Residual pulmonary abnormalities in adult patients with chronic paracoccidioidomycosis: prolonged follow-up after itraconazole therapy. Clin Infect Dis 2003; 37:898. Copyright &copy;2003 University of Chicago Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_59_31665=[""].join("\n");
var outline_f30_59_31665=null;
var title_f30_59_31666="Transperineal fistula repair1";
var content_f30_59_31666=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F62973&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F62973&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transverse transperineal approach to a rectovaginal fistula located at the sphincter complex",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 357px; height: 540px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A wire probe is used to identify the fistula tract. A transverse transperineal incision is made above the sphincter complex.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_59_31666=[""].join("\n");
var outline_f30_59_31666=null;
var title_f30_59_31667="Classification of humeral shaft fractures";
var content_f30_59_31667=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F82018&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F82018&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 481px\">",
"   <div class=\"ttl\">",
"    Classification of humeral shaft fractures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 461px; height: 518px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: M&uuml;ller AO Classification of Fractures/Long Bones (leaflet), Edition 2004/I, ISBN 3-905363-03-8. Copyright &copy; 2004 AO Publishing, Switzerland.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_59_31667=[""].join("\n");
var outline_f30_59_31667=null;
var title_f30_59_31668="Dexchlorpheniramine: Patient drug information";
var content_f30_59_31668=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Dexchlorpheniramine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/43/20149?source=see_link\">",
"     see \"Dexchlorpheniramine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10024089\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700543",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before giving this drug to a child. Check all of your child's drugs, including OTC, with doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024091\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691589",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease allergy signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691896",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat hives.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat swelling of the face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024090\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701916",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to dexchlorpheniramine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703742",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024095\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697161",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an enlarged prostate, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697164",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a bowel block, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697349",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have trouble passing urine, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024096\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698625",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure, a fast heartbeat, or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024093\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696039",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is most useful if started before contact with the allergen. Take at least 1 to 3 hours before.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024094\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024099\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024100\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12365 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.66.252.144-564C5304BD-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_59_31668=[""].join("\n");
var outline_f30_59_31668=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024089\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024091\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024090\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024095\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024096\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024098\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024093\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024094\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024099\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024100\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?19/43/20149?source=related_link\">",
"      Dexchlorpheniramine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_59_31669="Acrivastine and pseudoephedrine: Drug information";
var content_f30_59_31669=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Acrivastine and pseudoephedrine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?2/39/2677?source=see_link\">",
"    see \"Acrivastine and pseudoephedrine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F130333\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Semprex&reg;-D",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F130349\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Alkylamine Derivative;",
"     </li>",
"     <li>",
"      Alpha-/Beta- Agonist;",
"     </li>",
"     <li>",
"      Decongestant;",
"     </li>",
"     <li>",
"      Histamine H;",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist",
"     </li>",
"     <li>",
"      Histamine H",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist, Second Generation",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F130336\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Rhinitis, nasal congestion, allergic symptoms:",
"     </b>",
"     Oral: One capsule every 4-6 hours (maximum: 4 doses/24 hours); treatment for &gt;14 days has not been evaluated",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F13258950\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F130337\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F130338\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid use in patients with Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;48 mL/minute.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F13258951\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no dosage adjustments recommended in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F130320\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Capsule:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Semprex&reg;-D: Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F130307\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F130321\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Relief of symptoms associated with seasonal allergic rhinitis",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F130347\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Also refer to Pseudoephedrine monograph.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Central nervous system: Headache (19%), somnolence (12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Insomnia (4%), dizziness (3%), nervousness (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Dysmenorrhea (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Xerostomia (7%), dyspepsia (2%), nausea (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Pharyngitis (3%), cough (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Anaphylaxis, angioedema, bronchospasm, erythema multiforme",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F130324\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to pseudoephedrine, acrivastine (or other alkylamine antihistamines), or any component of the formulation; use with or within 14 days of MAO inhibitors; severe hypertension, severe coronary artery disease",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F130311\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with cardiovascular disease (including hypertension and ischemic heart disease); contraindicated with severe disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use with caution in patients with diabetes mellitus.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Increased intraocular pressure/glaucoma: Use with caution in patients with increased intraocular pressure or glaucoma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia/urinary obstruction: Use with caution in patients with prostatic hyperplasia and/or GU obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pyloroduodenal obstruction: Use with caution in patients with pyloroduodenal obstruction (including stenotic peptic ulcer).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; avoid use in patients with Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;48 mL/minute.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid dysfunction: Use with caution in patients with thyroid dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; may be more sensitive to adverse effects.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298680\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F130316\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Blockers: May diminish the hypertensive effect of Alpha-/Beta-Agonists. Similarly, Alpha-/Beta-Agonists may antagonize hypotensive effects of Alpha1-Blockers. Alpha1-Blockers may diminish the vasoconstricting effect of Alpha-/Beta-Agonists. Similarly, Alpha-/Beta-Agonists may antagonize Alpha1-Blocker vasodilation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May diminish the sedative effect of Antihistamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antacids: May decrease the excretion of Alpha-/Beta-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Aluminum Hydroxide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzylpenicilloyl Polylysine: Antihistamines may diminish the diagnostic effect of Benzylpenicilloyl Polylysine.  Management: Suspend systemic H1 antagonists for benzylpenicilloyl-polylysine skin testing and delay testing until systemic antihistaminic effects have dissipated. A histamine skin test may be used to assess persistent antihistaminic effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzylpenicilloyl Polylysine: Alpha-/Beta-Agonists may diminish the diagnostic effect of Benzylpenicilloyl Polylysine.  Management: Consider use of a histamine skin test as a positive control to assess a patient's ability to mount a wheal and flare response.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Betahistine: Antihistamines may diminish the therapeutic effect of Betahistine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bromocriptine: Alpha-/Beta-Agonists may enhance the adverse/toxic effect of Bromocriptine. Including increased blood pressure, ventricular arrhythmias, and seizure.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: May enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Carbonic Anhydrase Inhibitors: May decrease the excretion of Alpha-/Beta-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Brinzolamide; Dorzolamide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ergot Derivatives: May enhance the hypertensive effect of Alpha-/Beta-Agonists. Ergot Derivatives may enhance the vasoconstricting effect of Alpha-/Beta-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ergoloid Mesylates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FentaNYL: Alpha-/Beta-Agonists (Indirect-Acting) may decrease the serum concentration of FentaNYL. Specifically, fentanyl nasal spray serum concentrations may decrease and onset of effect may be delayed.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Antihistamines may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving antihistamines (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Sympathomimetics may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the hypertensive effect of Alpha-/Beta-Agonists (Indirect-Acting).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin/Norepinephrine Reuptake Inhibitors: May enhance the tachycardic effect of Alpha-/Beta-Agonists. Serotonin/Norepinephrine Reuptake Inhibitors may enhance the vasopressor effect of Alpha-/Beta-Agonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Spironolactone: May diminish the vasoconstricting effect of Alpha-/Beta-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F130330\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F130317\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F12875804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal reproduction studies with this combination; therefore, the manufacturer classifies acrivastine/pseudoephedrine as pregnancy category B. The use of antihistamines for the treatment of rhinitis during pregnancy is generally considered to be safe at recommended doses. Information related to the use of acrivastine during pregnancy is limited; therefore, other agents are preferred. Also refer to the Pseudoephedrine monograph for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F130340\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pseudoephedrine enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F12875805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if acrivastine is excreted into breast milk. According to the manufacturer, the decision to continue or discontinue breast-feeding during therapy with this combination product should take into account the risk of exposure to the infant and the benefits of treatment to the mother. Pseudoephedrine is excreted into breast milk; refer to the Pseudoephedrine monograph for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F130326\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Semprex-D Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     8-60 mg (100): $337.20",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F5539809\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Duact (DK, FI)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F130310\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to Pseudoephedrine; acrivastine is an analogue of triprolidine and it is considered to be relatively less sedating than traditional antihistamines; believed to involve competitive blockade of H",
"     <sub>",
"      1",
"     </sub>",
"     -receptor sites resulting in the inability of histamine to combine with its receptor sites and exert its usual effects on target cells",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F130323\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pseudoephedrine:",
"     </b>",
"     See Pseudoephedrine.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Acrivastine:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Absorption: Rapidly absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Distribution: ~0.5-0.8 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Protein binding: ~50% primarily to albumin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Metabolism: Minimally hepatic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Half-life elimination: ~2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Acrivastine propionic acid metabolite (active): ~4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Time to peak: ~1.1 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Excretion: Urine (84%); feces (13%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Brogden RN and McTavish D, &ldquo;Acrivastine: A Review of Its Pharmacological Properties and Therapeutic Efficacy in Allergic Rhinitis, Urticaria, and Related Disorders,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1991, 41(6):927-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?30/59/31669/abstract-text/1715267/pubmed\" id=\"1715267\" target=\"_blank\">",
"        1715267",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Levien TL and Baker DE, &ldquo;Reviews of Acrivastine and Midotrine,&rdquo;",
"      <i>",
"       Hosp Pharm",
"      </i>",
"      , 1995, 30(3):229-35.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9332 Version 44.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-422ACB6E1F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_59_31669=[""].join("\n");
var outline_f30_59_31669=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130333\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130349\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130336\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13258950\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130337\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130338\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13258951\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130320\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130307\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130321\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130347\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130324\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130311\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298680\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130316\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130330\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130317\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12875804\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130340\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12875805\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130326\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5539809\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130310\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130323\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9332\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9332|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?2/39/2677?source=related_link\">",
"      Acrivastine and pseudoephedrine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_59_31670="Closed reduction of a nasal fracture";
var content_f30_59_31670=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F53351&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F53351&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Closed reduction of a nasal fracture in a teenager",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 405px; height: 514px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Note the obvious nasal bridge deformity sustained during wrestling.",
"    <br>",
"     (B) Asch forceps are used to elevate the fractured cartilage.",
"     <br>",
"      (C) Nasal bridge appearance after reduction.",
"      <br>",
"       (D) Splinting bandage.",
"       <div class=\"footnotes\">",
"       </div>",
"       <div class=\"reference\">",
"        Courtesy of Glenn Isaacson, MD.",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_59_31670=[""].join("\n");
var outline_f30_59_31670=null;
var title_f30_59_31671="Sliding versus paraesophageal hiatal hernia";
var content_f30_59_31671=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F62190&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F62190&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 543px\">",
"   <div class=\"ttl\">",
"    Sliding versus paraesophageal hiatal hernia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 523px; height: 684px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAKsAgsDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5m+8Trbalc23lFvJcJkHrwD/U1Z/4SGAG1V1IadN4Htkj+lcFdyedq185yVa7k6egLD+grH8TalLF4u0+3jOBHawgj0Jy3/s1cvtmmz2lgITSS3sezrexkZp4uFPeuOtruQxx5PJFaMVw23rWqqHDLDWOjEynvT9wx1rmJLxlIGaq6lqUsUXysRxT9oSsM29DsQ6kcMOPelDA9CDXk+gaxe3FhqszTtkXccS+wwSf5iug8G311caykUsrPH9ndyD65jx/M1KrJtI1qYGUIybex3NFFFbHAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFB4GaKqaxMbfSb2ZescDuPqFND0HFXaR5RbMJMSDI8xnfg+rZ/rWBr3774kXG37qeUn5RIK6GzUrBAuAQIl9uTj/AArnmHnfETUskYW6dP8Avk7f6V53Q+rp6Sb8n+h6BGR8gHpV9CQwHbFUIR+9wK0IhmXGO1bI8uZFJ806is7xE4S1lbsFrRX/AI/MGsXxTKF0+5yeMEUPYqmrzSMPwkB/wi7u+QZr+Rs+oVE/+vXX+AlzrU7Y4W2A/Mr/APE1yPhjK+D7FyQo8yeQH/gWP6V23w+X/TNSb0SID83/AMBU0/jRvjXanUf9b2O1ooortPngooooAKKKKACiszxT/wAixq//AF5zf+gGviqy/tXw38O/DGnzb59A8SXlrqFq55+zXMU22WP2DKFb8PrQB90UV87+LviN4ptx8RtVtNXXTx4Xv7e1tNLNtEyXSM4UmQspkO8HI2MuPetTw74j8a+Jvih4qs4vEA0rSNFFndHT30+KV2WSHe8PmEBl5zljk9MY7gHulFfMngv4heNNSsfhnc3viOWU+JLy8srxfsduAqxvhHTEYw4yeuV4GVPObuh/E/xBfeE9Ms7nUL+bxHea/c6TaTWYtbcTrGFIMzSQyIv3x9xATj65APoLUNU0/TpLWPUL61tHu5RBbrPMsZmkPREBPzMfQc1cr5TXxZrHi7Tvh/P4hminvrDx6lgZowo8xU2EE7VUE/MRkKucDgV7P8X/ABRc6JJ4d0zSZ9Ri1fWLs29qto9vGrEAZ8x5opQo+YdFz/KgD0WivmCL4qeMrjwHos51SOHUj4v/ALDuLmOCJ/OgCg8goFz833lVc4HArWl+J2taVbeMNO1bVNRurqx8QxaTplzax2sUz+ZvKpKzRNEFwhy3l5/oAfRNFfIvxB8SeIte+HPi7TPE1/vn0DxDbW4kj8ptysxG12WJA20jhgiZPUY4r0zxR4l8SW3jnU/DNv4kudPttJ8Oyasl9Lb2zTX0oPBfMezYOhCKp+U80Ae3UV83af8AEjxhr+raBCNTfSUvfCM2qyxw2sLZuEeYLIPMRiAwRTjpg/jUnhD4g+Mda1T4dwy60B/wlOmX6zJ9lhCQTwrII5k+TOcopIJKnngDAAB9G0V4J8IvH/ivxr4q0jSLu5aBtCtbj/hI/wDR4x59z5rRxx52/Lwu75Nv8Qr3ugAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACsrxW/l+GtUbv8AZnA/FSK1awfHb7PCl/z95VT82A/rUy0izWgr1IrzRwenKWaEZGMIuD9TXM6btl8balIOd15MwP8AwM11ekYN5bKVyd6YOPp/jXH+GCT4luz6zuf/AB41wdj6WP235Ho1uAZTxzV+2P75vaqNid0rVbib5nIrZHmzGR83DGuW8YEjSLlh6muptz/rG9K5fxeP+JHLz1zSlsa0P4iK+lx+V4U0qLg/6Iz4Pbc7nP612/w9T/kJydjIqflk/wBa5CGMLomkBgT/AKHCV9OQD/Wu1+HwB02+b1u2/wDQEopL3wxsv3Mn3f6nU0UUV2HhBRRRQAUUUUANljSaJ45UV43BVkYZDA9QR3FZb+GtCk0y106TRdMbT7VxJb2rWsZihYZwyJjCkZPIHc1rUUAZN74a0K/1SLU77RdMudSix5d3NaxvKmOmHIyMfWrFvpGm219eXtvp9nFeXoUXU6Qqsk+0YG9gMtgcDOavUUAY9t4X0C1SwS20PSoUsHaSzWO0jUWzMcs0YA+QnuRjNRy+EfDU2ntYTeHtHksWmNw1s1lEYzKeshXbjcf73WtyigDFt/Cfhy2igjttA0iGOC5+2RLHZRqI5+P3qgLw/A+Yc8DmretaLpeu2q22t6bZajbK28RXcCTIG9cMCM+9X6KAMOPwh4bitY7aPw9o6W0dx9sSJbKIIk+MeaBtwHwB83X3qS48LeH7mO9juNC0qWO+kE12slnGwuHHRpAR8xHqcmtiigDEt/CXhu3sLuxt/D+kRWN3t+0W6WUaxzbfu71C4bHbPSkuPB/hq5s7S0ufDujS2tnn7NDJZRMkGTk7FK4Xn0rcooAzpNC0iW9S7l0qwe7S3NoszW6F1hOcxhsZCcn5enJqK18NaFaSWElpoumQSaeHWzaK1jU2wbO4RkD5AcnOMZya1qKAOZ8G+C9N8KXWuXdjLdXF5rN417dz3LKWLHoo2qoCjJwMZ5PNdNRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXOePjjw6y5+9PEv/j4ro65j4hMRo9so/iukB/AE/wBKip8LN8Kr1o+pzGiIP7VtkwcrKvP4CuM8G7Z9XnnHRnZh+JrtdEJGqozfdDEj2wP/AK1cX8PQpJJ64FcS6H0K2n6L9T0LTx981ahx5LN7VWsT+6f8asA7bVh6itkefPcbCMW8h9a5Pxu+3Rjj3rr4126fITXE+Pm26PUz+E2w2tVeppzoYrawhYn91a2y+2Qi5rsvACbdDdufnuHb+Q/pXKa3hbwhc4UIu36Rj/Cuy8Drt8N25IwWklP/AJEaqpfGzHGv/Z152N6iorq4hs7Wa5u5o4LeFDJLLKwVEUDJZieAABkk1zsnj/wkukX+pxeItMurKwj826ks7hbkxLnGSse49T6V1HjnT0VFa3Ed3aw3Fu2+GZBIjYIypGQcH2qWgAooooAKKKKACiisrRvEOl6zfapZ6bdedcaZP9mu08tl8qTGduSADx3GRQBq0UUUAFFFZd5r2m2ev6fotzc7NT1BJZLaHy2PmLGAXO4DaMZHUjPagDUooooAKKKzPEuu6b4Z0O61jW7n7Lp1qA002xn2gsFHyqCTyR0FAGnRTYnWSNJEOVYBgfUGnUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAZ5xRRRQAVynxFP/Etsh/085/KN66uuV+IYzptlj/n4P/oqSoq/Czpwn8aJzGnHbcSnLABJSeOB8jVx/gE4OB04rr7MlBdNwQIpj/441ch4C7etcS6H0C+Gfy/U9Bsz+5erEhxbD3qtacQSZqxJ/wAe6+la9Dz5bkr5GmY9a4T4hc2MEfd2C13dyf8AiXqBXBePhkacGzhplB/OlPY2wf8AER0HiH/kLXPy8eYwH0CkV3PhAY8O2fuGP/j5rhteydYmO4Y85wMfWu68Jf8AIuWH/XP+pq6Pxs5sb/Aj8vyIfH1hc6r4F8R6dYR+beXem3NvBHuC73eJlUZJAGSRyTivG7v4TeIJ/hvNLeSx3XiUeGIdDttOgjWBIlVkcq8hkZZHBXG7KrxwK+gaK6TyT591Pwd8RoF1ax0S61qDT5ZNKa1ZNXBeIKmLsRl5CVUH+H7p7AjipfFfgv4i23iLyNG17xHdaJDbwLY3cVyktwjqcyecr3NukhY55ZZBtIACkZr32sDxlrz6Hp0S2UK3WsX0gttPtCcebMQTlvRFALseyqe+BQB5Y/hj4hr4kOow3WrADxgJVRtVzB/ZDD5swmTbtyBhMbh2AqDQvDnxSiu4M3l9bX62eoJqF5e6gLi0u533fZWt4Q7eUFJUn5E4GMN39h8J6INB0ZLR7iS7undp7q6k+9PM5y7n0Geg6AAAcCtigD540vwt8S10K/gvtS8WRXVxBAjLBJBLiVWBd0kk1DeAwyCF8nqMBcbatT+H/iRNpOl/bLTVRCtveJJY6Xr0iTpcN/qJpJZbgsVAxlBK4B5wele+0UAfL95D8RL3xHqnh6PUNYu/E1to+nuktnqht7a1nLfPLIvmKHBXIICPuPbvXRDwP43sfEmp6rpq3kN1ceKLW6Z7fUFjiuLHZiZni3hWGQOGXd6DrXv1FAHz3d6R8U18WXGpWyXGkWHl6kkol1Zp7Vcwt9nl/e3L/wDLTaflijCehHTmvClz4z8Qya3YeD9b1OS+g8OW0cs1xrAvoTfmZTK0ciyyRozoHC4IIHZe31TRQB4LDofxEt/DdxbCDWr959RikEd1fNBJaRbGDmJo9RLzLnHySTpg8gH+Gx8P/CfjiLxD4Dv/ABbFPcS6TFqcN1dXF1HLIqyEeTuIdi2QPViO5r3KigDxL4n+G/H+o614tu/DU+rIn2OzOjrb6r5Ef2hZV875PMVfubs7xg+5xVHXfC/xMjl1q30a81I6R/bMFxAkmomSeW08s+asbmdHUb8fIZI89iO/vdFAHgcXhL4hzRaNbz6h4jltoLDUUmeTUFtJfOZc2wbyrmQvhujF2OPvYFY+v+BviTqfhfUdPuE1G++3+GbaOeG51RJVOpJdIW2hpMKfKUklcKfUmvpSigD5+u/CvxHu4L6PT5df0nT7jWdPaC3bWVe6trZY2W6fzPNdQhYqRHubp93tUvizw18RrfxBbQeGP7YlsdPksxDqMmsNI97GuBL56vcJGD7CBt2D8w7++UUAeF2/hj4jRa4l/Hd6qsn/AAlV3JibVPMgGluv7vMJk2lQc4UDcPQcVb+EWgfEDTPEkNx4xv8AV5U8iWO6WSRJrWZy5KOpN0zKcYA2QRjHBHc+00UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVyfxEP+g2C5xmdj/5Deusrj/iLjydPz0DyH/xw/41nV+BnTg/40TndNj3XEoH/LRZE/Eqw/rXIfDtgWANdroSqdViBHJkPauF+HHNyR2Fca6H0C+Gfov1PR4v9W4qe5+S1U+1QZwr49as3o/0JD7Vqee90FwwOnp64rhPHzEz6Uox/r1/mK7Z+bMfSuI+IC7Z9KbOAJ15/EUqmxvhF+8XzOh1pcavcHt5z8f8C613nhUY8O6f/wBchXBa58ur3e7Od7kfTIru/CZz4csMc/u8fqauj8bOXHfwY/10Neiiiuk8kgvru3sLKe7vZkgtYI2lllkOFRFGSxPYACuU8G2lxrGpS+LdXieKW5jMOm2sq4a0tCQcsO0khAZu4Gxf4TmDVP8AitPEzaOo3eHdIlV9Rb+G7uRhktvdU4d/U7F/vCu5oAKKKKACiiigAooooAKK8S+OGjXGofEbwRdNpYvdMt4L0XEk+hzatbxllTYHhiwSSRxyMHntWb4k1Px9YQa4vhBNRttP03SrGbTLay0AQwTylws0awyRtIo2knyw25cDng5APdNR1Kx0yKOTUr22s45ZFhR7iVYw7t91ASRlj2HU1br5y+IzeM/EGvPaahZ6yba013T5rKztNMLWzW4wXnaYRk7gTgr5gxzleOL7an8S9W1J9NmTVUlu5r+2vrU6dHHZ2tvsIgkhuGjw7H3d85OQKAPdLjUrG2v7SxuLy2ivbvebe3klVZJtgy2xSctgcnHSrVfLnhTw74kWH4WpAniS1u9LttWjuJpdM2HT5DbrsjXfDtZGPRmDbizANkYXoZ/FHxOk8O6TPdQazZXT6FJMv2PRxNJcakJSqxToYm8lCgU5wg5J3DpQB9BUV4lpuo/Ey513xJearNqNpp2l2FtKmlWemRM15PJZkypbzuCCY5uf+WnIC4xwcHT/ABZ8VpNM8QGOw1d0VbOW2ludO3XFvG5IuBGDbwLNIv8Ad8s+24ckA+i6K8P8TXXidda0O+8J2+p65PFp2pkXesaIkEyTBF8pCxgiMYJzgDaH6Ent3fw1u73UdCdtS1TxDPqLQx+eNT0tbL7NKVO4RDyEDgHPeQDA555AOn0/WNM1K6vLbTtRs7u5s2CXMUE6yPAxzgOAcqeDwcdDV6vmvwt/wmfhT4cWVvZW3ilNSv8AVL1nZLOMLbfMSryr9klk2vnIIXGf4lGKuSeK/ia+h+GruaHWvtclli+06y0p4Ll5zOyhzJJaSwKNgBKExnvnBFAH0RRXi2o6l4qvovG9trP9tx3apfR6VpUOirc2F1CIG8kvKYHDsx/hMi5YBdpzg83rvif4i6Zpuh2/h7SdfgntdN05poV0xDazFkQSokaWpKFSSGUyx7cfKuKAPo2iiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArgfihdusum2dn5bXjiSTD9I0wBuI/HAHf8K76vEvEmpXOp+NNYjsgPNil+ymWRSViiRFOB6ku0hx+dZ1fhZ04P8AjR/roX9EgOntd30sz3E0VvNK8r9TtViAB0A46AVyfw8cLdEV0dpaz2+k64bm5ad2sbjDtkHhG/hBwPwArlvh+Qb4gntXH1R9DBfu5v0/U9NjP+s+tX7jB0wN6VRjGBIB9atk79NI9K2R5st0RKxeyyBxiuK+I2fsdk/92RTXaWhzpTeorkPiMm7w8j9wwqJ/CdOF0qr1JfHVxqNr4glksoJbpMsHhCrtIJ7HO4N+BHtXdfDTWbXVPDkUcLlbq3LLPA42vESzEZH079K4jxtq39nah580O+OQhiyyANkrkYU9fzqzpepWSaPY+JNNuF8zTrowXijh2tZZOQ6nn5S4YZ9D61rS+JnFi0vYrXtp8j1uuY8a6zd2wtNG0Jk/t/VCyW5Ybltox/rLhx/dQEYH8TFV71sa9q1poWj3Wp6jIUtbdN7FRuZuwVR3YkgAdyQKxfBWkXaPda/r0YXXdTCmSPO4WcAz5dup6fLkliPvOzHpgDoPLNjw9o9roGjWumWCsIIFxudtzyMSSzse7MxLE9ySa0aKKACiiigAooooAKKKKACiiigAooooAKKKKACob67gsLKe7vJUhtoI2lllc4VFUZJJ9ABU1cPrZPi/xQNBiydE0t0n1Vx92ebhorX3HSRx6bFPDGgDU8EXOqanZ3Osar5kEN/IJbKxdArW1uBhN/Gd7/fYE/LuC/wknpKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiikZgoyxAHqaAFoqs+oWcf37u3X6yqP601dTsGIC3tqSegEq/40AW6KRWDKGUgg9CDS0AFeUQog0JLsKN9xqt80jerecw/wDQUH5V6vXlNxJDp3g7WjeNhdO1ucKB95w7ZAA7kiXpUVFeLOjCyUasWyTT4FuJLi1yM3MU0GDz95WH9RXmfgy4+z6pHnjJxXX+F9Vu5dT+03dvcW7Eh4YWT5QoI53dyffHtXJazbPo3jC8gYEKJjJGfVG+ZT+Rrhelj6XD+85RfVf1+aPWY3BdSOjLVu1+a1de9ZWlTLPZwyKc4FalscMw963R5k1bQitD/okyjqCa5vxynm+FpCf4SK6azGHukPY5rH163+1aBewjkgEj8KmWxdGVqifmhl4Y7lbG4KKS1tAwYgZwyKP8/SpYfDFh4m8OavaSQouoAb4J1GHQlAAM91JQ5B4rn4Xv7rw1olzp/lM8ETRSpK5UNsYjHQ84ANb/AIL8SW1jrDx6or6es8ewvPgR7gcr84+XozdSKKb99MMXH9zKHb9B/gSa68ef2RqepRPHpGjKiwxSDH2u/QbXmIP8EZyF9XLH+FTXqFeWeHPFekeEdf8AEOhavdi2txdte2kpBZDHKofaMZ6E/jmtCb4iPqJdfDGnG4i6C8u2MUZ9wuNzD8q63JLVniwpyqO0Vc9Dqjqmr6dpMYfU7+1tFPTzpVTP0z1ry+5uNc1SZ01bW7lF6iGx/wBHQj6j5z+JqoNH02ylSVLVDIWy8jgyOeDyScn0rF14rY7YZfN/E7fid7P8QPD6L/o9zPeN2FtbyPn8cY/Ws64+IFw5I0/w5fSehuZY4R+hY/pWFcMqQptGRuUgKOwOSfyp0wlZCYWXBHHH8jUOvLodEcuprdsuP4u8U3Sbra00izUjI8xpJj+m2qUmseKbmBZH12O2DLnbb2afl82aVXPlqIYyRjAycAex7022j2xgFVMq8Mf61DqzfU3jg6Mfslby9XuWf7X4j1dipwfKmEXYH+ED1qN9PdrhUm1jWZCRn59QkP8AX61dWLcnmqNkrfNn+h9RTmRZIWZsqTzz/CR/hU88u5oqFJfZX3GfJosJR9tzfs+P4ruQ8+/NCaLaOituu+QD/wAfMn+NaMW8QKcAu3J9iaSMCSJQxYFeCASOfwpc0u4/ZQ/lX3GWuk24kJWa8Cb9uRdSDHA/2vXipG0lRKix32qJkEkrfSjj/vqr8arHC6Ku5QSAPXPP9aY0Pkp5oJMi8tz1XuP8KOaXcPZU39lfciE2t9bgNb69ranIGGvXccnHRs1MLjxBbgvF4nvAAMnzYYnH6rT5t8i7fKG3qQxHPtTVS3m+VSXHXG4kD8Oxp+0l3JeHpPeK+4cuseMfJJi1mzZiDtM1kOPQkKR+VV/C2peIvDWjxWNvbaTeqC0ssxMiSXEjHc8jkk5ZiSTx7DAxVgGYh4xtJHG8nBI9cYpzSBIuFww4CH17Cq9rPuZvB0X9n8zTt/iDqaj/AEzwzKeSM212j9PZgtbOkeN7HUbtLZ7HU7Od+gng+X/vpSRXGzXSWenG4eOd0RcssMTSP74RQSTnsAapaL4w04arHK9proCfKANEvWPOCeBEfatI1pM56uCpRTadvme1A56UVyi+PNIx/wAefiT/AMJzUf8A4xS/8J5pH/Pn4k/8JzUf/jFdJ5J1VFcr/wAJ5pH/AD5+JP8AwnNR/wDjFWtK8W6dqd/FZ21traSyZ2tc6JeW8YwCeZJIlVencjJwByRQB0FFeRJ8YLmOy1DV77w7FF4dsNafRp7qLUDJOjK4QSmIxAbCWXo5Iz0NdVZ/EDTWtNXubxZDFp+pT6dI2nWt3e7DEAWMm2AFDg843J6O3YA7OiuHufit4Nggtpjq0ssVxZHUo2t7G4m/0YMVaQ7IztAYEHOMY5rAi+L+m2njbxBZa3dW0Ph20hsJLK+htppA/wBpTdmR13KqnK4JCjnqaAPV6K4yL4neE59e1DRbbUprnVrAyC4tLexuJZF8shXwqoS2Cw+7nPOM4OFHxN8Jmxe6/tKUBL1dOaA2U4uPtLdIvI2eYWPoFoA7KiuHX4reDngtJY9TuJBdtcJCiafctIxtwDMNgj3DaCCcgd/Q1o+G/HvhvxJqMdjo2ome6ltBfRq1vLGJIC23ejOoDDdwcE4OQehoA6eiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAA9K8k8T6Npd3r1017apKxbhpCSPp1xmvW6828SsTfXShHJOR0rGu2lod+XxUpu6OaOi6NDOgWwtSmCGxGDt9CadPoWiyRsqafZGQqSoEa5rWYYixDgZxgjt70bUgT5E/BR1rluz1+WPYyV0DTIUMtnBJbnGQbaZ4z+G01dR9VsY1bTfEGpL/dSZxcK3t84J/Wp4YlMSlskt8x5OCTzRHGsZMmDk9FHRfoKanJbMiVGnLeKLll4313Tf+Q5p0V/ajrPY/LKo94ycH8CKwfDFzZ+PPG3iQxRyxWixCe3hmABE+xY/NK+o2/rWkSJXbeCI0/vDAJqlaXCaR4y0fVYlWO3nk+w3DAY3LJwpPsGC81tCq5PlkcNfBqmvaU9GtSdGO0Md0Z/iHpk8j8Dmsf4g6d9v0O21eEg3FhtgnA7xE/KfwJI/Guw8V2osdalCoRHP+/THQk8OPz5/wCBCs+18mQPbXnNpOhhlAHLIwxn8Ov1FYtWbiz0adW6jVj6/wCaMHwBqJlhNu7dBxXbRNiX6ivI7VLnw14kmsbk/PC+3cOjr2YexGDXqVjcLcQRyqc5pwelmLF00pc8dmW+Uud2OHGDTDGD5yEcODUs3IVvSkkGSrCtDjRyXhZS2n6pprgNNY3InUf7D4Bx9Co/OtG0lW1uElkTzFicMykZ3AcMPxU4/GsnU510LxxaX0mVsrpfIuD22NwSfocH8K1biBoLponJLByrH+R/z7Vjt8jukubfaSv/AJ/15nMfGTwfp+mavo+p6dCsWn3kgimjQ/IrZyNo6AEZ4HHFdJ5MdsEkt0VUACsq8Db6/hXQ20dj4g8Haho+ssqRQRk+Yf8AlmgyVcHttII+gHrXnek6xcaNFDpvilWsbpYxJHJOMCWM9D9ex9PrW9VOaUkedhGqE5Upb/mdKwd1WVMFtwZQfQ8Yp6SBpMFGVwOQR0H16dqxINbl1FvK8OWMl5ltolbKxg+3c/gK2rHwHrept5mtai8KHrFCfLGPw+Y/mKzjRlI7Z1oRV2/6/rsVZr2x05pDdXMMI6je4HHoB9aoDxHanI0+1vrvJ48qBtn/AH0cCvRdL8A6HYBT9nErj+I8H8+v5muhg06ytxiG1hX32DP51sqC6s5J5hBfDr/X9dDxq1utfvGf7FoZAY5/eyg449EBNXRoPjG7O4RWlvkY4jYnH/AitesX2o2lgo+1TpHxkL1OPoOa5288ZRjIsbV5R0DvwD9AOv51Xs4R3CGIrVdacNPP/PQ5OHwh4ucjzNRiiHotvH/8UasnwJr8yESayy56gbF/khq7L4s1WUnYIYMdsAfz3VUn1zVnBJvJM9QFXb+oxSvSRsoYjvFfeKPh7q5+9rtxn2lA/wDadNHw71UNka3OD6+aM/8AoukTU9Uz89/Ov/fX/wAVU0Wv6rCdq3gc/wB1wOfzBNHNS8gdPEdJL8SI/D/W1zs1yX8XU/8AtOopfA/iRQRFrBb/AHo0b/Ctu18X3yHF1axuOnGVJ/Hn+Vben+KtOush3aBx1Djj8x/XFUowlskYTli4atX9NfyZwMnhnxlbgbJbSZR/ehAJ/Jj/ACqp/Z/i61L50y0lycnYJRn/AMdIr2SKWOaMSQusiHoynIP40+j2UH0MFj5rRr8/1ueIS3evWshe50PIxg7Jwv8A6FiqFr4uhl1S4tJtJ1GK+gUM0exXOw9HXB5XPGR34Ne/VzvjDwvDr9tFLA62es2jGWxv1QM0MmOhH8SN0ZDwR6EAhexiV/aPl/X3Hlv/AAk9jEXEiXUGTn99buoHr2rY8Ma3pN1qsItr+N5WbkZwSfpXUeFNSs9cludL1zS7aw8S2IH2u1C8Op4E0LdXibseoPynBFbqeG9JjuFnSyRZl5Dbjx+tT7BJ3TLlj4yi01/X3msnKj6UtAGAAO1FbnlBRRRQB5xb/CLRo3uIrjU9YutLuNTfV5NMmkiFu1wzbskrGJCoIGFLkccg1Fqvwa8P6kJhNe6oFm1a51h0LQyRtLOFDq0bxsjINg27lLA5INemUUAeKf8ACjxDrOn2lhrN5beGbfQZtHlKSp9slEk7SMpJiKbCHIJGG6Y7mug1H4M+Gryw1qyE+pW9rqttY2kkcMqfuo7Tb5QQshP8Izuzn2r0uigDhLr4YaPcaF4p0o3mqRweIr5r+6eOdUeORipIjIXG35RwwbvnNczd/Baw0qwEnhhp31VdSi1KKaW5hshBIiFcoI7V4wDxlDFg+2K9hooA8j8E/B2LT9P0ebxFqEs2sWMmoSk2bAQk3i7JAdyZbA6HC89scV0nhT4aaP4Y1XSL+wudQkm0zSzpMKzSIVaIyeZubCDLZ7jAx2ruKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAA9K8/1/wXrGpanLcW+uNbwschFUcf+OmvQKKTSe5pSqypO8Ty4fDfV8c+JbkD0XaP/ZacPhvqo5/4SW8/Nf8A4mvT6KXJHsbfXKvc8qm8BeJrZB9j19JQOiyQqx/kP51m3Fl4q0stJeafBeADGYyYz/Vf1r2eik6cX0NIY6a3V/6/roeF/wDCS2bEQ6lDPYOSBi5TCn6N0NSeLDFd+GLuSKZCiJ5iOjAjcORg/WvW9S0DTNRRlurSM7upUYz9ex/GuF8SfCbSbm2lOmo8LkZ2I23P0xwfoR+NZ+wV7pnVHGwmuX8/89f0N2OYeMPAun6rAmboxCYKvdxxIg+pDD64rk0bADjlP8n/AOv+dU/hb4tsfC1rqfhnVZ5bi/s5/Mt7azge4mkR/SNAWGD1zgDdyabr58RvqDtYaRHothcszxy6mwlkAyN37mJsdyQGcHB6cGlWhf3kRgqrg3Rlv/VyLxzpr6po0eoQpm+05MS46vBnr/wEn8ifSuY0P4i6Tptu0Es0t5On/LG0Qytn0JHyr/wIit+18MRSz7/EV7da0ExmC5bZbkf9cUwrDqPm3H3rlvFug22g621vYxiPT5VE1uoGAEb+H8DkfhXO3b3kerRTqr2MtFuv8i+/xE1nUknjttMi0+Bhtjkkl8yYe5AG0H6FqyV8Ta79lNs2qTbAcFgAH/766/rRpqL5zw45ByPcVQv4jBfSqejHcKzlNvU7aVCnD3EvvLurahqd9p8Jvrx5ogcKGAz+eMmvSNK1Q6r4StNS2s8sIFrcogy25QMMPquDXnd8gPh6JwOQ1anwv1U2muSaVKQLbUwIwT/DKOUP58fjTg9bPqZ16alS5or4fy6nUaNfy3d/HdXkDRaZDLsmgLfNNtIzuA42ggHbznbjp19G8c+FbHxjoTWlyVWUDfbXCjJjbHB9we47/lXEeStuHjClPnOeOhznP51vWHiCS00N9Pg51FsQWAbkFmOAD7JnJ/2R7V1UZ68p4WOoXiqi3W5g/BC5S3ik02eIJdQFoSfU5LZHswOc/wCzXrlee6jp0eheMfDZthiKa3W0c9MmJlCk+5Dt+VehV0nDXfMoz8rfdp+Vgrktf8U+VK1ppmHl6GXqB9P8T+tV/FfiAvI1jYP8vSWRe/qM+n8/pmuYARA2MnPGD1J7Z/wrKpV5dFud2EwSS9pVXov8xHLTMZJpN8h+YuxyP/r/AFo3M5HmEhscbj1/CrFvDClvJdX1zDbWNuN00rdF9APUn0rhdc+Jc0dw0Phq1ht7ZT8txcRiSZz/AHueF+mK5JO+smepCM6suWCvb7kdukbtzg56bVU1Mlncy4XyLg8Z4TNeXW3xM8WwkH+1BIv914Iz/wCy5o1H4leK71Cn9peQh6+RGqH88Z/Wp5oeZo8HiL9Pvf8AkeqDS9QCkrbXG09tnNMk0+9hUs8EwB65jPP868Nm1rWJn8yfU76R/wC81w5P86tad4s1/TplktdXvVKn7ryl1P1Vsg/lS54mjwNW2jR66ylicIY8HnH+f6UyWNZF3FsgdSOo9+nFccvxW1OaILqWm6ddn+/taNj9SDWxovjLRdanjguo30y6YhUMj+ZCxPbdgFfxBHvVXXRmLo1oK8o/dr/wfwN+0urnTmEttPJEf4jnIb/H8c11eleMEJSLUo9jHgSx8g/h/h+Qrmby1uLWVopoyvPAI+9j371VwhQ5Ckj7yY6f4VrGtKOjOepSp11eav5nrcE0c8SywOskbchlOQakry3SNWvNIkzC5khP3o35B9//AK45+tehaRqttqkG+3bDqBvjPVf8R711RkpK6PHxODlR95ax7/5lDxX4cXWhbXdnP9h1uxJeyvlXcYyeqMP4426Mp69RggEN8K+IjqrXFhqduLDXrID7XZ7sjB6Sxt/HE2DhvqDggiuhrA8VeHRrK293ZXBsNbsiWs75F3GMnqjj+ONsAMh68EYIBFHGb9Fc94V8RHVWuLDU7cWGvWQH2uz3ZGD0ljb+OJsHDfUHBBFdDQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcv448baZ4OXTV1CO4nudRnMFrbwGNWdgMklpHRFAHdmHWp38YaPZ6Zb3uv3cXh9Z3aNYtXmjtnLKcEDLbW9cqSCCCDVbx/4UbxZZQWzPpbQRli8GpaaLyJyQAGxvRlYDdgqw6156/wAFZ9H0azbQdZ87UbGwvrQR3FtujmFwCSkQ8xfJwSQCWYDPOeaAPUv+Es8OeS839v6R5UcC3Tv9sj2rCxwshO7hCeA3QmkTxb4bfVk0tPEGkNqbkBLQXsZmbI3DCbtxyCCOOnNeO6d8E9Tv/CVrDdasmkXl34fg0bULWS1Fz5ZjcOGR1lUA5AH8QPP4b2ofCDUdQ8QaTf3njC5ntdM1C0vra2kgkIiEAAMagTCMBsfe8suP7x5yAd6fHPhJXkU+KNCDRqzODqEOVCnDE/NwAeD6Gp7zxb4bso7J73xBpFul6oe1aW9jQTqehTLfMORyM157pXwaFhc6DKdcEo0q51O42mzx5v2xNuPv8bOued3tWdB8CZLTRlsLTxKoE+kf2NeyTaf5nmRCUyBoh5o8pucc7x3xmgD1m88SaHZatDpd5rOmW+pzFRFZy3SJNIW6BUJ3HPbArF13x/odn4c8Qalo+o6brNzo9rJczWlreozjYD8rbdxTJGMkVjaR8M5tD1PWDo+tIulaxFDDewXdq01xtji8r93OJF2kr/eVgDyB2rBg+CL/ANntaXfiFZFg0SfQ7FobDyjHFISd8v7w+awz22DvjNAHoWmeNNCudIhvbvVdMspPJt5LiGW8jBtmnQNGj5IwWB4yBu7CppvGXhiG9ks5vEeix3cbvG8D30QdWQZdSu7IKjkjt3rzPVfgfNdtqEdv4kSG2vxprTo+nl38yzQIpVhKAAwByCDgnrxWofhCDrP2860M/wDCU/8ACS7Psn+zjyM7/wAd/wD47QB283jPwvBa29zN4k0WO2uEaSGV7+IJKqnDMpLYIB4JHSnX3jDwzYS2sd94i0a2kuo1mt1mvokM0bHCugLfMpIOCODXnWj/AAUXTru0lbXRMlvHqUew2WAwu8/9NDjbn/gXtVPWPgfqOo+FbHw8fGlyulW2nLYm2NtIIi6vv84Ik6gngDEnmAdscYAPW4PEGjXGqvplvq+nS6khZWtEuUaZSoBYFAcggEE8cZqHX/FGieHyi6vqVvbzSf6uDO+aT/cjXLt+ANc54E+G9j4W8Q63rUr21/qOoTCSO4a0VJbddgUoHySQcZPT6V1Wl6FpWk3F1cabp1pa3F05kuJoogrysTklm6n8aAME+IPEWrEr4e8OvbQnpe60/wBnX6rAuZD9HEf1o/4Q+71QE+K/EF9qKt96zsybG1HttjPmMPZ5GHtXYUUAeM+JNKXwb430e48JWdlYCWRbYwBBFDIsg4Vto7sp57E5rvby9tvEemz2KqbfWYVEws7j5ZEYfzU8jcMjBrG+Menyz6CLq1yJ4fmVgOQynev/AKCfzrqYodO8UaJYXdzBHMk0STxOCQ0ZYA5VhgqfcEGk0mrHTUly8lWPb8Vp/keeIQyKxydvUEc7T6/T+lUPGViNU8JtJGhN1ph84ccmE8OPw4b8DVnxNo+p6Nrk0Wm36yW8qiWNL1DIfmJyN4IJ+Yd8/eqPwpfXHnNDrQQOp8uSNVIRo2XHBycgjP4/hXC42bTPahVbSqRXn/wDzIOyLHdRH5oz8w9q150t9atA0Z2XCCs+SzfTtYvdNuOsMjQnPcA8H8Rg03w8ha+wCQqZzWPkexKzXMmX7JPP0uaylx5q9q5uXzbaQEFknhbII4II6EVurdKNdfZ9zhTV/W9JW6y8OPNC5x6ila4oz5Hr1O6tNRHiDQINWs2UzSDy7iM8BZh1z6A9fxrD0+C9PiRrq5ui0loiiExAqiO2fu56kADk9c46VyPg/X38L6jOtxE02nXI8u5hBwRjoy+4r1FVhms4L2ydbiwmGUmT7p9iP4SD2NbKV1dHnVqPspcr+Hp/l8h+ueIPt+s6CZY9lxZ+bPIB918GPGO4zz16e9aWr+Jrq/jMMCfZ4m64JyR7njj2H51yrw3J1+ObaGtvIeNT97BJU8+3H6VoSBUOHIxwcKMd619vJIwp0KUfs7bDY1wnXHOSWHWrFnB580hmZURfnkkbhY0AySfTipLSwmvC7KVWJAS0jv8AJGO5JrhPHfi6K8t5NH0IkWO7Fzc9Dckdh6J/P+eT096RvGMqsuSG/XyMn4heKhr12tlp+Y9HtSRCuMGVu8je57egrj2TA4qZ4T/DwabtkXquawlJyd2ezSpxpRUI7ESginrUiOo6qalQo54xSNGxqICOTTHiz0FTPFjlaYGKnkUE37FVkKmmgVcdNw4qDy8GgpM6nTviD4jsraO3N4l1bIMCK6iWTj0yRu/Wu88Ha3aeKkkRI0tNWjG42yN8ky/3o885Hda8b2GlieW3nSW3keOVDuV0OCp9QatVH11OSrg6c0+Rcr/rc9wcBAQy4IYqQQf1FPtLiWxmintGKSqTx1yP659O/wBazvCHie28VwR2l+8UOvBdhLjat2B0IPZ/bv29tGVTFI0ci7ZVbaQf1zW0W4+9E8x3TcJrXqv66HpOh6rDq1ms0RAkAHmJnO0/1B7GtKvK9Iv30e9hnhLFTxIhPUHqM/X9fqa9OtLiK7to54G3RSDIP+e9dsJKSueHjMN7GV4/C/6sY3irw6NZW3u7K4NhrdkS1nfIu4xk9UcfxxtgBkPXgjBAI5DxD8UZfD3gTVNW1LRSmtaTNDb3unSTmJA0jhVkSXad0ZBLBsdiDgggenVz3j3wnZeNvDU+ianPdQW0zxyGS1ZVkBRw4wWVh1Udqo4zD034l6V9jt5dYvdHZ7u5a1tF0G7l1ZZXVA5TMcKkPg524PBHrimax8VvDMXhePU9I1Jb2e9tbifT4orWaVpTEG3Fo1XcihhgltoHPIq/ceBI77UdEvtY17WNSudIuzeWzzi2T5im0qwihQFe/rnv2rBtvgvoNnYafb2OpazbPZw3VsJ0khLyw3DFpI33RlcZY4IAYetAD/Dnxb0NvCei33ie+itdSurCK9uo7W1mkitlkIUM5UMIlJOAXYfWumufHOgWuuWmk3VzdQXd5KILZprG4SG4cjIEcxTy3yPRjXKP8FPD39niyg1DWbe2ksYdOvEimi/02GI5QSExkg9spsOOKpWvws8ETePzd2etzya1p97HqZsFubeSS3K42ocoZlh5HyFtvTGKALXwx+LVjr+gWMnie4t9O1e5F3KqLbTRW7xQO24rI+UJVF3MA5I64AqPT/jBp13421CFriGHwja6ImqC/ntZ4JGZpggI3gbkII2lVOSeCelT6V8E/DtjHbwXF9rGoWdrBeW9tbXUsQSAXQKzFfLjViWDEZYnGeO1IvwT8PyQTxajqWs6gsmlxaQhuJIVMMETq8RQxxL8ylRgnOe+aAN9vif4SWJWfUp0kN7Hp32d7G4W4FxIpZEMJj8wFgpIJXBxwaNN+JnhXVbm0ttO1JpLm8EwtlmtZ4VkeIEyJuaMAMuOV+8BjjkVm/8ACpNFk1KPU7zUNWvNV/tW11eW8lkiDzy26ssSMFjChAGPCqp96dp3wl0KwuNJmhu9TZtNvLy+hDyRkM9yu2QN8nIA6YwfUmgBll8YPCv9k2t1qWoLFNLY/wBpOtnbXVzHHb+aY/M3+SpC7hgllXHpjBO9qfjzw9pdxaR393cwx3bRJBcmxnNtIZBlAJwnlZP+9XMWnwU8OWtjJaR3urmN9EbQCWljz5DTGUt/q/v7iRnpjt3qHVfgd4b1PUo7y5vtWLxpaooLQPs+zgBNjPEXTIHzBGVWz06YAOk+G3ii98T/APCU/b4raP8AsrXrrS4fIVhuii27S2Sct8xyRgewrsawfCfhey8Mf2z9gluZP7V1KbVJ/OZTtllxuC4AwvyjAOT7mt6gAooooAKKKKACiiigAooooAKKKKACvOfjHrN/okvgqSzaM2934htbGeMyTxsRIThg0UqAgBWyjh1bIyPl59GrF1rwvpOt6npt/qlvLcT6bMtxaqbiURRyrna/lBgjMMnDEEigDx/SvjNrV3rGg6bLBpC3d1fapa30ARxJAtsm6E7S+VLc5yOccYqrpnxn8Wf2Zpt7c6RpupNqOhXGqQ2tjDLHIkkUhTaSXfcuBu4APX05+hKKAPnjxn421q70bwTq9l438PG3fWrZb+bTIpI4LYPGTsuf9JOUBzlWKZ4+7g5up8StV0281aKJtPt7Z/E8mnSaxfSTz2lpGIlcOyvNhdxOFVXRB6evvVFAHz7a/GHxbqFpZGCx0i0mk0i/1EyT20zxzm2Y7WjHmKVjcDjJJHXnv7L4E1uXxJ4L0PWriJIZr+ziuXjQkqrMoJAz2ya3aKACiiigAooooAKKKKAKWs2Y1DTLi24y6/Ln+8OR+oFeXfDrxDP4cvdQ0LVhjSbaQPBOTzbq5OA/+xuyN38J4PBGPXq838fabLpGs23iTT4DL5RInhUf66NuJIz9RyP9oe9B0Uv3kHT67r9V8/0Nrx5EHj0+6XBXeYtwPZhuB/NP1rkQRHJlskYOB7g4/lW1rNjHN4Sk1TwlcIdPdVufsbZMRCsGPl94m4IIHHXjPNcgfEFnCMagJLGXfzHcKQOR2YZBH0NclaPvXR6WBqr2Vn0Mf4oWwh1fTdTQYN7b7ZSO8kfyk/8AfJWsLQ/ltJm/iOea7Dx7HHf+BVuYH3/ZLpJA2P4JAV/mFrhNIl2h4s/eHFc0/iue3h3zUbdtP8vwKsDYuwfV66HV7l7e8tZI2xgfmKxI4T/aSrjHOav6y4aSIenFStjeavJEOuxxs6zKBtkHI96r6Brur+H5nbR7to0f78LgNG/1U8fj1qS+cG3jRm6VkSF0fcmR+FF2ndFRipR5ZK6PQbb4iI6g6r4dhkl7vbTGMH/gJB/nUlz8R9OhtyNP0BzKf+fm4O1T9FGT+YrzpruVhyBmoGZ360/aSMvqVJvVfi/8zd8QeM9Y1yEW13OkNmDn7Nbp5cefcDk/iTWLHPgcKTTYogSM81eEe1BsAzUtt6s6YwhTXLFWRW85hgmM1NHIknHSnlymPMXA9akaCOVcgAHsRSC6GmKPuRSSWY27k4PtUaZV9j9Qa1goEftigTdjPtQHQhuooMUcoIHUU+2jIkc/wnpRZJmaX0BoC5VVDG+xvwp0sYKkgdKnvFw6YppIVyrcAjIoHfqVkUEVHIuWxVsRoxIVuaieMo3zDigaZU5jZWRirKcgg4IPqK910TUR4m8Iw6qpU30H7m8XHVgOH/EY/P2rw+VK9F+B1/HHrOoaRcsBFfwZUHu654HvtLH8K1pPXlfU4swhel7Rbx1+XX+vI6cbXIBQhD97J79K6bwRqRguH06ZvkkJaIn1/wDrgfmD61gX8L2l1LDIFJ+ZSOmcd/xFVt7xLE6PtkhbOR1Udj+B2n863pS5ZWZ51Smq0OR9f6R6/RVbTbpb2xguExiRQSPQ9x+ByKs12HzbTi7MKKKKBBXzvosXivwrpvjW7t4PFMtzfeLZo4jb2kQJgIGLog2srMhHBKRsPlG0DnP0RRQB87HxX8UP+ER0qe5TVl1KGe6W5trfSJUubxFIERWQ2csSdf4kTIGcjt1Wmav4qu/E97b+JH8RabZ+Vbf2fa2+lJcw3QaIGQXMywOFbflWAMYHOOOa9fooA+aJfEHxE0jwB4etdE0bXbHVU0trh1ttJjS1Momb90YEtHKuV5xuhXHOSTz9F6PNPc6RYz3kZiuZIEeVCpUq5UFhg9MHPFXKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKhu7eO6tpIJhmNxg4qaigabTujym6tdS8EXV6kMDX2g34bzbePAZGIwXjB4zjqvfGRWPa3drqunnayTqUAkjIyQ23owPQ8d69k1O0S+sZreQcOvB9D2P4GvHH0mzvZmklh2SjBWWNijjJycMMHvWFeOiZ7OCn7SMprfr/n/AJk95ZqngrXrOHe8H2VpYwxztCEOAPYYOK8m0yQ/aYzXsmgWl4ZZLKa5W5t54GiUuvzjchG0kcEe/X614rYfu8s3GK46nRnsYJ6Tj6f5fob9oge9kmb7qjFUbubzrpmB+ROnvUysYrJE/jlJJqOWOIR4U4OKg61uVnnE0ygjhRUN1cZO0dRVZWIuGUmiZC7blOGqTXlSGGPPIJBpreYOMA05ZgDhhg1pWaQyD5yKCm7GYjSDoKmid943dK12s4COCKqXFp5Q3KcrRYnnTJJIvMiH6VFAZIjtKEiiGd4sYG5Kvx3MLgE8Ggl3Q02yu6sRzU7KNmD0qJ7qNRwc1We4lblV4pk2bL0UahcDpUNvHsnlA6ZosJt+QetSTfJLvHTvQLZ2K16BvT60OFdcMMirE0azoGQ5qqYJF4DcUFIRIURsrnP1qK6IKgd6lMDnq1QzRMgB6gUhojnjKxZPaiwvLjTL+3vbJ9lxA4kRvcf0qwpWWP2NVXhK5HUdjQPRqzPcF1WDxRoVtrVshjmJ8i4i67JBz+R9fTFVOJHORnzBtK59v/11ynwhuGafWtMaRgk1t9oRf9pGHT3w36V1StsO3bg43Ae3X/GuhvmtI8d0/ZTdNbLb0Z1/w8vTJa3Fo7EmM71z+TfqAf8AgVdhXkekaVa6n4iggupdQjQhsGz1Ce0PK85MLqW5jHXPX3rsv+ED0j/n88Sf+FHqP/x+u6D5opniZhDlrN99TqqbLIkMTySuqRoCzOxwFA6knsK5f/hA9I/5/PEn/hR6j/8AH6e/ha30/R9Wj0uTVZ7i6tZIVS81W5ugSVOMCaRgpyeoxVHCXtE8VeHteneDQ9e0nUpo13vHZ3kczKvqQpJArZrwHw38LfGFp4J0y9OpwWPirS9GlsNNtY4VQW7yNljJKHcSNjgEBQCQcVUg8KfE4+Gbu3jv/EkN5PdWL7JLyNDAq5E7RTG8nZgRglW2gnGF6qAD3S98R6HYyXcd7rOm20ln5f2lZrpEMHmfc3gn5d3bPXtWrXz149+GvjDUdL8V6Ta3Wsaxp6xaa2lm/wBVBad42Jnz8ygNg/xBQSFPVQRf8R+HviHPqV62gjXbYSCx/saSXWAYtOVf+PhbtDM3nseef3ucjkdKAPdqK8Nfwx8Q18SHUYbrVgB4wEqo2q5g/shh82YTJt25AwmNw7AVm6H4V+Karqq6pq2rjUJrC+gEiTqbWWZ1fyZFc3RaIg7MFIEx0P8AeoA+hKK+cdS0D4s3ujakLVNdtLo6Hp9pAraxEGa7jmi8+RSsxALKrncSCwODycVt3PhXx/ba7cz6bc601rD4ltZrRZNZaRTpxX9+GV5TuXOPlbLf3R1oA9zooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACvI14uJl9GUCvXK8jZ/mkkHJYl//Haxr/Cerlm0/l+pf0JlTUrIrkfOoPHBrwS7BjvZ4QeFlYfka960dc6nZBc481M8en/6q8CuZfO1K5l/vyM35muKfwo97A/HL0X6mlNPhQx/hXAqnDcNJnNLO2Ym+lQWMZZjWR3pJIbNnzWYduavWsJlGQOKSKAM05PYVo6QqiAk+tNClKyMu+g8sgkfWlSAMoZSV4q3q/OKiUFLcH2pAnoNEcoHyvmrFpIZQ0b9agsXMhPoDU8K7NRGO45oFIgYG2mwRlTVmM2788A0mqLwrjsabDFDMAScN6UwvdXLqQ2/90Zp7WqlcxnFUZYXt/mViyfyq3azb0BzTM2numUhmC654rRbEicc1DfRCRNw+8KpwXJjwG5FIr4lclMcsDExcqe1RtdP3TBq4tzG46gGkYoehFAX7oqRzuzgEcVNLjZ81DMiAkkCqkspncIuQvf3oHa5FGHLHy+lPO8cOKsfLBHnHAoLLNHkUirmj4AvBp/jnR5ScI83kN6EOCnP516fqMAgvpYXJwrlQSccA8V4rFI1tqFrMp+aOVXH1BBr3nxVFjWpiD8r7eh/2f8A61bQ+E87GK1aL7r8n/wTP0aZYdd0+U8AyBDn6qM/oa9Xrx13KmKYKQVkJ6dvm/xr2Ic12UHeJ4mZrWD9f6/EKKKK2PKCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAIL+X7PY3E3H7uNn/IZryZFwHAzjKqP5V6V4pl8rQbr/bAjx67iAf0Jrza3I2ISfvMX/DGf61hXfu2PZy2Nqcpd3+X/Dmlo7bdZt8nADM5A7YH/wBevnqHmQt6179au0Ru7piP9HtpXz6AIx/wrwa2X5hmuOeyPbwPxTfp+pNLxGAe9WbRfKi3EfMegqADzroKPujrWlaxhnMrfdXpWR3N2Q1lMFmxf779ansB5dsue9Qr/plwevlpVtPvbB2pmb2sUtTGdn1pxj3W4HtTL/mZRVqEZjoHskUdOTZuB7GrMY/07P8As01EMc7ccGnZ23SN+FAPUNQ+6v1qkmfOUJ1z2rYuIlkTBGRVeKFIvujn1osKMtCWc/uyD6Vm2chSQjsTVi6lIBUA5qmUIGR160DitDYDblqltEM53D5Wpltc44PWrT7ZkwaBWsO+yxS89PpVS6sniy0bErUimS391qxFcK4oFqjKgCvLh+akC7brgcVYurfa4ljHHeo3+dcj7woLvcfMm9CKqIxjfB/GrkThhg8Gh7feelAk7bmbd5Zsivd9Zla5kspJFAaa3idz3OVH+NeKtDiRc17dr8RS4gTIISCJCQenTpWsF7rOHGNOcPn+hlzAyKwJ43Aj3yR/jXrNk/mWcD/3o1P5ivJiWYtGMHay9PqOK9X08FbC2B4IiUfpXXQ+E8XMvgj8/wBCxRRRW55AUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQByfxCuNllb26n5pGLYHXgbR+rfpXIRqsbEOMKF2g9uev9K1PE92L3XpSCDHB+7X8Mjn/gRb8hWUQzKDnPmH5fb/Irkru8rH0WGp+zoxi/X7yHWnFt4G8QXRJDeQsH1Mjgf1xXjEI2xFjXr/xLJtfhpboDhru9Xd7gBj/NRXkMalwqduprnq6WR6eA1hKXd/lZE9ku2NnP3mq/MfKslUdWqmoyyxr1NWrz5njQVkdb1ZZtEW3tN3qMmk05jIJHbuadcnbZn0xS6OA0bgUyHs2UbkFrwelXo1wlI0Y885FPlO1RigG76EZGaguFITPpUkMgbPsaklA8s5oDZjY5dyA0plQdSKzcuHKRniplts8uxNA3FFwPFIeQCajuLVMEpxmqzQtD8yHIq7bv5kfNAnpqjIlRo5MGpI5WU81cu4dwqovIIPUUFp3RpW7iVOar3EflPuTp6UlixBxVq6AK0EbMZHLvUA9DTDb4fKGoY844FWImI60A9NhjW5+9jmpokcgEVIXZsAAVp6basQAVJJNUkROdldmHKkplXKEjPavYtbPnT2r4yXghI45HAOaxNJ8NPeOuFxzXptnocPlwGdctHGsY/AD/AArohSbVjyMXjIKUX2uYnh7RN7iS4UYBB+vSu2UAKAOgGKZHEkahUAAFSV1wjyqx4Ves60rsKKKKoxCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKoa5e/2fpk84IDgbUz/AHj0/wAfwq/XCeOb/wC030VhEcrFy/puI5/Icf8AAjSbsrs6cJR9tVUXtuzm41LqxHJk45Pb3/D9TUkaO10iqCzBtoA7k/5ApAQoJYblUEfj3/XipVu49D0i+1mdQ7WiHy1PRpWOFH0z/KuC/M7s9+cn03OJ+Musx3es2mj2rhrfTI9jlehlON35AAfXNcQjBE461WnkklmkmlJaR2LsT3JOSant13kZ6VjKXM7nr0aKo01BdC3YR5k3ntUzHfd4FOQiOPjio7M77gt70g8y/eL/AKIQPSotIfY2D/FVi6OY8e1UrPiVaZC1iaVwgD5qtje/tVm7b5M+1UbNyznNAo7XI508mfd/C3Wi5YiPirF+mYz64qrEd6DNItO6uJbx7F3N1qB55C24HC56VelX91xWaoLOF96ClrqX+WTn0pLNsEj0qQDC4qtGdk5B6GgncvSDdWfOhR8jpV8GkktzKpGKYk7FO0P73ir0ilh0p+n6e5c5HFblvpTSYAFNRbM6lWMWYNpbZBJFalvYtJj5P0rds9AkLAbe9dTpXhx+NwrWNNs462MjHqclp+gPJICI+PpXZ6J4aCEM6102naSkKjcBWzFEqDAFdEKSW54+Ix8paIradYx2yjCjNaI6UxVqQVulY8yUnJ3YUUUUyQooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigCvqF0llZTXMnKxqWx6nsPxPFeV+bJLI8znMsrHn6nr+JyfpXW+PbxzFFYwZ3Md7Efkv9T+ArjwFDsWz5a5Ue2O/+fWuevLTlPbwFLkpcz3l+Q5QrNGmMAHn/a9P5VzXxX1HyF0/w/GSPL/0u5/324VfwXP5iuy0gwxebe3YPkWqGeXI9Oi/XoMV4xqkt5qur3WoXmTPcSF29vQD2AwPwrllpH1PTw0Oerd7R/P+v0M242k4Aq3aoAAageB/NUbT1q75bRxZxzWJ6jehFcSnlVq3psWFBPU81Tigd3Awcnk1twwFEHB4pozm0lYhuzhcVVtP9YPrU16G2k4NN02F2G7BxQJaRLN8+I8etV7FSXP0qe4t5HboTVuxsXUbivNOxPMlEp3vCkH0rOtScVr39rIScKais9MlOBtNFmNTiojMZSqMEf8ApDn0NdGNLkIxtNOstElZ2JQ9afKyPbRS3MgRk1E9o7SrgGu4tPD7HGUrWtPC7O4Pl/pVqk2c8sbCJxNlpruoyDW7Z6KWx8hru7Dw0ExuWt+00eKIA7Rmto0Tz62YrocBp/h9t/KcV0VloKqRla6pbZFPCipVjUDpWyppHn1MZKRm2mmRx4O2tSKJYxgClVT2qZE9a0Ssccpt7jVXNSquKUDFLVGbYUUUUCCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiig9KAMy9sYbyRnYAt0Gawbvw2doEfAHfFdd5Y7U10JAA6VEoKW50U8ROGzOLvdCZdHNopLGZ/MlPqB0H581y0/hRAT8mK9b8vjkVBJYxuclah0kzohjpxPHT4TXzCdvT2pk3hTfgBelewHTY/Sm/2bH/AHRU+wRusyl3PJbfwqI+dvP0q1/wjp2/d/SvUf7Nj/uilOnJjoKPYoTzGTPI5fCxk/h/Sr1n4VEcYG39K9M/s5P7tPFkoHSj2KE8xm1uebjwvyDt/SrC+Hiowq16F9lUDpSi3X+7T9kiHjps84bwyXblatQeG9oHy/pXfC3Ufw0vkr6U/ZITxs2cYnh8f3R+VaFtoMaKPlGa6RYh6VIEAHSqVNGUsTN9TIg0uOMfdFaENsidAKsbacENUlYwlUb3GBQOlBqUJS7BTIuVsE9BTkiJ61YCgdqWiwcw1UAp1FFMkKKKKACiiigAHeiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACjAoooAKKKKADFJilooATbRtFLRQAmB6UbR6UtFACbRS4oooAMUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFY1x4p8P2+qnS7jXdKi1IdbR7yNZv++Cc/pWzXy01zeeCNQlg8H67ofizS9Z1gTzeHbu1zflpGySV+/hcA72AAODjsQD3S7+JnhG0N0LjVthtdSXSJv9GmO26YEiPhOfun5h8vHWtjxb4m0jwjokur+Ibv7Hp8bKjy+W8mCxwOEBPX2r5k1PVNQ0mbxrLpd9dWUsvxAghke2maNnjbzMoSpGVOBkdKofGbWbjUdI+JVv4m1S6TVrTV4YdO0t7p44xZh/lkSAEK+RglypI45GeQD6p0TxRo+uavq+maXeeffaS6R3sXlOvlM4JUZYANnafuk9K2q+VviF4n1+0sfjMbTXNUgOn3mlJZmK7kX7Mrk7xHg/IG74xnvVnxB4j8WaHqfxDsvDuqapdGHQbK+gjmne5aB3MQmkjLklflaRsDAHXHAoA+oKxG8U6Mvi5fDBvP8AieNbfbBbeU/+qzjdvxt6jpnPtXjPwm1o3fxnisdK8R6lq+if8ItHcMJ9SlukNwZIw7nezAPkkEcbeRgdKpfEuBp/2gNVMdzd2ssXg2eaOa1uHhkR1LlSGQg8EA4zg45yOKAPdbrxNpFr4osvDs93s1m8ha4gt/Lc741zk7gNo6HgkGteWRIYnkldUjQFmdjgKB1JPYV8x+HPG2vyT+Ab29vdU1LzPDGoXVzZw3Lxm8eISbc7er4UANgtnnrWb4M8S6rr3iqxsIdalurDXvD928+mW2o3dybaQK5VC8szuJeFzt2cEDHOSAfU+m6hZarYxXumXdve2coJjnt5FkjcA4OGUkHkEfhVDxJ4l0nw0mntrd39mW/u47G2Plu/mTPnanyg4zg8nA96+ZvCniG00T4I+ELXTrp/tt5qP2O/nm1u7gh0py8oVpVilUxqQSdmUVsbjkgGqEWu6lrPhPRIdU1STVV0/wCI0FrbXUjs5aIKSuGdmYrySNzMeeSaAPqbxV4o0fwpZ2t1r959kgurlLSFvKeTdK4JVcICRnaeTxx1rarxX9qxd3g7wyuSM+I7QZHUfJLXB694l8X6XF8UNO0LUtVuLXTNYskR3uJJprS2kEhl2SNudR8qDPO0ZIFAH1NRXyX4z8Q+INN8DeK59J8ZwXNkbuxksxpeuXF/NYhywdDdMikhsZ2kkjHI7ntfEGm6ho3xk8B+Fh4q8UXemajDfSXTT6m6ySExuRzHtACkDbgfL2oA9m1nxPo+i6xo+land+Rf6u7x2UXlO3msgBYZAIXG4feI61s18rfD7xh4j1Cz+En23W9SnNxq99bXBa4bNzGgTasvP7zGT97NR+G/HmrX3j3whe2epS6emoazNY3ehSajdXcsMeQP36zSsqk5O3bGmMHBOMAA+raKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAor5Mn8LXnizxJ8VbDRPD63WuPrkX2XWGkiiGnYcszbywlGQDwinPeul+JvxE8R6JJ4li8MarftL4Whsxfvdm2Fu8khRcJGYGlk3ZYkmVMc4PQEA+jqK8I03xb4t134qa/axeI103QdHs7DVJbRdOinaSNoY5JYlc4Zd2W+Y7iMjGKw/C/xS8Uy+KvCcyzXl9oGvw3rwW189s9zJ5CNtbEEEfl5dcYJfOD0oA+k6K+ePh145+IfiL/hG9cRluNK1Ge4gvY7trKG1hfLCFINr/aCRj5g4JPUDHNM0v4k+LtBbVbPxnDrY8WQabd39vYmC1OnzCPcQVMaeaAAB1cg4bkcUAfRVNlkSGJ5JXVI0BZnY4CgdST2FfO+nfELxXZy+G/M1s6uNf8NXOqzBraFf7PmSF5FZNiD5NwCYfdyOvas7TfH3iyaw8DfbtYk1ZPE+l6g1/aPbQIIfLVtsqGNFYcA5BJB2np2APpDStSsdXsY73Sb22vrKTOy4tpVljfBIOGUkHBBH1FW6+Vvgx4k1vw7onwisrPUWfSNdm1G3ubGSCMqmydiHRwu/dlz1YjgcVtaH8U/EN94t8I3un3l5P4X1zVJ9PWHUmtjK4XA3BIoEMe0txmR89x3IB9H0V8x6Z8S/GGoad4Q1yTXWgOteKl0yfS0toPLt7cOAY8mMybsHli2eRjFaPhX4gfEHxDdQ6xaRSfYYtdNjf2UzWMNpBbbgu0MzifzwSOowc8DsQD6Lqnpmqafqscz6XfWt6kMrQStbzLII5FxuRipOGGRkHkZr56tvip4huPFnhq90q8vJfDWq6+dIMWpNalnG8AlUigRkC7gQWkYnjI712P7NH/IB8Zf9jTffyjoA9gooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKp3eo21pL5c8gV9obB9Of8AA0m7bjjFydkXKgvrWO9s5raZpljlUqxhmeFwD/ddCGU+4INUptcsIbdp5J1EasEJ9Cen8qltdWsroZguEYfWjmRTpTWrRn+HvB+i+H9Qu7/TraY6hdqqT3d1dS3UzqvRfMlZm2j0BxxW/UYmjPR1/OlEi/3hTJsx9FM81P7wpPOjz98fnQFmSUVXlvLeJC0kyKo6kmqsWtafL5vlXCP5QBfHYE4FK6GoSeyNKis2DWrKa5SCOTdI52gD15/wrSoTT2CUJR0krBRRRTJCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAKdjpWn6fc3dxYWFpbT3j+ZcyQwqjTv/ecgZY8nk1xHxcn8FeGdFn8T+L/AAxZ6qA0du7jT4J52BOFGZMZA+teh15J+1HpOo618Jrmz0ewu9QuzdQMILWFpXIDcnaoJwKAO21n+y/Cmn3/AIisvDkt1eeXEkqaRYo95cICqKoAwWCjHBPCr7U7RfCXhe2ltdU0/wAL6TYXuPOSRdPiimiZl55C5VsHB5r5/wDHPhHWbe9+MFjoeg6kul31nYSWkNtaSGK4mzCZDGAMM+d5bGT1zWf8T9E8R6quuI3hm8t7yysNP/sibTtBE09448vzGkuhGzoyBWAUMh6A5AIIB9AWdp4FufHGpafbaRo7eJ7eET3bDTVEuyQYyZSmG3A4I3E881q6f4d8O+F4bu80fQdM04+UTK1jZxws6rzg7QM/Q141p+gXOnfFrWdYvvCj3t1faFBLp88umtLE18IhvDyBSInZgQWYr3yeRnlPAmieIIvHfhy/TQ9TsDdabfRatBb6B/Z9rA/lSeXF8kSiTkIQzFskgA9qAPbPBEXg/wAUeALjXPDehQ6RY61bTxTNDZw29wyBnRtxTIJyCRkntVD4Daf4MvPANlqHhTSHS3dJLRrnUbaEXk6KxBErIMMO2PQDinfATTL/AEz4F6NYalZXVnfRw3Ie2uImjkUmaUgFSARkEH8RXjfw58Ha5pWn/Ci8Tw/qllqcOr3SahL9jkSSO3ZhgTHAIjIzjdxyfU0AfTdv4Y0C2XT1t9D0uJdOZ3shHaRqLVnOWMeB8hJ5OMZqGHwb4Yg1AX8HhzRY74S+eLlLGISCT+/uC53cnnrXzz4E8H+IYfEWjXXiJtSs/FFprjS3Nzb6BPM97GzDd5l8JBF5BUYxgFecAnrV0f4azL8E/GWozeHdVHiyWe4t7eN45/NaBpY2wkPQg4JyFycdaAPXtZ+Gmg6frEnjC9i1PV7zT5X1KOztLO1R5ZhllwIYo3lcH7odzz1zk11Wl6H4d1s2PiSbwtaW+qTolwsl9p8aXkLEZAckFlcfXg14C/hHWLDUtWXTdB1KC2v/AId+TcLDaSBJr7ytuxsDDTex+bk+tZniPw/4gvfDWlaZf+GLuJLTwlCLS4t9AF1dy3arxA8xjdoNpLHHyHjggmgD6ZHg3wwNT/tEeHNF/tDzhcfavsMXm+aDkPv253A85zmtLTNL0/So5k0uxtbJJpWnlW3hWMSSNjc7BQMscDJPJxWL8MBfr8OvDK6wtwmorp0C3C3KlZQ4QAhwed3rnmumoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACuE8dqw1aNh0a3AH4F/8AEV3dcj4+iGLCc9A7RH8cH/2U1lWV4HXgZWrI47xCf+KRv2A2kTQn/wBCqv4Uuf8AQWO4520T3UGp+G9ehtpPMMKIxbsSjgkD8DWR4Un/AHLJ7Vy7NHuKKlTl6/oj0u1nLWitk9Ku2MpkhbLHgVj6Wd+npj0q9pJO2QfWtkzzakUrktvOWu2Usaez4ucA54qlZ86iw9qkLY1Aj2ppkuKuZmtS7NNuWY9zXO+EpvOtdakAyP3S/wDjxP8AStHxVKyaVOV6FiKxfCD+R4d1KchiXuEGFGSQqscD/vqspPU76Uf3TfmvzR03hv5vENiAOC7H8kY16TXnfgZo7zWIJ4XDxiJ5Fb17f+zV6JW9Be6eZmDvUXoFFFFbHAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUU2R1jjZ3ICqCST2AoAdRVNNRtnICyqSTjrVgTRliodcjgjNK6KcWt0SUU0MD0Ipc0yRaKSloAKKKM0AFFJuHqKWgAooooAKKKKACiiigCrd6lY2d1aW13e20FxdsUt4pZVV5mAyQgJyxA5wKTTtTsNS+0/wBnXtrd/Zpmt5/IlWTypV+9G2D8rDIyDyK4L4peFtZ8Q+LvAt1o73FvBp15PLdXlu0Ikt1aPAYLKGDZPGNrfTvXm0HgP4j6VYanFpkl4sFx4pvb65EVzGlze2zogilzFNAByrEoJI+SOMDFAH0jUdzPDa28txcyxwwRIZJJJGCqigZLEngADnNeKaD4M8cXniPwwuua/wCKIdIstMb7VOt5FBJPcrdMyJNGksobMe0FgTkAAsCSKzNB8KfEyzh0Ca4utbe6e11aLU1m1jzVDMr/AGMgGQgNuIwy8jAyRigD3yyu7e+tIbqxuIrm1mQSRTQuHR1PIZWHBB9RUVnqVje3F1BZ3ttcT2j+XcRxSq7QtjO1wDlTjsa+ffFPh/4sT+H9Jg0q31KPVbTS7QNeRa0xaW5UjzUkU3SRj+LLGOXf0yO1vUfAvjbT9Q+IkvhiK+tr/VriO5sb5dS/dPFlDJFtMoKy9QrFeACodQRQB9BVleF/EOl+KdDt9Y0G6+1adOWEcvlsm4qxVvlYAjBUjkdq8Ys/DfxDiXTUuZ/Et3o41R572yF7HbXXkmPCrHN9tldow4yVaYHngHt3nwH8P6p4W+FukaRr1r9l1G3e4MkXmK+3dPIy/MpIOQwPB70AegUUUUAFFFFABRRRQAUUUUAFFFFABXHfFbefCTxwlhPLMiRsvVcn5iP+Ab67Guf8ZALbaZM6hootQg356YdvK/8AalJq6sVCXJJSOH0K0t4itksaR2kyGBgox8rrjJ/OuM0VJLHVJrWf5ZIpGjce4ODXRXl09t4iGmW8TTG3kZbhxghBztGSe+c+uPrUPjK18vUbXVoR8t2uJcdpVwD+Ywfzrha09D6alNN2W0jrtBINnt9Ca0NM4aYVheGJt8HXqa3dPG24lBPWtYnn1lZsZajGpNTsf8TJ/pSQcai1DkC9lPotMjr8jkvFtwF09489WNJ4djNv4QtSAM3FxLKSfQYX+hrI8Xzb5PLU5JPQVq67HfaZp+k2tlAJRZxAXMYcAksCWC++Wz1HSst2z0LctOK87mp4C/4lniqSID/Rb5CqD+5NjcQPZlRj9V969PrzLSZoZ9P0C/tW3edrShTjkDypFIPoRlq9NrqpK0UeHi5KVaTQUUUVocwUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWb4kfy9DvD/eTZ/wB9ED+taVYnjJtvh+cd2ZMfgwP9KmekWa0FepFeaOM0jfJqluAW5kTOPrk1kaXqtxL4hvZBMxjNxJtGe244rW0M7NVjchcRktnvgLz/ACrj/BTb5HLcnlq4k7WPoeRPmb7L9T1C3vpBEW3k1agv5CAS1ZCYFop9RU8R2xg+lbczPOdOL6Gv/aDgdaRdVfaTms2Vv3R96hUYts+tPmZCpR7Gg2rTk4DYBrMg166fxFFZmQ+XJFI2PcKTTXIVox61i2RD+M42H/LKCYn/AL4NJyd0bQowtLToywdVvRIwMzYA9evWvR7Fi9lbsxyTGpJ/AV5Ux3LJ8u0hR7Z5Ner2g22sI6YQDH4UUG3czzGKio2RLRRRXSeWFFFFABXnPiD4uaLour6jYtp+rXiadc29nd3VskXlRTTfcT55FZj67VIFejV5b4x+EkPiXxS+pHUIbCznube5u4bWCYS3Rh+6Hbz/ACic/wAXk7gOM9SQC7e/F3QNP8Xt4dv4LuK83TqrxyW9wD5SlzlIpXlQkD5Q6KT0xnNczr3xwS48GLrnhDS2uCL61t2F1NbSfJKzDlI7gujfLgBwvLDjAOO2T4XeEYr/AO2wabcQzieW6Qw39zGsUsqlXeNVkCoxB6qB0GOgw6T4YeEpbfUYrnTJbptQaJrme6vbiadzH/q8TO5kXbjjDCgDE1b4t2lvqWvaRDomvxalpNkbm6naxS4t7Q/ZWuAJWSYDOBtxuAZuA2Pmq/4c+JFvrdxZafpmmanq1/8AYLS9vZLWKGGK1FwgdC4km4JB3bVMhA7mtu38EaBbrrgSylY63bx2uovLdTSPcxpEYlDMzk52EgsCGOckk81m33hHwhoMljqbxT6bJbx22nQy2t9cQtKqlUhicRuDLztAD7vfigDH+InijWbP4m+CfDWlG/t7PUvtE93PapbMzrGowo87OFXlnwu4qQEJORUdv8bfDc+labqCWWriG/0681OJTFHuEVsXEgb9594+WcAZHTJFd7feHtLv9f03W7u18zU9OSWO1m8xh5ayDDjaDtOQO4PtXM2/wk8FW67IdHkEYguLVYze3BSOKcESoimTCBsnhQMEkjBoAzB8afDsen6jd39nq1glnp1vqgWeKNmngnIEZj2SMMlmUYYrgn6kYeg/Fa6tPF3imLxPbalFZLqunaZp9i0UHm2r3ETH5yjYIJXJO5iM8dxXdT/DXwlcQTQz6OskU2nRaU6tPKQbaIgxp97gqVBDD5sjOahf4W+EJLe9il024l+2zw3M8st/cvM0sIIjcSmQurKCRkEe9AGHefG7w3aoS9pqQYapc6SBJ5EKGWBVLsZJZVjVcOMbmBPpXpWm3a3+nWt4iFEuIllCllYqGAOMoWU9eqkj0JHNckvww8LJp11p8VrqMVldzS3FzDFq12i3DyhRIZMSjfkKOGyOvqc9bp1jbaZp9tY2EKQWltGsMMSDCoijAA+gFAFiiiigAooooAKKKKACiiigArE8bwNceENYRCVkW2eSMjs6jcp/MCtusfxheQ2HhbVbm6dUiW2kBJ7kqQB9SSBQBwd9pcOnS232YbhdWyTvIeskhHzMfckZ/wCBVSv2i1LwzqSQlW+zMJk56MpwwH4Mfyp/iJNW1G10WK4QaZbi1CsgfNwy4XG4jhM7TwCSPXtTtE0+CzsLy2toikMtrMPvE4zGfXp+Fcc0udo97Dyk6MZPp+hU8H3XCqe4xXXW0hW8P0rgPCzkBCOxru4xmZG9qUHoViYpTZbhYfbWPtUFzIEa5c/3aki4uS3tWdrUnl21y2f4atvQ5oxvKxyOgw/2h4qWaUboLTNxID329B+JxW09x9qmMpYSNuYsynOSCRj65qr4TjEXh7ULrcFe6uBCCf7qjccfiR+VVNJVtE1uGaeWS40mWfzZmKgtAQdxf5RynynPHHJ9aySvZHdUnZuXRaHV/wBi/YPG/hq0glxCyS311ABwZo4ygkHpnzsH/dWvRK5fSsX3jzVr0OrxWlnBawlTkHfmVjn3/d11Fd6VtD5uTcm2wooooEFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzvjpgujIDn5pgP0auirl/Hzf6DaR4+9MD+XH9aip8LOjCq9aJydmdsF9KSMR2tw6+o+Rv8a5XwYoWJ2HXbXSM5TQ9XKkgiykGD2yQP61zfhQERFe2AK4ux9Cvhn8j0EjFnF9BVheIqgl/1Ma56AVP0RfwrY87oLc8RA+tNkO23j96kvuYoxVe5z+6UGgS1SIrjP2iL0AJrF0g7vEmqSA4MdnJgnoCcD+ta9w3+kH2SsXw6377XZ8EnYkefq4/wqXub017r+X4sTaWZlDZz8ufwP+NeugAAAdBXlNkplv4o+eZFTn3YD/GvVq0w/U5cyesUFFFFdB5YUVmalrdpYP5TM0tweBFENzZ9/SqguNdvDmG2gsouuZm3Mf8AD8RTsbRoSa5novM3qK5e48zJ+3eIlQ944ABj8jmqn2jTEO1tf1Mn2Z/8KLGkcLKWzv6J/wCR2dFcpbyx5/0HxFID6XQzu9stj9Kt/btXsl33VtFewdfMtj8wH07/AJD60WJlhpLS+v3fnY6CuH0X/isfEq69JltC0t3i0tD924m5SS69wBuRPbe38S4i8Sa1/wAJRPB4W0KaWKW8QyalMoKvaWmcMAezyHKKR0G9h92u3srWCxs4LSziSG2gRYookGFRQMAAegApGDTi7MmooooEFFFFABRRRQAUUUUAFFFFABRRRQAUUVy3jTxQdH8mw05FuNZugfJjIysa9PMcDnGeg7nigqMXJ8sdyz4p8VWPh5Ejm33F/KCYbOHmST3/ANlf9o8fWuFvG1XULu31fxFJHEY2Elppy/NGnPDFSPnb/aPGfuir1lpkXh7df6qx1DXrrDkzckHsW9h2UcDHtkVJ5pbq4ae4kMkzn7xP8v8AGonUUPU9bC4SMfelr+Xy/wA/u7j9QvZr+9kupgBIwChRyB6D8OfxJqGS5t9M0nUbyVwEjt2iXPXe42qP1J/A1NZW7XEmyPCuM5Yj5VUdST6V51488RJq1xHp+nHOnWzEh8czP0Ln27Aen1ricre8z0aVL2jVOO3X0J7TX4tOES28YuCTlvmxgf41uX/jdlntPsEW+EYM29cE+w9688gUgCtEDAHrWamztnh6bd2jsb/xvMNUhexTNkgBkR1+Z89fpVPV/F7300sIgEVpIMIx+8D79sVyqk+eRS3Cneo9RRzyZMcNSi1oem+HcHwdY4BOZ5iceuVqzYXbWN4lysau0e75GHByGX/2YVifD65S50G+05j+9tZPtKLnqjABsfQgH8a1iATkLtGOcjpmtU7NSOOUVzShLu/xLXhi+g8HeIb+DUY1tdI1V0ntrhW3QxPjaUJ/hU8bewxg4r1EHI4ry6Ga3nspNN1eLzbCQkBiMtET/MH07/XrZ0rWb7wa0VlrUhvNAbAtr8ZLQIegb+8g456r3yMGu6MlJXR42Jwjg7wX9eX6rp6HpFFNikSWNJInV43AZWU5DA9CDTqZwBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcj4+OZNOX1Ln8ilddXFePWP2+xHZUYj8SP8KzrfAzrwSvWXz/I5u848M6y7A5+yhevqy1zfhYZiIHXIrf1ding3WXJPKQoAR6uKw/CgDRKe+RXH1R70fgn6/ojvJfuxirLYwg75qtMcvEKsty6D0FbHnPZBcsSyCo5xm4jHotPlGblRnpTZTi5YnsKBIoXIzJcOD0GKy9C40G9cg4mugmQOwBP9RV/UJPL0y6lPcE1U05fJ8JaeMhWlkknJP1x/SoZ0w+H5r/MteHED6xaqBkGYEZ74y39K9Nrz3wbGX12EHrHG0pPvgL/7NXoVbUF7p52Yu9RLyCsC9vrnUrt7HSW2IhxPc9l9h7/5461Pr93NmLT7E4u7njd/cTu3t/8Arrn9fv00mzXR9OPz4/fSdznr/T9B9N20ldkYag5NO2r29O7/AEHXWrWWjhrfR4lnuv8AlpcPzz9e/wDL61g3l/d3hY3l1I/qoOAB9P8A6wqttREySVj/AImzyTU9rDPMRHaRFyx4Crk4/kPqa5J1pSdonsQpQp+917vchEQbJCFserf/AK6aUKqDtQAnAHB/pS3z2OnT/Z9S1mys5gMmJnLsPqFGBXO33ifQoLtYotTubgd5obP5B/304P6Vk79TaF57XfyZ0Zi4yyj2K4/+saran4hm8MWEl5DNKzqQsVsh+aeRjhY1B7kkDnPr2rMGvaVvQW2u28rk8CWGWMD6kggfn+NUNIkPiHXU1e/Qrp9puTTlJ+WRjlXuAe4PKoemNx/iFVCTjqmRUvbla37r9Gdp4IsoXtZW1SYw+Kr2Y3VxeocCSQ4ARf8AYUBUUegz1Jz3mkalLJM1jqKCK+jGfaUf3h/n+oHnA5+8RjJ2n+6fX/GuntJ5dZ04FSV1bTzuV+pdR29+31/E11UqnPo9zhxGFio6bfl/wO/bc7eiqek3qahYRXKcFhhl9GHBFXK0PHknF2YUUUUCCiiigAooooAKKKKACiiigDP17VLfRNHu9RuyfJt0LkDqx6BR7k4A+tcH4et3sLK68T6ziXV7590atyFOMAAf3VHAHtnuKn8dPLrvjDSfD8BzBbYvLj0LnIjB+gDNj6VB4hvBeakY4Ti1tV8qIduOM/1/75qZS5Vc9LBUObV9fy/4L09EynJJJcSPNcEyTSNzk9fb6f4emKkiiiWCS9upxBbQpulmYZCj0A7nsBTbSB7maNICd7HAA7DH+TXI/FLW7S4Fpo+kTrLa22XmkQ/LJKf545/OuJu95SPWjF1JqnH/AIZf1sUvE3ji41K3m03R4vsemSHDnrLMP9o9gfQfrXLQQgU2JQq1YiVpWwvA9awbctz1IU40o8sFYmt4vMk4+6KtxLvmYDtQu23gz0ApNMJbe56k0Et31I1j/wBOYegFTXkWEDqMladZp5l5MRTvO/00wuBtIzTJbdx2lXtzpN/DqGnsBLH68hgeoI9K73Ttb0rWm/cN9ivnHNtMflZvRG/ocV566G1lJxmFuvtRd24KB06H0qlJrQyqUo1HfZ9z0iSJojskUqwOzaRyPw/pVmzvjbwtaXsYuNOk+/Ef4f8AaU/59/WsTwlr0GrWcen6jcLFq8XyQzTH5Z17KT/eHQZ68VrXEEkMhjkRtw++pHT3Faxk46o45LVwmtf61RNbT3PggR3GnGTUPC8zEtCvL22eSUHbHdPxGORXpFheW+oWcN3ZTJNbTKHSRDkMK8102/8AsEjB1E9jLxNEehHqPQj/AD7SW10fA+tpIspk8K6gdxbHFs5/jHoM8MPofUV2QmpK6PJxeF5fej/w/wDwf+HPTaKQEMAVIIPII70tUecFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXEePFJ1O1PbyiP1NdvXG+PFIvNPfsyup/Aj/Gsq3wM68C/3y+ZyOtKX8F6xgggCA49BvFY3hUBYV9dwrc1JfN8K61GCQxtlfn/ZdTXPeEyGGCehFcnVHvR/hz9f0R37f62OrQ/4+AfQVTb/AFiVbQ5mP0rZHnSFX5772qK74nlx2FS2ZzeMaguvmeY560dBLcxvEZMehbM8sMVJeIYNM0y1IG1bRT/wJucfrUXibLra2y8s7BQKta86nVJI15jjKoPbaP8A61RLqdVP7K9WbXgOLdeX8xH3QqL+JOf/AEEV2LMFUsxAAGST2rnPAkOzSJJO8kpOfoAP5g1d8VTmHR5I0BMtwwhRQcZLdvyzXTSVoo8nEL2uIcV3sZFvemO31HXpfvSnybZW7KOn/wBf6GuQd3ldpXJLuS7Mep/zz+J9q6Dxi6wx2Olw8iCMFz6npz/X/erBQll3DJEhxz2H/wCqs8RP7KPWw0Uo866/ktv8yxY2y3Eu4skVsmXeRuFRR1Y1wHjzxk13ctp/h+aSDS4+GdCVa4buzHrj0H+Rs/EvUP7O0Cy0uI7ZLrNzNjuvIUfTOT+VeYWkJlcla5Jyt7qPRwlBT/ez26L9R1vbNO5JyasLZoHK4LN2FbGlW6eUCv3jVuO2S2d55SpYD5QT3rNI65VbHEazZy3Nwul24ZWdRJdOv/LKI9vYtggewJ7V6H4P19Lezt9E1ZS2mLhIJV4e0PQY9U9VrH8NWr21jcyXjLLc3DmaebH33PHHooACgdgBUVsoaeUfw1d+XY5+T2qbqLX8j0+SGe1lks7jbvQ4D+oHce3T8DV/w7dmy1i2kJwHxG/up/w/9lrP06Z7rw1o11Kd84VoiSeSquVH6H9KRiQqsOGDZB+o/wDsq3pu01Y4eXnThLzX6HoeiH7Jq2p6eBiMMJ4/ow5H4cVuVz6kL40jdc4mscke+7r+S10FdrPnq/xJ90gooooMQooooAKKKKACiiigAooooA848O3Pn6x4r11uWjneCEn/AGP3S4/74P8A31WKq5QjJ+fBJJ9f/rY/KrfhCTPw3v5h/rJLtix/7a5/qahXIVFAB5HB7/LXPiHokfQYRWhf0X3Jfq2ZvjDVJNM8Ozm3AWW6b7KJAeVXGXx9eB9Ca8rA4Jr0n4jKi+DbMFWEhvztz2UR8j+VeeRAMgFcc9z1sHb2bfmS7cwE1fslXy8DrVS3IKlG6jipYo5IzmNgR6VJtLsS3sUpAyPk64FT6WQY2x2qa2nEg8uXh6LeERTSYHDCmZt6WYmkcyTt71Q1IkXpZTgqM1c0hsTzoeoOap6mMXJJ7ijoOPxsjW91i4s+NJtWXHU3uD+Xl0llea09syf2Tatt4yb0j/2nWrZDZp6+4p2mcRSMehJqr+Rg4Oz95/h/kcvcS6w07BdMtlYDnF4f/iK7jwx4s8RX6QaPd6Ta3N3922nfUChwB9xj5Zz04rCRgb+RT3pblnsrqKaFikkbB0YdiDkGiMrdB1KPtFyuWvTb/I6173xGkhz4fslCnaVOon/41WnpWoeIdS0+fQ5vDunSrKC8Jk1MjacHI/1XPf8AX1rRS5XV9NtdURcC6UiZAeFkHDY+vX8ahjlkt5op4ziWJg+foef6Gt6cuWXkee4OpG19flo0P8AeJfFaQzeH5dBsp73TAF3S6oULREkL/wAsjnbjaT7V139q+L/+hX03/wAHB/8AjFYWu407xr4d1+1wsN+wtp8HgrJgc/RvLP1Jr0euw8GtBRlps/6/M5X+1fF//Qr6b/4OD/8AGKltNS8UvdQpdeHNPht2dRJIuqlyi55IXyRkgc4yM+tdLRQZHnPxi8T6v4am8GnRDK/27XIbS4t4UiL3ETKxMamTCqTgc7l+oriLP4x6tpeq+I49X028upW16LS9OsJEVTbBoyxV2t0lLdOiiRj2zXuV9ptjqD2z39lbXT2songaaJXMUg6OmR8rDJ5HNc/4xg8HaD4d1bVPE+m6XHpMkiTX7yWAlErlgis6qpLtlgMkEjNAHFH4ua5LdeH9PtPAN+2saqlw5srq7+yNF5LAFgZY13KVO4EhT2xRp/xinvdRsreXQBb2d7qd5pEdzFfB5ElgXO4xmIDDcdzjng9/RbLw74e0dILnTtD020NmkjQta2KK8QYZcIEXI3Y5C8n3pmmaL4eu7O1urXQ7OKPzWu4RLpwgkjlfhpNjoGRz3JAJ70AeTp8b303wLo+qGyXVbqXTzf3NvLdubtIhMY97eTaeUF4HzN5Q7deS6L4r6xpviP4h6hqdul14b0a0sLq3tY5AJohPECoGI/m3lgWLN8mONwr1S48E+FLmK2iufDOhzRW0ZigSSwiZYkJJKqCvygkngepqy3hnQXvPtbaJpbXfkfZvONpGX8nGPL3Yzsxxt6YoA80t/jHqLx2kM/g67tr++1C2sLE3Mk0FrcecrNvEssCvhdpBAjPJGMgg1q/s+6nqOq+Cr6fWLqe6ul1a7j3TTtMUVZMBAzc7R0HA+grq4vA3hKGyns4vC+hJaXDK80C6fCI5GXO0su3BIycZ6ZPrWV4P8S+Gxc6po+gaRcaelhqbafLHa6diIz4DF/3IIVT/AH3289aAO3ooooAKKKKACuU8fp/otnNjIWQqfxXd/wCy11dYvi+DztCmI6xsr/hkA/oTUVFeLN8NLlqxZwlpb/aY7uzGT9oglh57fKSv6gVxvhCT9/tPByBXa6fM1vqUEoPCsrMeoI6GuNtoP7M8YX9n0WKdlX/dzx+mK4ux9HDXmj5X/r8D0N/9bHVmP/XNj0qAYbyz7VYgGZZD7Vsec9h9jjz3JquxDTSL71NYkGeQegqEEea496OgurMRmFx4vskPKROHYeyjcf5Uy4k86WVyTubdnPTJOKj0M+bq2uXbn5IIzGD7scfyzTo08+TYhyXKxofxAH6k1lI7YpJ+iX+Z6T4ahMOhWakYLJ5hHpuO7+tVdW/0jxDpVsDxHunf8On6j9a3EVURUUYVRgD2rnfPA8R6rddRZ2uz6cbv6Gu6Ksjw6Tcpyn5P8dP1OR1uZrvWLyVW+UuVU/8Ajo/TaagRHlnEecHGAB7nH9Kjjwwx1YyHOfYf/Wq/oUAl1eHK4IkHvwOa45+9NnuytTjbsvyPKvijcNN41voCfkt9kCAdAFUD+eaydPiMDKSOHqTxJOL/AMYarcAlke7kKn23HH6ValjASNfeuaWsmz1qa5KUY+SLNhY+dFvMhjz93B61WuY2gudk7M4HPWpFu/KniVThE4xU/wAt7qCFuVHJoJu07vYXM10gjt4yqepphg+zoIk+ed+OO5qfUL+SJvKgXaBxkCr/AIC06XUPEtvc3GTb2h+0SnsAvI/M4GKaV3YzlLkg5vZHbzWi6ZY6bpQfMltGBIR/fOXb9TVTDSz7AclnAB/D/wCtU95dGe7e4mGQck4Hc8/y/nVzwzbfa9dt4yv+qPmyH9f58fjXRT1mrHnqXs4c0umv6nVY3eN41TpFZ4J+h/8AshU1h4v8N6jqR07T/EOj3WoAsDawXsTygjqNgbPHfimaGftmu6re8FEYW8Z+n3vz+U14tpfgLxXcaBaeHp9Bk0+aLxK+rjWJbmBkgh83ePLCO0hdhxjao9TXaz5+v8SXZI+h3ZURndgqKMkk4AFZPhfxJpfinTjqGhzS3FlvKLM1vJEsmOpQuo3r/tLkdea8Xbwl8SbnxLqjarqOsyWs1zdhDZ3Ci2mtpEIjQg3amLHYrBuB53N2z4/APxC0zwX4Q0vS5tUtbeGzmTUbazvy08Ny2QrqftUKlQMYQSbAcko2TQYn0fVTTNSsdVtftOl3lte225k823lWRNwOCMqSMg8EV5PpOieMY/E9rN4oTxHrGmfYLSO2ax1JLE28ygCZrmJLhQ7E/N8rSDGQM1q/ATwtqXhDw5qGmaxY3lvcreSussl6J4Z0LsVaJfMbZwRuyqEkgnJ6AHoel6lY6tZrd6XeW17asSqzW0qyISDggMpI4IIP0q3XgWn+EviNcQ6LDqt3riRx2uqi7aPWSjea7sbXLLLlsfLjqFHBwMivWfhxDrVt4F0SDxUZDrcdsqXZkkWRi445ZSQxxjnJzQB0lFFFABRRRQB5V4PT/iidasgMG2vHUj0xMR/JarKWAUk4II/Dgj/CtjRUW18c+J9FYgJe5nX/ALaJuz+BEn51jqGVZEYfMDjHXkcgflj8qwxC0TPfwkrwt6P8LfmjL+IdjJd+DoLuJ962V0fNA/uuFAP5gD8a83twNoNeyXUMmoeG9YsbdQZLm33RqP4mU7sD3wDXiqZBIyQa46i2Z6uCleMoPo/z/wCDctSrmRNvDGrVsjLwXJqrbPliG+9TrrPy4JAqDpfYv3Kfut4PzDnNX7GUTwBj97GDVFDuswX67eado7ELj3poykrxIw/2fUs9ARg1Z1G2E6B0+91qjrSsk6uOh61PY3ZeMIT8wo8htOykiZW26eFJ5Ap9kQtjkelRTFRGwJAyKijlH2NgD90c0E2uimr7r3cPWr+qjMIPfFZtpzMhrQ1KQCL68UkaNe8jsfh1cLL4b1C2cgtBcJKoPowKn+QrZI+cowHrgeh4rmvhqP8ARNaJXK+XEOnff/8AWNdKPlnHGMADrnrmteiPOqK1Sfr+iJfFLPN8MHmjJM1jNvVu4wN4/XH5V6jbSie3imX7siBx9CM15le8/DLXwfu73/8AQBXfeFmL+GNIdjlms4ST77BXoLVHh45Wl83+j/U06+avj54P1XVfEXiP7BpkuuXWr2tnb2GbO4J00pIpfy5fKMIVwCWJkQjJ4PQ/StFM4TwnWfhX4rv/AIjW/iJJfD8UVtqi3Ub22LWaW2xgxyMluZGkPA3GUrj+EGsmT4Fa3P4X8SaTu0C3jvYE+xNKFurhJxOJGeS6W2ikII3L8wcjPXtX0ZRQB4xb/CD7V4vvtb1LT9ItIxpkVvp1nY3MojtbhVZS2AiKV+bjKnqeKqeHvhNrGkS6DLqdn4c8Sw2Okx6e1jqUzrDbSrIWMsJMLg5B5yqn3xxXuVFAHAfE3wdfeJtV8O3ttHpuo2emyTNcaPqjsltd71AVmIR/mQjIyrDntXC+MfhT4o13xFa39hH4X0uC0ayktFs1WKS2EQAkiMgtvMdeoTDxrgDKenvNFAHgZ+Bt0PDOvhJrJfEOo6m8/mfap/InszOsv2eQYwucckIeQOoqxo3wj1uy1KC5QaFYQp4nTW1tLSRzHDAIinlp+7XJBPAwoIHUdK90ooA8T+HPww8TaB8Q7bxFqs2hRRC3uILqPS1WBZ9zZjYRJBH0773c5GQ3Ye2UUUAFFFFABUN7ALqznt24WWNkP4jFTUjsqKzOwVVGSScACgadndHkUO7C7jtY9cjpwOP0rF8U4TxvFPnm4t4ZG+u0Kf8A0GrC3F1qZD2n+jWeSRKwzJIoGPlHQA56nP0FUfGhJ8WaagwCLSIce5J/rXnvY+ope9P5M9AhH+jxH2FWbI7nl9RVFDi2gAPTAq9p/wDr3HqK2R509mQWpxcy0x/lklb05p6ELeyr3qOfpceu3+lIfUwPDg3+Hr+ZMbpr/ac9wq5x+taXhuH7RrtiuPl3iQ+2Azfz21h6PcGPwdfMnlqYr5zmU4UHy16/lWh8LNfs9S8QG3LCO7S2YeWzA5OU5U9+AfepjG7RviJqEZ99T1muRBJsfEk6nJeVoifYEj+TV11cdAwXwrqshB+e4JP4lRXcjysKvzS/H/gHIwA8E5GTu4PsP8ana6k07S9W1BWw9tayGNunzn5AfwyKhtclIyCBlccjPZR/Sl1ODzvBfiESngW+7PuHDfzFecnd3PcnZ6Pq1+Z49p0e6cZ6k1sTjzLmOIcAisjSiUnXd0PFb0qhGWf+6KwR61R6lryrK3iCSICcc1nzCOGYSWj474p0DCXdPOMqOgpzXakbUg2g9CBTM0mmMWWe6kWOOLdI5woUZJJ7CvTLG3fRfD0OnMiC6lPmXOG5DHopI9B1qr4R0+PQrT+0L2L/AImcw/cxuvMKH+Ij+8e3t9amZmY+bId7uScN65/xrVLlXmcNWp7V8q+FfixjMqgFXUxjkn364/rXRaCDpWg3mpSZWef93Dnrn19//sTWVpFg+qagkK5WJOZH9PU/59veursUj1fU4jAhXS9P+WL0kcYwfoOD+Xqa6qELLmZx4qoox5X6v9F8/wAjU8OWLafpMMUgImbMkgJ6Me34DA/CvPX+Mel31o0dnY6tZSXYvbexvLiKExPcW6MWXCyMw6AjcoB/MV6rXmvgz4QaHoMTPqbPq975108U0ryokKTk71SLzCitg4LqAxrc8KUnOTk92YHgf4yQR+DrN/FlvqkmrRaEdamnWGHZdxB9rGMI4AOeNrBOn0zoX/x38N6fp9rc3um65ayXSSTQ213DFbSPCihvNXzZFVlbOFAJZiDgGumPwx8IG2jtzpH7mPTW0hV+0zcWrNuMed/rzu+971f1LwRoGoLpnnWk0UumReRaT2t3NbTRR7QuwSxurlcAcEkUEnHXfxz8NW8N3cx2Os3NhaQ2c9xdwwxeXFHdAGNiDIG6kAgKSD2Natx8VtDg1uWxe21E2kWqLosmpCOP7Ml4Rnyjl9/HQts2g96hvfCvgHUPEWreF723ludY1PT7a6voZrm6d5raCQJE7SluocD+LcepzW5L8P8AwxLrx1h9Mzem5W9I8+UQm4UYExh3eWZB/e2596ANbQtctNbWZrOHUYxEQG+26dcWhOc/dEyLu6ds479a1KKKACisvX9e03w/Bazavc/Z47q5js4T5bPulkOEX5QcZPc8eprUoAKKKKAPOfiJHJo/inRPEVuvyOfsVwffO6Mn8dy596b4mt1ttUM0QJtrtRMhA7nk/r/6EK7fxBpNvrmjXem3efKuEK7h1Q9Qw9wcEfSuE8M3D6ppdz4d1UeVrOnttQMcEsB2Pow5B9D7VMo8yselgq3Lo+n5P/J6/NlO2klhnjaJtpU7lYenX+f865nx54U86CbX9IQbAc3lun/LNupdR/dPUjt9OnQyB43eOQGOSNsEEfdP+FXdNvfsUu9UZlb5ZI2GQ4PUHtXDaz5ZHrc0qb54b/meJI37xTU9x8yp9a0PFmkPousyKiH7DMxktpOzRk8D6joR61m7soMduRWLVtGetGSmlKJfnYpaYXvxSWcvlSqpOA1LEVniwe/6VWmiZOHBwOjCghLozauUWaL5hkGsTyGjmMa54PBFWLG6dz5btnHer1pF5kxcjpxT3JV4BDZRAZnYs5Heql9ZiJGeJiOOR6il1KZmnWJCR9Km1E7dO5POMCgSumn3M7TwA+5jwoqS5LTvn+Ad6NOt2lA67atyQPLcxWtsu+WRhGijuScAUki20megeE9PSx8FwTDJn1CUyt2wqEqo/Mk/jVk8EgnJ3Lz9CP8AGrt+sNnFbWMMg8uxhEIOfvED5j+JrNYHyTu+8wx9Cef6j8q3a1sjyoNzvJ9X/wAN+Ba8QHyPhZqbk8Ss+D6/usfzFekaHF5Oi6fERgpbxrj0woFefeM4A/h/QdBwPMvZow6Dtvfn8lMn5V6cBgYHSu88XGS5pX73f42/QKKKKDjCiiigAooooAKKKKACiiigAooooAKKKKACuV+I+pRWGi20FxIIoL67jtZnPQRHLSfmisPxrqq5HxZaRah4w8J2t0iyQI9xd7GGQXjRQv5F8/hQB5vbXOo3M0TwWotrInjdzLt+Xnb0A9uTWZ46kZPGkJz923t8e3yCuxmQrOyKcYZl/WuN+JMXleI7Kcfdms4mB91yh/8AQa86Wx9Xh/4i80z0KzO+0ibPHFX7Ntt2R2IrD8O3Cz6OhzkqK2IW/wBIjI7itkefUjZtCJxrGD3FFwcSzrj+GnTjbqUbHjNE2DeOuOq0yV09DjvDFwF0TWt6ttjvw52rk42HgD/gNSaFbaZ4nvoLZJ9l0uTHKmUmt5AmVYA4IwV+hqPwpGoi8UW0m7HnQn5SQed44I6VPpmgaZJqFqr2/lM0qr5sTlJFJYjIcHIPI71nB2aOrEptTS/rRHpHgvVLnVNFzqKqupWsr2l2F6eahwSPYjDfjWVyPB2oEd7gf+hJUfga1udH8T+JNKvLyS83GC9imlADurKU+bHBI8sAnv1qxBz4Z1eN+DHcupHuCtd6PIwm/wA4/mclb58qMAgAKcg9O1UPFOR4D1ZlYgHyRgHjHmCrkBVvKP8As8YGew/wNVfEkYl8E60oJJXy5MfSQA/zrze57u0o+q/M8ttMeQSD05q/AtzdxlVwI/7x71macpeUwjoxH5VuXM5i221svIHNYo9We9kMVJoE2qysD2Ndz4X0mPTbeLU9TiVruT5reFuka/8APRh3J7D8fSs/wPpUb+ZqepKJIIDtijYfLLLjPPsByfqK6WaSWSXz5yMkn5ev41rFW1PPr1OZuC26/wCX+Ys8ksk3myuXdiWwf6mm2dvNf3iw2ylpXP3uyj1/z0+tOtbOe/uRbWgLO33yOi/j2FdFbwGLdpGhFWuCP9Ku+yD0H6/5yR0UqXN70jkqVVSVlv8Al5v+tQggRn/sPSc+Xwb25Hp6D26gf/rNdfZ20VnbRwW6hIkGAP6/Ws8DTfDGiyz3U8VrZwL5k9xMwUe7MT/noBWm8qRwtLI4SNRuZn+UAepz0rqPDr1vaOy2/Pz/AK2H14B4e8N/E+21q7n1zU9eZyl6jPZPDLBPvRvJZBLeARsrbSoECDPDHHzD2nRfEuia5d3lro2rWN/PZ7ftC20yyeVuzjJU4/hP5Vwlt8aNHuZ7SK30TXpGvHu4rUhLcec9tzKozNwQOQWwCO+eKDA5LS/DvxKi0KS2mTVWhj1CzaZm1Z0v9QtFDeeq5u5Y4GJK/ckTcB/DwKxdRTxvpviHwho+sT+IJ/7RuNae20y11fZdG3ESG3SWcSqrOhy24ueOMnofQNT+PPg/T9O0y7b7bIL6x/tARDyUeKLeU+YSSKGbcGGxCzHBIBHNWZvjT4fS6mji0/WLi2iu7aza7iii8syXCb4sAyBiCO+3jvigDz6b4e/EOaY6heyXsmuR+D/sUd/aamIZGvhdGRI2ZXUthCMlvkJHJJ5rT8UaT8UrzWtPm020vbdrYWDPcQaqSlzhV+0CSM3KxLg54ELbsE7h31dc+Kl3f6r4UPhq31GFH1250nU9Oljt/PkkhjyYgxYoOSMMHA961rb42aDePo0Wn6R4ivbjVEkaOC2s1keLy5fLcSAPxtOSSMjA69qAPMdM1LxTL8R9M0eHX7y6186pqJu3g1cXFmIVRhEGt45WESo3VXjQ54+Y9Nzw34f+KOnWGqTagdX1HUX094TZz3/l21xP5oIkjnW8aSNtpONkcK4GDt6123/C6fDq6lqlhPbXqXWn2M9+6RzWtxvjhBLqDDM4V8A4V9poX41eG47G/utRtdU06O10+31QC5ijJngnIEZTY7DJLKMNjGfQEgA4Kz8G/ES9spLfWbe9uLeLxDpmoWiXd6sjRQpuM+N9xMwCnHBkYnqPQfRdcj8PfH+j+O49ROj+akunyrFcRyPFJgsMqQ8TujA4PIY9DXXUAFFFFABXFePtBmeSLxDoyv8A2rYr88cfW4iBzt/3h1X8u9drRQVGTg1JHncs9v4q0dNY0wqblEHnxj+NfXH5j14x2FYsbcZUFl6FT1rY8UWE3g7VX8R6MjHT5mzqFuoysZP/AC1A9D/EB9fWotWgt5oo9X0w5srj72zny364+ncf/qrGrT5ldbnt4Sspx5enTy8v8vuKjraXlnJYanCZtOuDkED5oXP8aeleV+ItIm8PavJZTsJEwHilA4kQ9GH+eoNemKACVIUb+p9D6j2qHVNLttdthYX8vlSxZaC4AzsJx1H909x2PP15GuZWO+jU9jK/R7/5nl8PXKNtJq9FMwIWUDnvVbV9KvdD1J7K/Ty5k5BByrqejA9wafbOJRsf7wrLbQ9B2kuZaoddqIpI5EAGTzWvaYEJYd6ytQwIF9jWjZEmyBprcyn8KM+1j+06nI7fdSn6qTMyQp61atYxbwyyHqTmo9Jj+0Xckz8heBRboO+vN2Hvts7QAfexW/4A0791Pr1xndC/k2i+spHLH6A/mfaua1fdJdLDGCzHAwBkk9hXpZtU0yysdLThbWPdI3rKeWP5nH4Vcd79jnrytFR6y/L+tBkpBwGDdOcjt35q5o1kL/U0jlwLeLMszHpjqc/nj8T6VQdyw3ZHXj3x/wDX/lU2u3s+jaHBpenReZrGqMqhD1Jb7qn2AyzenTvXRQhd8xx1ZckN7fp3fy/Oxa0Uv4r+JMmo4J07RwdpPRpmXCr/AMBXJPoWr0yuc0Oz0rwV4dgtbq8trcDLzTzyKnmynlmJOOp/TAqnc/EXw3G2y3vJbyT+7a28kmf+BAbf1rqbseBOTqzvFenodfRXAz/ER2VjY+HdScD+K5ZIQf1Y/pVK48Y+J5Buh0/SbRSQP3sjzEZPttqHUiupUcLWltE9Loryx9c8Vuw36pZRFjgCG06f99E1Ct3r9wiyTeIrz5hnEcUSAfktT7aJqsBVe56zRXkCDU5Xk8zxBq5w2BtnC9h6CmTW94vlk65rbKWAP+nSDr06Ed8UvbxK/s+r3R7FRXj/ANgnDbv7a13P/YRl/wDiq6PwGtwl44m1DULlSgYC4uWkHv1pxrRk7ImpgqkIuTa0O9oooNanGFFcx45Sd9N/0a8uraQdDBKYyT9RXCx21xLErpruu4I4P9oSf41nKqouzOqlhJ1Y80bHsNFeQ26alC7iLxDrII6eZOJOMf7QNW11fxNFkW+tRTlDjbdWiH8ym2kq0S3gKq2PU65PxITF468ISfwObuAn3MQYf+gGsGz8f6tZyFNb0ZLiNfvTaa5Yr9Ub/wCKrL+JnjzSn0rRb/Q7yKbU7W/WVbdwVdRscMHU4IHIH8qtSUtjmqUp0/jVin4s1eDTfEE2mo0f2oykkucJEDkAsfUjGBWd8SIll0XSLxB/qJHtnOOzDcv8mrq9X8NQ6Q0bsPOmu03XM0nzGSU/ebn3xx71VFkmraXd6Q6xoLiLbDjgRyqfk/DIx9DXHNauJ7+Gq+7Gq+n/AAzMjwDdebZtET7V2MXAj9RxXknhW8m0zVTBOpR0cxyKeoIOCK9YRw0QYd8Gim7orGU+Wd+jJ73/AFsDn+9RdgJeI3YjFJc/Pbj2+YUlwfNEUnuK0ONdDldJU23iXxHac5ntfPQepRwf/ZjVWy1wRtt1GNrG8Vsr5w2ozcEbW6dR9av6xiz8Z6Ndt8sMzfZ5W7YcFOfzz+FT3tvslliuFD7WKsrjIOD/AIZrJ6HZrKzT3X/A/Q7GedE8d6LeRtuh1LT5oAR0JUrIn/jpenRxbp/Edj/Ew81B6llJz+ZFcm2lwaXpFhr2nPJANHvBJcW6MTE0TfK7BOisEc8jGcc5rtpyLfxdayD7l3AyZ7Ejn/4n867ou6ueJTTpznDr/lr+h57ANrfJjhvXsc4rQ023S9e6sZR/x9QSQ8/7S/44qtdRCC9vYxwkbkY9Npx/SrmiD/icW+3cD5ikbj9c/pXE1advM9yq7xbR4ppalL1sjBA5HpWtpFtLqF7HFEN01xKI0z7nArMjmD6tdsOAzsR+ZrsfhtHnVftGCTbW8kyj3xtH6sKwirux6lebhBy62Ovligto4bG0G60tBtLd2bux+p5+mKgSKS4ukht1JlkO1QOo/P8Az+RpxJZuThGf0684/oPzrT8OyJY2up6tLt3Wy7Yy3QMSRn8Mf+PGuinHnlqeXKXs4t7v9X/wTUaD+yoRpemun2+Vd1zck4WFOp57dfrz6kY2/Df9nR6SRotzBfKhIeWKVW3yAc5IyAenHYYrw7SdWvddvbq8vdHm1SzklLQwNdCCJwD1k4Jf6dOT1rsV8W+KoY1gsNH0OxhTCrGWdgoJwMBcCup1IrS55FWnVq6RV137+fp28jy34y+EPjT401dJ30+1Ol2soltbCyvozGhB4dvMK+Y3uR34AyRXofhv4P6d4j0y01Lx/eeKNYv3AaWx1e9IjgcHlVSMgYzyMEgj8qvP4g8bFGeS+0eIAZxHbM382qT+2PF7qM6zYpx/DYg/zal7aHcy+pVu34o77w34Y0PwzbNB4f0mx06Nsb/s0KoXx03EDLfjmsm0+HHhW0lsJLfStj2Et1NbH7RKdj3C7Zjy3O4eucdsVyiar4sMjxt4giyoByLCPofx9jQ2peK4wD/wkatkgfNYxcflS9tAr6jW7HUQ/DXwtb2+nRWVjc2X9nwG1t5bPULm3lWEsXMZkjkDsu4k4YkZp83w58LTPcvNprySXN3BfTO93MzPPCMRuSXzkD8D3zXKR6t4seMONfh5HQ2CcH86ZFrXjQorprGnyAjOJLPH8jR7aHcTwNZdPxOpuPhl4TnyW06eNzqEuq+ZBfXETrdSgCSQMkgIyAOAcDsBVrRvAHhjRbnTbjTNJjt5dOt5LW2IkchY5DucEFiGJPJZsn3rj4fFPjeJnB/sK5CnB3RyIegPY+9dj4P1vVtTV11iytbd16NBIWB/A81SqRlszOeGqU1eSMy0+Evgu0jMcGkyiL7NPZrG19cMkcM+fNRFMhCBsk/KBgkkYNXW+HHhN45Y5NHjkjl0+LSnWSWRgbaIgxpgt1UgEN97I6112eaKswMvQdCtNDikjsZdQdZCCftmoXF2RjptMzttHsMVqUUUAFIzKv3mA+ppa838b6dpt/qbC9tYZW7Fxn8KmcuVXNqNF1pcqPRwwPQg/Q0teHyeF9FV0ZLGJMMNxRiv06H1xVtNNNoV+xanq1pk4/dXsm38QSR+lZKvE6nl0+jR7I6q6MjqGVhggjII9K8v1O2PgbWnKw7vC1+dpT+G3c9UPopPKnseOKrxav4q06Vfs+rxagh/5Y3luvT/AHk2n881qP44sbq0l0/xhpUlpbzpskkX99bsD6kDcv5cetaRqRlszNUa2HfNa6KGpWYtpVVW821lG6CXsw9D/I+h/CqseSuF/wBapyCe4/zxTfD91bx31x4Vmvre+t3UTafdpKHBQ5C5I7/wt+BpzpJFuWTKyxOQ47+/48fmKwrU7e8j2KNRVY3X9f11H6zpsfifw/LZBR/aNsDLZsR8xwPmj/Hn8fpXk0WSuRxIvUV67bytBcJNE251O5D6kdv8+9eeeMrA6X4pudoxbXR+0QnsUfnH4HI/CueequdeFlyycOj1X6/16mVcymWJc9a27EYs0B9KwgmZ1QetdEFEVqD6CoR01NkirqJ2wYHGeKf4fQm0kb3NRagQ9urDsateHGzZTqOoJprciXwFvwVCt147tTIAyQbpjn/ZUkfqBXWyu++aQDLZyST14z/M1yfw9b/isLhCMmS3mQeudhPH5V1DbcyjbuPDBvbAq18Jy1v4vyX6lrTYopdRjWYZggBlk/3EBP64I/GuVhm1XXPF+palb3ptIo82vnIAZAf4whP3fTI5wMV2GjKJL28iUZkubKWOMerHJx+QNcj4OLWx1O1IJkiunLr3KsdysPXINdF3GldHNUiqkuWW39f18jSg0qwguwZI/PmKj97cEyuTk/xNnmtEmOOeNQAuQQMD6f4GlHlzI4UNhupwRz+NUp9QsLK3/wBPuoYyfvb3GSR+tc92zRJRXYtTGRSu/aYs5YgYIx/Si6Z3jZI42PqenHt71j/8JNaOu2yt76+94oGI/MgCpLTUNYulVbTQ5TwBmSVc5/3VyapU5PoHMtzWYiOMvGu7I4OeTSeX5AUxklBwy+3qKpjSfFsxzHY2sAznawkbn8QKsR+G/Gkn3ms4x7RA/wA3q/YzIdaC6r70PmiwimM4fOM+oJ5/xp1xkRgImVUgn2AOaD4K8VyFd+qxrg5wsCDH6mn/APCB+JSOdcI+ir/hT9hIj6zT6v8AFf5jZYlnU5dtjDopwDXQ+Dm/0pc9Stc8vgLxKowutqB1xsX/AArc8I+Gtc0rUfM1DUFuIMY2iNR/KnClJSuZV69OVNpP8ju6DRSHOa6jxDn/ABiivYLuGRu6HpXDCFZJWYjag4AUkZ9Scda7jxpa6nd6YE0hImuA2cSdMVwX9heNj/y76d+R/wDiq5qtOUpXR6+DqxjTs3+JKMPMBE20IvJX9B+hoeJ9+Y5D5h6semPpUY0TxlExdrKwfjBALD+RPrVG7utdsQRfaIw/2oZecewcAms3Sn2O2NWMvhd/xNQyRxKFRlJ6Bc8k1j+ItAs9UsZRPErXbD93IBhg3t7U6DxNpskwiuWls5+0d1GYz+GetatvsctMhLZ4Bznj2qNYsr3ZK26Oi0+4HiL4eWF4wHnxRASj0dPkcfmCfyrm4ztl3Dl84yOOR0P+fSr/AMKb5YdW8QaBMQWEgvY17bHADD8Dj/vql8Q6cNO1N4kH7pxuTPp/9b+lbVVdKaOHBz5JSoPocJ8RbN4NVt9ahQCG8AWUqOFnUfN+Yw3511HhXUlvbBFJy6jBqVra21XTbnSroiOK5XKuR/qpQflYfQ9fY1wfhy7n0fVpLO6UpLDIY5FPYg4NY3s79z0+X2tLk6x/L+tD1qLBix6U1RmJl7isXVfEllottBNd+YwnbaqxAE9OvXpXLXfxCki1bNrZrJp5XA3nbIT3PcfhVuaW5yU8NUqaxR0fjazN3oErLnzIvmBHUU+G+Os6RYakCC8ybJvaZBhs/Xg/jXFx+NdRnu7vNvFLbT8LAx/1Yx2I/Wrfw31SKSW80e7KxC6k823LfcWXptz2yOPwFRzKTsjqdCdOneXT8nudz4fvoIZJYr0eZYXcZimUjIx0zj8SD9fauru7S1fRrNrK9jUWIUw3DyBhhRj5m754z71w1xFLDIY3i2vuIKHqD61D8pO9g272QZ+mcVpCq4Kxx1cKqk1Ui7MlnLyT3DuUZ5pSdy5wcnJIz26mo7i6/s7RtU1UEq0ELLGf+mjfIv6kmnRo00giSPdMxwoHOPfPrXI/E3WY47a38O2ciyNA3mXbocjzMYCZ77RnPvWblvJnXCHtJKmvn6f1ocRpoOXb616L8MwR/aUmM7bPH5ulcFpqAKyg/Niu1+GlxH/aM9lK203cDQoc4+cEMv57cfjWVP4kd+M1pyOmBBRGJ5DEkZ6cn/CrEsb3XgbWreAFpgxJA75DKP1quQyyGLHzBt2T/n1/nU2nXS2d2WkUvbSgxTIOuDx+fA/Ee9dNCXLLU82pHmjZepieEZI5dC0xYCyqsO0kD+LIyOe/BrYdQxWIFgxO4nHPH6dcVnan4c1XQriS70REvtLuT5uzdtAY/wASnopPcHjP5VXg1TWZXyuguzYx/wAfUeB+RNOVGSehEKicVb8ja+Zt0MmM+v8AeXvQiss/l7iYwNwyefpVFf8AhJZtpj0FQe26Vj/6CppwsPGDyMy6ZZpkADd5p/8AZRU+xn2G6kV1Lu4G66H7pGfXmkdJPNiZ3BUN90LjseetU5NK8YsBm0sQRyMRy8H8qDpvjL5SdPsWxz0l/wAKfsZi9rDuXJEZpGSJyoPLkdvp70RShE2SEBk+XgdfSqLQeL4uW0W3cdyjSD+a1C1z4ggdml0AtkAfJcAf+hAUvYz7DVSLNGEOzSFWZGLZ2suRjsa63wWpWSUs+/cOvp9PavNptZunZftGhX6sp58pkfI7g4PIrtvh7rC31zJH9jvbZgOk8OwVVOEoy1Rhi5J0mehd6KQdaWus8IKKKKAA9K4HxYnm3nlsPkPLe/tXfHpXA+KPCuuanqDTWOqm3iPRdin+YrOpFyVkdeDmoTuzElCJEYo0ADYXAXgZ4pXhXZj5m7AMxxQfAXifb/yHQT15jQ/0qGfwz4ztDlLi0u1HZ4Quf++Wz+lc/sJHqrEwez/Ff5k0aiAHzHZ2PViP04pgWOZfOnUFOdoccAev41lvf6xpjlNX0S4GSSZLc7//AB04bH4U+21zTL+6jRZ40defLl+RwewwefWocJR3RspJmNrfh2K0P9t6TF9nu7djKYk4V07jHYkZ/OuyvLlNSsbDVoSD9pURykf3wBhvxBX9ahw8xcbh5J46cn1x7Vn+Abd59M8Q6SSzpYys0RHPAOQB74ZhW1J86cGZtRpyUtv6/p/It5Ag4HzKcqQM/h+VUvGdguo+E5bgZ+1aTIHQ/wB6FyAR+B5q9A5yp2glvlP1/wA5p5he403UrPq01pLEvuduVH5gfnWCXRmzbi1Ls/8Ah/wPKbVw1yjV0N823TyR6Vylm2HHqDXQXD+ZpxGe1ZI9GrHVDbXE1ic9elS+G3Ky3ETdSKr6QwZWQ9abE/2bU+eA1NdyWr3iXfDeoLo3jezupjiFZMOfRWBUn8Aa9Bv7b7NePF/ATtz146g/kf1rzHXYDuWdB25Neg+F9Qj17wrCS26+09fJnXuY/wCB/wABx+FXHZxOXER+Gr8n+hPBLLazRyxH97A25eOvf/P4irGo+El125GteG7z7HdsNsqDBx32kHgj06cfkKbYAOfv9s5wf/rfyp8EskEgltZmil/2Wxn/AB/zmtqdRJcstjnqQcldOzLFp8PdYu/l1fWJPKySVhxGD+C8n/voV0Ol/DvQbD5hbmSXOS7dT+P3v1qrZeLb6ABby3WcD+IHY3+B/AVqx+MLMj57a6B/2VDD+dbxcPsnn1Y4u+n4f1c17fSNPtxiKzhz6su4/meavKoVQFAAHQCueHi6w/543Y/7Zj/GkPjDTwP9Td/9+x/jV8yOSWHxE3eSbOjormR4zsCcC2vvr5a//FU8eL9P/iiukHqyAY/WjmRP1St/Kzo6KyIfEmkzDKXij/eVhj8xWhbXdvdDNtPFMB/zzcN/KmZypTh8UWieiiigzCiiigAooooAKRlDKVYAg8EEUtFAGLqvhfSNTjKXVlER6KoA/Lp+lcdcfC+O1d5ND1C5tM9I1kKr+Ryp/IV6XRSavubwxNSPX7z590qz1bwb8T9PvNTnaWC7l+yzSuoHyvwAccYztORxxXtHinTft9jvjH76H5l9x3FZPxQ0ZdW8MXAC/vkHysOoz0/8e2movhx4wGu6LYJqaPbak8ZA8wYW52EqzIe5yDleo+mDScU1YuU+Vxrw6/mc1kggqo+Y4IPZh/n+VYvxBsPP0xNZtUAuoisN2wGCV6JJ9eNp/Cuz8UWP2PVX2riCcbgewPt/n0rNs1hnMtpeMTBdRmCb2B4yPocH8K4mrNxZ7dOrdKrH+u6PGYtpeJpGLANjk5xmreq2+y2ilVeA3P0qDU7GbT7+6sLgYmgkMbe5Hcex61paNPDe2jWl0wEgGBnvWFuh68noprYr6CivdkH+7UVoU+0TwPx8xwfTmrNhBJpurKko+Q8Bqrara+Tqb5O1JDlW96OgrpyfmjpoPGmp2WyDVoF1GJAAshYpLj03Dr+INXh460PYPMstTXqSgkQg/jgVxwuJ4I9lxF5sfZsZqnNPC/3YsH6VXOzL6tTl0+5nS6x4/u5I5IdBtl0yFwVaTdvmb/gX8P4c+9cckRA3scsx71Oiea+duFFObDXCKOgqW3Lc6KdOFNWgieMC3eIjoRg1ZDtbTCaIkc5yvUH1qK7A2r/d701y9sRzvjPT2pBuesQXKavplvqtsd0rgJOoONso+9n0DdR/9akdMoXIVg/UHoK8+8Na+NH1DzgnnWko2XEB/iX1HuOor0N1heKK6sZvtFlI3yuh/n6EZwRWyfMrnmVKbpS5enT/ACNLw9rcujz+TNuezc9CclSe4/zz9evodtPFcwrNBIJI25DCvJzsOVQFkPY9fwz1+lWdK1S60ebfbOzQZ+eJiSv+f1+vSumnW6SODFYNVvejpL8z1Sis3RtYtdViDW74lAy0Z6j/ABrSroPFnCUHyyVmFFFFBIUUUUAMlhjlGJY0cf7Sg0yK1t4WLQwRRt6qgBqaigd3awYooooEFFFFABRRRQAUUUUAMlijmQpKiyIeqsMg1zWueBtD1hf9ItVVuxABx+fT8MV1FFBcKs4fCzy1/hXLA5Gm65eW0JP3Fc4x7Zzj866/wb4WtvDNm8ULNLLIcyOxySfc9z7+1dHRSSS2NJ4mpOPK3oeVataGw1S4tgMBXzGPbqv6YH40ltMba6huFJJGHx645xW74/tCl5b3af8ALRfLP1HT+Y/KubXasbNjlT0Hp1/ka5Kq5Z3PdpT9rSjJ9Ueb+LNLOjeILiFR/o0h863bs0bcr+XQ+4NTWhE1mVz1GK7Pxvp51Hwm84X99pjiReOTE5ww/A4P5153pdz5b7W+6awkrM9GlN1aeu60LGnMYrog8YOKfrQKyJMtPuocMJoz05I9aW9xPa8ckc1Jon7yZPbXEd3aBHPOMGqmn3l94c1VL7TpNrLx6hh3BHcVkLM8DfKePSrS6huXDjNHMU6drrdM9N07xPo/iAqs5TSr/ush/cufZv4T9a0bq1nt9vnruj6r0w3uD0NeOvIjc4wa19E8WanosZhtJw1s3WCUb4z+B6fhir509zklhHH+H9z/AMz0MFQ5L74/Trgf0oYgqW8wEg9wMkVy4+IUky5n0eyLesTOn6ZIq7a+PNFlAF9pl/Aw7wTK/wChAp3XcydKqt4/kbeVAGZFBJ6EikJRSNrow/2QKonxx4XSLKQavI/oVjX+tY958QbZZD9h0c7O5muCSfwAGP1odl1FGnUltB/gdQxBX5ZRn0yAP5UDB2bZBz155/Q1z1h8QdGkIXUtMvbfH8dtMsn6MB/OtKbxf4UKhlu745/g+zAkfXkCjR7MHCpF2cH+f5GgUd8/dcD+8OKiRMFX+ZCD8pHI/D0qjB4i8N3T7IdRaEtxi4gaMf8AfS5x+NbsthcrbxTQATWzYZZY2EiEeoIpq61RLk4aS09dC3p/iDULMhftAuIx/DN83/j3XNdNpviizunEVyDazHs5+U/8C/xrg5Ry3mJknoV5/wDr0xlOxQreYD264Psa1jXa3OerhaVXdWfkevA5GR0orzbSddvNLVVjPm2wPML9voe3+eDXdaPqttqtv5luxDDh42+8v1rpjNS2PJxGEnR13Xcv0UUVRyhRRRQAUUUUAVdUtzd6dcQL950IX69v1rzj4a29lqFvr3h/U4EmjtrsXcKtwVSUZBU9QQwbkcjNeo15L4pupvBXj621a3gea0uyLe4ijXLMjnKlR/eDBsD8O9B0U/fpSh21/wA/68jo/E2h6tFpjmxvhfQQfOsN7/rVHcLKOo7/ADAnjrXBLrVwuow295ppgE2FEjSAoW9AQOvXg4r2uxvLXU7GO5s5Untplyrqcgj/AD2ry7VLRUlngkRWRHbhhnlT/wDrrmrqzTO3L5tpwvscl8UbQ/adN1ZcE3MXkTEf89I8c/ipX8q4ZmMdwjqcE1614lsE1LwlqcK8y2ii9jPoU+8PxUt+leRfeliJ5HWuSotbn0WDleHL20/yOk1NiNIhlmb97xg96kkRNQ09S2NwHX0NY+rXDSLCuflUZxVmynP9lyYOG7Ur6l8loplYzy2j+VIcp70jPu5EYNJuN7Bh/vjvVBHkiYqp6Hoak1Ub+pbd5CMLHtp9lbMH3ydagW7cH5kBpz3shXCrtHrQOz2ReDI7FD0NRsGhGxgXTsRVFHAHDYPqae1wygHzAaLi5SQ+WwOAwq54f8RXPh+9LDM9lKQLi3zgOPUejDsf6Vlm6U9TzSBo3HBovbVDcFJWktD2m2kt7+xXUdMuEuLVgCdo+ZD/AHXXqG/zzUeASpQqJCeW9f8AEV5PpN3d6XdC5064e3lxglDww9COhHsa9H8Ma5Dro+y3CpBqZ5VU+VJj/s/3W9uh7Y6VqpKR5tWhKlruv63NFHeC5WW3JguEO4MDwf8AP/6677w14gTVVMMwEd4g+ZezeuP8K4E7vmSRWEgbgnrTfnhmWaBjHNH8ykcdP8/h9K2p1eXR7HHXw8a8bPfo/wCuh69RWJ4Y1tdWtSsuFu4+HTpn3x/P/wCuK267DwKlOVOTjLdBRRRQQFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGL4wtPteg3AH3o/wB4D6Y6n8ia88hYsUKkDcuCO3qP6j8K9bkRZI2RxlWBUj1FeRSx/Z55oXzmGRg3Y9ck/nuFYV1omexls7wlDt+po6fEbi21C0b5jcWcsAX1O04rxCI/IxB5HIr2uxn+yahHKMqisrfXnB/pXlfjLTTo3inUbMD915hkiI6FG+Zf0OPwrknrFHsYN2qSj3V/u3/QZYzkwZkPHvUdpMGDL/DnimMcWRx6VWtDxiszt5Vqxb2HJLL+NVlAYYPUVedv3zKfSq0yBJA3Y0i0+hGYTjINNET56Zq7GmRxSuRGMspxQFyquR2INSbN45WnG4jH4Uz7SvVcUBqNa2bquaheKRf4Sati6PpQbpP4wRSHdmYx55UinJInetIPCwyoBqMwQuewNA+buV1Ct0q9p+ranpZ/4l1/dWwzkiKQqD9R0NU5LYw/Op49KmRQyBj0NNOwpJSVnqjq7D4i6miiPVLe21BO7uvly/gy4/UGut0LU9O8RZGnSSw36jcbWbBYjuUYcOB6cH2ryaSHjK9ak027n0++gu7VzHcQOHRh2Iq1N9TkqYSDV6ej/D7j14cs2/IfoCOh9v8A61Jbzy20yTQOYZxyrA/oat6Rqtl4zsjJahbbV41zNbE8Sf7S+oz+I79jVZ43jxDcLtOcZPUH0+ta6x1R58ZXvGSs+q/roegeHtci1WLY4Ed2g+eP19x/n/GtmvIopJLa5WW3crNEcqw747f5/ka9I8PaxFq9nvGFnTAkT0PqPbrXXTqKaPJxmE9n78Ph/I1aKKK0PPCiiigArmvH2hLrugzQ4JlUErt+9+HuMAj6V0tFBdObpyUkeb+BjcahZyTWN2ln4htSI76Bvmguj/DKydiw53rg5znOMVm67qscetvDqcLaddO+fLlYbGyOSr9GBP0PqBWt4u0W90XWY/Efh5F85AVlh6LKh5KN6AnkHsaztY1rS/FaRyRovmhAlxaXCjfEwbowP14I4NY1l7p34aPJV5ofDL+repLo/lvdRxvgwSgwyDsQflP868Mu4ZLK+ntpf9ZbyNE31U4P8q9S0fRrbS9T+16ciRK5AkhxntkbfTnt0rjPiXbLa+N9WVBhJXW4X33qGP6k1xzXu6HvYKTVRxfVfl/w5iTsXgDd1q3bDbaYPeqUR3QbfUirk7COAKOpGBWR6D7CaZ/Ee2aqXA/fuyjuelTxSCCEqeuKltlAUE4yaBbNsqLOMYdM+9XIPLkHKYHvUjorDoKpzSSR/cTKj3oDfYvGGAjGKi+xRMc1nG+cHkGl+3SY4BouPkkW3jjiJ+T/AMdqMRRSDKgD3FPt5GkXJOahO6CQkDIpDVxrq8LYY5U9DV3T8qfMViGBBBBwQfWmqFuojjI+tWLWDykxnJoFJ6HpPh7WRr9tJDdbf7VgTcSOPPQfxf7w7+vX1qyMsozkyZ4brx/ntXm+nzz2GpwX1rJsnhbch/z2r0nTr608QW89xZqYLqMB7i2HVT/fT1U/pWyfN6nl1qfsndfD+X/A/rsJDLNZ3CXNoxSaM5Kjr/8AX/qOK9O0bUY9UsI7mIjJGHUfwt6f57YrzA4Kl1JLg4IBzWl4Z1M6VqaK7AWlwQr56L7/AK5+mfSuijU+yzhxmH9tC63X9WPS6KKK6jwQooooAKKKKACiiigAooooAKKKKACiiigAooooAK848W2Qh8RSuBhZlDn6Hj/0LJr0euR8ewEC0uF45MbH34I/k1RUV4tHdl8+Wrbuv+CcgN7JbszDqFbj/PcVyXxYQNeaRdDrJa+Ux9SjkfyIrqwS0TlT8gbec9uh/nmsn4k2xuPCNpdKnzWd20bY/hV1Bz+aiuHdM96k+WrF+dvvPPYH8yBkPpSWgwT7VHYt8x+lWIcKpY9OtYnpvQSXm5OPQU285QUsXLFz36UKRJKfQUAQ20207W4+tX0ZHGDTAiuMEA1BcWzpzCTj0oFoy55NsRyoFNNrbbshRWS0kqH5s037TIehNFyuR9zZaOFBwBVSRoy+3g1SiZpHw5NXPKCdFpBy2I5IMKWj4PcUlthpBmrcXzDmnR2yrLuGaA5u464UeS2fSq1on7sqas3TBUx3NOtkHlZpk3siGNPlIPaqrjFwRWgoxMwPcVUkwtzmgaYlpcz2Vyk9rK8M8Z3I6HBBr1Tw1r3/AAldpNFeRodYgTdlRgXCDrx2Ye1eWyBW5FWdHv5tJ1K2vbUkSwuHHPX1H0I4q4yt6GGIoqrG6+JbHqQVtxiJG4fMrHriptK1CXStQW4iGAPlkTPDL/nHP09Ks6pHFcRQ6hYgG0uoxNEy/wALHqvFZxUFVbknvnkge/0rVNwlc82LU46rRnrFrPHdW8c8Lbo3XcDUtcR4F1LyZn02Zvlb54c+vcf59Peu3rui+ZXR4GIoujUcenQKKKKZgFFFFACMAykMAQeCDXlHjjw7Zwa2kiRmNmAaOSJijoDnjI9Cv5GvWK4b4iri5smA5Zdv/jwH/s1TP4Wd+XS/e8nRpnFCPUdOuN8bC/gA+ZXAWUDPUEYB69Dj61zHxbjP/CRWE+CBNYRk/VWZf6Cu7I3SZLYAzj86474sEmPQZTjBhmQfg/8A9evPlrFnu4bStHzv+X/AOHtv9aozwOatbfOYsTwOlUrdvvepqV7jy2VR+NYnrNaiXYKEZ71bi/ewBckfSq9580St70tixEjJnpTE9iUTPbnbKCy9mqyjRSjginXMW+E7h1FY0KFiwDYZTiglJSVzUfT0bkVBLYMvKnNRqbhBwc/jUkV06vtlBGaQ/eXUhiZoGP6ir8EkEy/NjPoar3cZUiRRx3oiWKYDna1APVXL6iNBwRioprpE4Xk+1NSzRhgyHH1pxtokOA/PvTI0IorrdKAQRWhb3txpmpQXtlIYpk5Vh6+h9QfSs27iKAHH0PrVmN0lthv7ULQJJNeR6qLiLUbK01WzQRxzL86ddjjhl/DqPY1AyFlIJAz8wwOnP+TWB8OZS13d6XJJmO7j3wgngSryPzXI/KuhKYbapYlScKSf8+1bXv7x5bj7OTh2/I7zwZqv2/T/ACJj/pFvhTz1XoD+GMfke9dDXl2iX/8AZusQXBYiF/kl9Cp7/wBf+A16iORkV3QlzRueHjqPs6l1s/6YUUUVZxBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWN4uh87Qpj/FGVdfzAP6E1s1meJf+QHd/7o/mKDbDu1WL80eaoo3ODu2sD0+uf/ZqfqiC78Ca8kozm3SYD0KnNNhzuUZxxj9Fpt0x/wCEX15e4sJF59AQK89aOx9DNbeq/M8ctjjI9eKtP8xWMdO9Urf71Wrc7nY1ge1Isqgxj0qranZOynvVyFg4JHPaqVzhJVf/AGqCY9id4pYnMkPKnqtS29+h4lG09watQDdFmsnUUUTo3ZuDQJWlozQkSCY5BFQSWMZ6EVSELDlHIFOzPHznIFBXLbZhLbmJuvSpobraQJV49ali/wBIhyRUEe1ZDG4yKQXvuXllhPIYU17pFHy8n2qOOCA4qysVuq54FMh2RnSSOTudTir1gwMRHvUrQpJEdvIqjZP5U7I3Sgd+ZaFhm2XOW4BGKZc25Ztymp7iISrVUyTQDDDco70CXkR+VL600xMOppzXZPRcUscpkPIoL1Ov8A+J/wCzz/Y+pvnTbhsI7f8ALu56MP8AZz1H4+uewnhltLqWKRcOH2H0Pofyrx6UV6f4d1Jtc8OQPOxN1bN9mmb++u3KMffAI/4DWsZXVmediaShL2kdnv69/wCvIuqHhmRoyVljYNGR274/z6CvUdKvV1DT4LlMfOvzAdm7j868sbaIwckMp54PHr+Rrp/A2oGO8lsXP7uUeZGPRh1H5A/lXTQl9k8zHUfaU+Zbr+mdvRRRXSeGFFFFABXFfEHDXVgvdcn/AMeX/Cu1rgvHb7tZt0Un5Y1z+Jb/AOtUz+Fndl6vXT7J/kYCbXYNxnCkZ9SSf61xnxacfZdCX+IfaG/AuuP5Gu0jyASuMg4z7ADNcN8W/v6AvGfsjMfxkb/CvPfws+gw/wDGj/XRnERHFNnyZ/yFOhHzCnxJ5tyPrWJ6xanUmCMepqWGMJfhfUVIq+bMiAfInJNIh3aiSOgoM7mjd4EXHasOAEzuRWzcHdGfpWZYrlnNNkw0RG822YL3NTXSZgDdCOagnjIvEPard1xb4pFvoWABJZrnqRWbbxiQlCcMDwa1YwBbr9KymAyWHHNMmPUteRNGNyPuHpULFpCSCQw7VcsHZoCWPeql43l3IKdT1oBb2JrWXzo2ik61ErNBIVIyKY+UcSL0NTXC+ZGsi9R1oAs2c5hnjntpWjljYOpB6EHOa9Zv2W4EF1GAouoVuVI7bgMj8Cf0ryBYYmi3D5fpXovgqZrrwzNbTuJGsH3R+vlP1H0Df+hVpDqjixcdprpp9/8AwTQkQkMgBVjypPPOc/z/AJ16J4PvTe6FAzHLxfuz+HTPvgivPMPsYuclDg/T/wDVzXQ+BLsQ6rcWZOEmXeo/2hnp/wCPfkK6aEteU8vG0+ei+61O8ooorqPBCiiigAooooAKKKKACiiigAooooAKKKKACszxL/yA7v8A3R/MVp1ieMZRFoM2ersqj8wT+gNCNsOr1YrzR51EN3lKxxlQSR16Ut0pXw3rzD5h9imA+m7/AOvRbRhWQsM4UjpnkGrRVH8K+JDIQFFlMPx5I/pXnrVn0M3bXzX5nh8BxmrSHZbs3fFVIvT1qe4fbCIx1Nc57bWpPpeRASfWlvlzCD71JaIYoAvc02++6kY6k0yPtGhbHFsv0rI1HLTKvoa1EO2MKfSs25GbtaGKG4y5by46mtD5keT0IpL+ItCcU+xGIF+lIpvQfpg2mZewNQSrm7YYJFWbAY8313VDuxevmmT1Y9LZH+6xzUU8TRdTkVKx8udWHQmpbvDIRQF9SSxk3QgVTu1ImYgY702ylMblG6Vcnj8xcjrQL4WQ291tGHqz5iOOCDVKBUJKSDDZ61ObEMMoxU0DdhWVPQU3Kr0xVWeGWEjJJU96I03qWbP0oHYc/wA7e1dv8LZUe81LT2fbJc2++If3nQ5AHvjd+tcPD1YGrWnXk2m6lbXtucSwSCRffB6fQ9KqDs7mden7SDgj1QMGdgfuEZPHX1/p+dFpM9peQXEY/eQuDg9//wBfFSXk0E8sV1bY+z3KLcxg9g3UH6HP5VFINzkkBd3H9D/P9K2T5ZXPMi7rU9ZhkWaJJYzlHUMp9QafWB4KvDdaKiOf3kDGM/TqPyzj8K367z5urT9nNwfQKKKKDMK818TTCbxJcYOVDbR9QFH9Gr0l2CKzMcKoySewryK4kNzd3NwCcuxPTucn/wBmrOq7QZ6mWR96UvK33/8ADCv81vtxkuM8HkEn/wCvXDfF5gdc0yIDAisEz+Luf5EV3oj3TxpGQM4x7noK84+K04n8dX0cZzHbLHAv/AUGf1Jrhl8LPbwutZejf6HKqdqE96t2sZWEY++9U0XzJFTt3rZtVzPnsi1ienJ2HSFbS3Cg/Of1NFtF5Kb2+83JqNE+1X24n5E7VYupB58cQ7nmmZvsFwdsJNU7EdfermpfLBUFivyg0AthLyPlXA6Gi4+aGrcgB4NQyJlStAJk1rh7ZfYYqo9mPMOWO3OcU+zk2boz1FWCwPWgWqZHlYo8DhRWfOfNkJHatNljYYao3tFK5jbFAJpGfE+35X6VYi+UnaflPaq11EycnkUkUpXHpQXuWwrwsWTlT1Fb3gvU4dP1+3lkcpby5hnHYo3Bz9OD+FYkE4brTpoFZfMjpp2d0Zzippxl1PWbqA2148BDYDYOM446/h0plnMbK/tbnn9zJzjuv/1wMf8AAqX7Qb7TdM1EOf8ASIUL+u8fI36jNQz7grK3zPjePqOf6D863i+WVzyo6q0vR/qevKQwBByDyDS1n+H7gXWi2cgx/qwpx6rwf1BrQrvPmpRcZOL6BRRRQSFFFFABRRRQAUUUUAFFFFABRRRQAVyfxCl/0G2tx1kct+Q2/wDs9dZXn3ji4+060luhJEKhSPf7x/mlTJ2TZ25fDmrp9tTFR+QQcEqCBjPJJNUPE0zweAtYkU7fPMMfHu+T+gq6QPJYA4cn5c/kKw/idOsHhHTLZCcXV0831CKF/m1cGybPdiuacY+a/DX9DzKE4bPYVPbgSzlz91elVeiHHU1oWUeIwo79awPYloXFwkZkaoLZDO5nbp/DS3/zMkKnGetW5cW9rhewwKZnsgQ7gT6cVnPzdZ9K0YBi1561nQjdcP7GhhHqXHTfFj2qC2BVSp7GrmMLUTDBBoEmNszid1Pfmo76FlmEkYz602YmORXHFWhMrryRQPZ3KhLTFBtI21O+SealEiDuKcpjk4GKBXMu5Qo+4VZtrgFQDUlxFwRWZtKuQOCKCl7yNKaISjcvDetJHNJFxIM+9VobgggNWiAJI+lAnpuG9JUweQap7fJmZD0PINLzBLj+E1PIBOuDwR0NAtio4KPuHTvT+HGRT0RyCrL070hhZGyKCrnpXhWYXPg2z6F7Wd7Zwf7rfOv82q3IXaIgldy98fUVzXw7ncX91p7fcvITtHbenzL/ACYfjXVrD5m4YJ3dBn14P8q23SZ5VRck5L5/f/TOg8Az7dRu4M/6xPMA+h/+yNdxXBeFrZ4dVgnIxn5WH1GP513td1N3ijwsfb2t11QUUUVZxGL4vuxa6JMM4af90D7H73/joNeepuVEVR82S7Z/z6n9K3PHF59q1VLaNsrCMED+8eT/AOyj86wiWDM6g/Mdqn19P1Jrmry2ie/g6Xs6Kvu9f8jR8OW4n1mEFfkVi2fXb/8AX/nXh/iS6N54k1W6Y5Mt1I34bjiva49TTQPDepau5G+GHyYM/wAUrdB+eD9K8DT5iSxJJ5JPeuappFI9LAxbqTn0Vl+r/QntV+bca07U4hkc9+lZqZbCrWlIBHaBfbFYnoSJNMH3m9TUZIOoZzznFWdPX93mqb/LfE++aZC1bNG/jygB71HAgROKuSgSwKw5qq52rgU2QndWK8swWQAipkwwBqvdQFotw+8OaLaQmHg0i7aaEN3+7l3r1pivNMMjgUr5mmx2FSSyCFQqjLdhQUMMMowd+fap7SY5KmmQTM+cjkU1vlnB9aBPXRk8mJNykYNUNgRyp6VelOJFYdxUdzHkbhQKLsV0+SQelX4Tjch6EZFZbzIhAdwG9M81egnSSbaMgpxz3znp+RoQSa2PR/B0/n+EjCy5NvdNGDn7quoP8w351exnyZDyc8k9wRWX8Nn8yx1u0IywWO5QDr8pIb9CK1FGyEljzvBAH1z/ACrbomeXPSpJef5nceAJt+jPEf8AljKVA9sA/wA91dNXFfD9yl1fwkfKwDL+BJP/AKGK7Wu+Lukz5/Gx5a8vv+8KKKKo5QooooAKKKKACiiigAooooAKKKKAGyyLFE8khCogLMT2A615RPO1xdXFyQd8jNjPYk5P6kD8K7bxvqH2XTBbLzJcHBA/ujr+ZIH4muFSNtqIuMjLk/y/xrCvKysezl1Llpub6/kgdSMAn7oyT6DoP61y/wAaW8nU9Hsughsg5X0ZmOf/AEGuz0SAXepRRsP3b4Zs9Ai5PP1A/WvKPH+tLr/iu9vIiDbhvKhPqi8A/jyfxrllpD1PUw0XKuvJX+/T/Mwo03EHsK07MYI9uaoQ84ArRtwFUmsD1JDD897nsKs35/dLn1qvZjfOx96sagPlAHrTI6osW67rPNVLVBvcnrmremtuhKHtUOPLuJV/GmR1aEuH2g+lNQh04pwTzM5qtFmKVoz9RSKQ6fDw89RVKPe7FV4HrUs7MXKjuamVRDHmgrZEYtSRy5zSLvt2GSSKcsrM/tT5xujJPagNepayHjzms+7j2tuFWrZsxlfakK+ZGVPUcUEq62KLAMuRWhYvlAKzypjJU1csDgUFPVDrwd6jUkAEA4qxMhcVYtrb5FJGT6U7EcySIInxjNSkmRsAVqW+mmUj5OvtW7pPhxnflOtWoNnPUrwjqyn4ThaDV7GUA5jlVifbPNeo2GkkXDArwrMP1qHQPDcVuis65auut4ljHHWuunS01PBxeM5pe6RWVmsDZwKu0lLW6Vjy5ScndhVTVLxbCwmuXwdi/KD3Y8AfnirdcT48vvMuILCM8L88hB6Ej+gz/wB9ChuyuzbC0fbVFF7dfQ5fzHkkknLbnckhj3JPX+Z/GnYMkkccbMQPzyQcUErjn5UClV9jirVnJHY29zqt2CYbKNrhx6sPur+JwK4W+aVz6CcrK5wnxd1RRc2nh+3bMdiPMnIPDTMB/wCgjj8TXnydat3txJfXU95dNunnkaR29WJyaghTLnFYSlzO569Cn7Kmof1fqXrOIcMalu3zhfU0iny4+ahjzNcj0FIe+psWnEFUrj/Xk+1XkG2Ks+Y5loIjuato2bbBqlcybZgvbvVq2OIKzpzumJpiitWaGMxH6Vmp+7mdOx5rTAIi/CsqckXIxSHAswoMk4qjfOI3Lt0ArQg5Bqlq0ZKoVGTuBx685oHewmnuxbDpt3AsOcn8fzpupyyQyQFE3qxIOOv+ev5VJbpMZhJ5eIwmwKTg9Rk/59KZLZXPmE+aGQZ2bxkjNBm5PoRpdOsSGVGkdnfhccANj+uKLi6mLTQR8uuAoQZbtV7TdP8AlIZd4YbcMM8en61vWOkBRtSMKCc4AppNmcm4qzZyy2LyS7nUrls4I5Ixj/69blhpCRneEzIRy55b866a20NnK4Tmun03w0X25WtI0mzmq4uETA8FRSafrsErKfJlBhl/3W4/Q4P4V19vok8l1JFIBhSVLDv2rf0zQIIQC6gkVvRQJGMKAK6o0dNTyK+PvJuJR0bTksjuQDcVwT+X+FatNXANO7VulZWPMnNzd2FFFFMgKKKKACiiigAooooAKKKKACiisTxdqH2DR5NrESzfu1I6gfxH8s/iRQXTpupNQXU4zxHef2nrEzxnMKDardsDgH+Z/EVQblH6hnOAR2GP6CkAIjKNgEjc4/p/IVPZwG8u1jTgudqg9ieCa4akueWh9IkoRSWyMvxnqH9i+D38rK3epsbdDnlYgAXI+vC/jXjxPIrsPibrEeqeJGgtWzZ2C/ZYvRiD8zfic/gBXIYBdQKwqO7suh6eDp8lO73ev+X4Fq2HNXHfZGarwrtGaZM5fCr0zUm+7L+l+p71PfHg/Wkso9kY+lMvT2oM95Emmthz9KZqTbbjcvUil04ndTNSO6X3AoD7RNZndGPWq+oDa6sOoNWLBT5fFV9RPyH60AviGRDLZp16P3fFNtSdq5qe4XMTfSgezKNtl5fYVckHyGoLFDtz3NXPLZl4oCT1Ktoeo7ipeRN7GkhtZDccA1t2ulPIysRTSbInOMdTFntWkAZR0q9p1g20ZFdPa6MzKBt/St/TPDzMBlcfhWkabZyVMZGKschDpLyZ2rmtfT/D8rMPk4ru7DQgh5Wt600tEA4FbxonmVcwtojltH8P427k6e1dZa6Ykaj5QK0IoFQDAqYDFdEYJHl1cRKbI44go4qTaKWirOe4UUUUCIrmeO2t5J5m2xxqWY+wryi7uZbu7nuGGZJXIA9+pH0HA/CvUtSt/tdo8JOA2M/zrlrrw1tI8vIVQQPrWVVNxsj0sBVp0k+bd/kcoNu5UDggDcST+n5/yrD+KmoGy0ey0G2/1k+Lq6IPb+BD/PHsK7uy0GX7ajTACFDvfA6gDp/n1rmvEHhqXUtSuLydSZJW3fQdh+AwK5uSVmenTr0/apt6LX59Dxxo2EfQ1LZRnGSO9eg3XhBgMBf0pieFWjTAXpWPsmen9dptbnCzlmbaOg61a06FslyOvSuqj8KSM2WHetGHw4yLgLR7Nili6drJnKS5VMVlHLXAAzXfT+HnI+7UNp4Ucz7itP2bIjiqaW5zeHWDAFV4bd3kxjjNd+fDDEAYqzbeF9mCV/Sn7JkfXaaOImhZYQMVkG3ke4ztNepy+HSwwF4+lJb+FPmyV/Sn7JkLHQijz63spNudpom0+R3QbSea9Ui8MAADb+lWofC6mQEqOKr2LMnmMEeZ2ujStj5TWnF4fdl+4efavULbw9GmMqK0YtIhUfdFaKgclTM+x5tpvhlxt+T9K6iw8OBQCy/pXXw2aRjAUVYWMAcCtY0kjhq46czGtdHjQD5RWpDbpGMACpwMdKXb61olY45VHLcQD0pcGnAUuKoi40CnUUUCAUUUUAFFFFABRRRQAUUUUAFFFFABXn3jO8a71UQrn7PbA59yOT+uB+Br0Gsm60W3njYMo3N1PrUzTaaR1YSrGjPnkeahtqF2z5jYI98nj/GpdRu/7F8NX2pwnFyB9ntTjnzGHJH0XJrrLzwxufMJwPT3qh4j8PNdQW1ttzBbpge7Hqa5VTkj1PrVKbSvp1PnlbeTqQabFCxm6HivX5/BwAOI/wBKor4R2kny+T7Vj7FnrLMKbPOJVZUAA5PFLaW7PLjHAr0GTwkzSZ2HH0qzb+FzEOE/Sl7Jg8bTtuccqFE6Vm3u7PTk16S/h04+5VRvCpkkGU4+lP2TJjjKa1ZxljE6x5xzTJLeSSQ8ck16VH4X2x4CfpT4/DGGyUo9kyPr0NzhLa0ZIelZ17ayOwABr1NtBONqpUSeGWZ8mM/lVeyZKx0U7nnFpp0hA+U8Vbk02RkI2mvS4fDm0fc/SrMfh0ZHy/pTVFmcsxiea6foMjIMqRW1beHeBlTXo1roaKB8orRh0pFH3RWkaByVMyb2PO7Lwzl8hK6Kx8NhcblrsILNE7CrKxqDWsaSRw1MdORh2uixRgfLWnBZJGOBV3AHSitFFI5JVZS3I1hUdqlVQKAKcKozbCiiigQUUUUAFFFA6UAIRk0mOKdRQBCYwc5HWontI26qKt0YpWK5mZkmmwt/CKhOkw/3RWzijAo5UUqsl1MX+yIf7gpRpMX9ytnAoxS5UP2su5iNpEJ/gpyaXEp4WtnApNoo5UHtZdzL+wRj+EUfZE6ba1NopNgo5Re0ZnrZJnO0VILVB/DV3aKNop2FzsqCFR2p6RgdqsbRRgUWFzEW2nAVJijFMVxuKXFLRQITFLiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKMUUUAIRmmtGGHOKfRQBVezRj0H5VGdNjPYflV6ilYpTaM06VHnjH5UDSk9R+VaVFHKh+0l3M06VGfT8qT+yUHQj8q06KLIPaS7mf/Zq+o/Kl/s5fUflV+iiyD2kimtigHb8qcLNB2FWqKLC5mV/sq+1KLZR6VPRRYXMyMRAelLsp9FMLjNnvTttLRQITFLiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     Distinction between a sliding hiatal hernia (type I) and paraesophageal hernia (type II). With type I hernia, the leading edge is the gastric cardia while with type II it is the gastric fundus. The SC junction&nbsp;maintains its native position in the paraesophageal hernia while it is displaced upward with the sliding hernia.",
"    </p>",
"    <div class=\"footnotes\">",
"     SC: squamocolumnar.",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      Kahrilas PJ, Kim HC, Pandolfino JE. Approaches to the diagnosis and grading of hiatal hernia. Best Pract Res&nbsp;Clin Gastroenterol 2008; 22:601.",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_59_31671=[""].join("\n");
var outline_f30_59_31671=null;
var title_f30_59_31672="NSAIDs (including aspirin): Allergic and pseudoallergic reactions";
var content_f30_59_31672=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   NSAIDs (including aspirin): Allergic and pseudoallergic reactions",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/59/31672/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/59/31672/contributors\">",
"     Ronald A Simon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/59/31672/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/59/31672/contributors\">",
"     N Franklin Adkinson, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/59/31672/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/59/31672/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/59/31672/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonsteroidal antiinflammatory drugs (NSAIDs), including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    (ASA), are associated with an array of adverse effects, ranging from mild gastritis to life-threatening allergic reactions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/49/17177?source=see_link\">",
"     \"Nonselective NSAIDs: Overview of adverse effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The ingestion of NSAIDs can give rise to several allergic and \"pseudoallergic\" reactions. Allergic reactions are abnormal immunologic reactions to NSAIDs, while pseudoallergic reactions are non-immunologic reactions that are believed to result from acquired alterations in the biochemical pathways upon which NSAIDs act.",
"   </p>",
"   <p>",
"    The prevalence of allergic and pseudoallergic reactions to NSAIDs in the general population is not known. These reactions occur sporadically in both children and adults. Symptoms include rhino-conjunctivitis, bronchospasm,",
"    <span class=\"nowrap\">",
"     urticaria/angioedema,",
"    </span>",
"    and anaphylaxis.",
"   </p>",
"   <p>",
"    In addition to allergic reactions, there are various types of idiosyncratic adverse reactions to",
"    <span class=\"nowrap\">",
"     NSAIDs/ASA",
"    </span>",
"    that are presumed or known to involve other types of immune mechanisms. These include, but are not limited to, aseptic meningitis, hypersensitivity pneumonitis, thrombocytopenia, interstitial nephritis, erythema multiforme, fixed drug eruptions, toxic epidermal necrolysis, Stevens Johnson syndrome, erythema nodosum, maculopapular eruptions, and bullous leukocytoclastic vasculitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/1\">",
"     1",
"    </a>",
"    ]. These types of reactions are discussed in various topic reviews. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/49/17177?source=see_link\">",
"     \"Nonselective NSAIDs: Overview of adverse effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/17/41241?source=see_link\">",
"     \"Drug eruptions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=see_link\">",
"     \"Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical manifestations of allergic and pseudoallergic reactions caused by",
"    <span class=\"nowrap\">",
"     NSAIDs/ASA",
"    </span>",
"    will be reviewed here. The challenge protocols used by allergy specialists to evaluate and manage affected patients are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26006?source=see_link\">",
"     \"Diagnostic challenge and desensitization protocols for NSAID reactions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION OF NSAIDs",
"    </span>",
"    &nbsp;&mdash;&nbsp;NSAIDs inhibit the cyclooxygenase (COX) enzymes (also known as prostaglandin H synthases). There are two known COX isoenzymes, COX-1 and COX-2.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      COX-1 is expressed constitutively in all human cell types and is involved in protective physiologic functions (such as gastric mucosal protection). Inhibition of COX-1 impairs these protective functions and is generally undesirable. As an example, COX-1 inhibition by NSAIDs results in diminished production of the protective compound prostaglandin E2 in the gastric mucosa, leading to gastritis in susceptible patients.",
"     </li>",
"     <li>",
"      COX-2 is an inducible enzyme expressed in many inflammatory cells in the presence of appropriate stimuli. COX-2 mediates the generation of the same range of prostaglandins as COX-1, but only at sites of inflammation. Thus, COX-2 inhibition is largely responsible for the desired antiinflammatory effects of NSAIDs.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The various NSAIDs inhibit COX-1 and COX-2 to different degrees.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     Aspirin",
"    </a>",
"    is a strong inhibitor of COX-1. NSAIDs that inhibit both COX-1 and COX-2 are called nonselective, while those that predominantly inhibit COX-2 are called COX-2 selective. In this topic, NSAIDs that inhibit COX-1 are said to be \"cross-reactive\" with aspirin (",
"    <a class=\"graphic graphic_table graphicRef62880 \" href=\"mobipreview.htm?39/38/40556\">",
"     table 1",
"    </a>",
"    ). The mechanism of action of NSAIDs and the different types of agents available are reviewed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/19/1336?source=see_link\">",
"     \"NSAIDs: Mechanism of action\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLASSIFICATION OF REACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;NSAID reactions can be categorized as either pseudoallergic or allergic.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pseudoallergic NSAID reactions - Pseudoallergic reactions are non-immunologic reactions that are related to the COX-1 inhibiting properties of the drug. In susceptible individuals, these reactions may be elicited by any NSAID that inhibits COX-1, including",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      (",
"      <a class=\"graphic graphic_table graphicRef62880 \" href=\"mobipreview.htm?39/38/40556\">",
"       table 1",
"      </a>",
"      ). Affected patients are believed to have acquired alterations in the biochemical pathways affected by COX-1-inhibitors, although the precise mechanism underlying pseudoallergic reactions has not been established.",
"     </li>",
"     <li>",
"      Allergic NSAID reactions - Allergic NSAID reactions are presumed to be IgE-mediated immunologic reactions based upon their clinical characteristics. These are elicited by a single NSAID in a susceptible individual.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, pseudoallergic reactions are induced by multiple different NSAIDs, while allergic reactions are usually induced by a single NSAID or a small number of structurally similar agents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PSEUDOALLERGIC REACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pseudoallergic reactions are elicited by any COX-1 inhibiting NSAID, and the likelihood that an NSAID will cause these in a susceptible patient is related to the strength with which that drug inhibits COX-1. Pseudoallergic reactions are usually seen in patients with one of the following comorbidities: the combination of asthma and chronic rhinosinusitis with nasal polyposis; or chronic urticaria.",
"   </p>",
"   <p>",
"    Pseudoallergic reactions can be divided into four types [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Type 1: NSAID-induced asthma and rhinosinusitis",
"     </li>",
"     <li>",
"      Type 2: NSAID-induced",
"      <span class=\"nowrap\">",
"       urticaria/angioedema",
"      </span>",
"      in patients with chronic urticaria",
"     </li>",
"     <li>",
"      Type 3: NSAID-induced",
"      <span class=\"nowrap\">",
"       urticaria/angioedema",
"      </span>",
"      in otherwise asymptomatic individuals",
"     </li>",
"     <li>",
"      Type 4: Blended reactions in otherwise asymptomatic individuals",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Type 1: NSAID-induced asthma and rhinosinusitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;NSAID ingestion precipitates a constellation of naso-ocular",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lower respiratory symptoms in some patients with concomitant asthma and chronic rhinosinusitis (often with nasal polyposis). These include one or more of the following: rhinorrhea; nasal congestion; periorbital edema",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    injection of the conjunctiva; bronchospasm;",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    laryngospasm. Some patients can experience hives",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    angioedema in addition to the respiratory tract symptoms. A few patients with severe respiratory reactions have accompanying extra-respiratory tract symptoms, such as flushing, abdominal pain, diarrhea, and hypotension. These reactions are termed type 1 pseudoallergic reactions.",
"   </p>",
"   <p>",
"    Patients with the combination of NSAID pseudoallergy, asthma, and chronic rhinosinusitis with nasal polyposis are said to have",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    exacerbated respiratory disease (AERD). AERD and the diagnosis of aspirin pseudoallergy are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/0/39944?source=see_link\">",
"     \"Aspirin exacerbated respiratory disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/54/18281?source=see_link\">",
"     \"Aspirin exacerbated respiratory disease: NSAID challenge and desensitization\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Type 2: NSAID-induced urticaria/angioedema in patients with chronic urticaria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with a history of chronic urticaria can develop an exacerbation of their hives, sometimes with angioedema, beginning one to three hours after ingestion of ASA or NSAIDs that inhibit COX-1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. The exacerbating effects of",
"    <span class=\"nowrap\">",
"     NSAIDs/ASA",
"    </span>",
"    may be noticeable in up to 30 percent of patients with stable chronic urticaria, and higher rates of NSAID sensitivity are typical in patients with active urticaria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/5\">",
"     5",
"    </a>",
"    ]. These reactions are usually dose dependent.",
"   </p>",
"   <p>",
"    Avoidance of COX-1 inhibiting NSAIDs can be helpful in minimizing acute flares in chronic urticaria, although it does not appear to alter the long-term course of the condition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. The management of patients with chronic urticaria is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/7/117?source=see_link\">",
"     \"Chronic urticaria: Standard management and patient education\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Type 3: NSAID-induced urticaria/angioedema in otherwise asymptomatic individuals",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is an uncommon form of pseudoallergy seen in children and adults WITHOUT underlying chronic urticaria, in which patients develop acute urticaria",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    angioedema after ingestion of COX-1 inhibiting",
"    <span class=\"nowrap\">",
"     NSAIDs/ASA.",
"    </span>",
"    Isolated angioedema following NSAID ingestion typically involves the facial areas, particularly the periorbital skin, lips, and mouth. These patients may develop urticaria",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    angioedema only after NSAID ingestion or may have intermittent episodes of unexplained urticaria unrelated to NSAID ingestion, but they do not have underlying chronic urticaria (ie, recurrent episodes of",
"    <span class=\"nowrap\">",
"     urticaria/angioedema",
"    </span>",
"    persisting for six weeks or longer). It is not known whether these patients subsequently develop chronic urticaria more frequently than the general population.",
"   </p>",
"   <p>",
"    The probable mechanism is related to COX-1 inhibition, as patients with type 3 pseudoallergy can react to their very first dose of a COX-1 inhibitor and to structurally different COX-1 inhibiting NSAIDs. In addition, such patients tolerate highly selective COX-2 inhibiting NSAIDs (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/11/40120?source=see_link\">",
"     celecoxib",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Type 4: Blended reactions in otherwise asymptomatic individuals",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasionally reactions to",
"    <span class=\"nowrap\">",
"     NSAIDs/ASA",
"    </span>",
"    do not fit into the above three reaction types. Patients without apparent underlying conditions may develop combinations of symptoms affecting both the respiratory tract and skin, including bronchospasm, rhinitis, urticaria,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    angioedema after ingestion of different COX-1 inhibiting NSAIDs. These reactions are usually triggered by multiple COX-1 inhibiting NSAIDs and may represent a combination of mechanisms. Until they are better characterized, these reactions have been classified as a separate type.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     ALLERGIC REACTIONS (PRESUMED IgE-MEDIATED)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic reactions to NSAIDs range from",
"    <span class=\"nowrap\">",
"     urticaria/angioedema",
"    </span>",
"    to life-threatening anaphylaxis. In contrast to pseudoallergic reactions, these reactions are elicited by a single NSAID, or rarely by more than one agent with similar molecular structures. Patients with allergic reactions to an NSAID have had at least one prior exposure to the culprit drug, which presumedly sensitizes them and results in symptoms upon repeat exposure to the same drug [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These reactions are believed to be IgE-mediated, and the allergen is thought to be a drug metabolite bound to a carrier protein. While most of these reactions have been associated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/38/15978?source=see_link\">",
"     ibuprofen",
"    </a>",
"    , the first NSAID to become available over the counter in the United States, they can happen with any COX-1 inhibitor. There has been one case report of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    -induced angioedema with measurable specific IgE to",
"    <span class=\"nowrap\">",
"     aspirin/human",
"    </span>",
"    serum albumin complex [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/12\">",
"     12",
"    </a>",
"    ]. However, the generalizability of this finding is unknown, and at present, there are no practical or commercially available tests to detect IgE to NSAIDs (such as skin testing or drug-specific serum IgE tests).",
"   </p>",
"   <p>",
"    Allergic reactions may be divided into two types, based solely upon the severity of the symptoms. The underlying mechanism is believed to be the same.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Type 5: Urticaria/angioedema to a single NSAID",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with type 5 reactions typically develop urticaria",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    angioedema within minutes to one hour of taking a particular NSAID or ASA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/9,13\">",
"     9,13",
"    </a>",
"    ]. Affected individuals generally do not have underlying chronic urticaria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Type 6: Anaphylaxis to a single NSAID (not ASA)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type 6 reactions are distinguished from type 5 reactions based only upon severity. Patients with anaphylaxis have usually experienced urticarial reactions to the culprit NSAID in the past, but did not realize the association and continued to re-expose themselves to the drug. Typical symptoms of anaphylaxis include shortness of",
"    <span class=\"nowrap\">",
"     breath/wheezing",
"    </span>",
"    due to bronchospasm or laryngeal edema and hypotension due to vascular collapse. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35290?source=see_link\">",
"     \"Anaphylaxis: Rapid recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Anaphylaxis has been reported with various NSAIDs, including most of the COX-1 inhibiting agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/14-17\">",
"     14-17",
"    </a>",
"    ], as well as from",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/11/40120?source=see_link\">",
"     celecoxib",
"    </a>",
"    (a highly selective Cox-2 inhibitor) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. However, it is notable that there are no confirmed cases of anaphylaxis to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    itself.",
"   </p>",
"   <p>",
"    There are also reports of anaphylaxis due to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen (paracetamol)",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. This agent is an antipyretic and pain reliever, rather than an antiinflammatory.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presumptive diagnosis of an allergic or pseudoallergic reaction to an NSAID is based upon the historical details of the reaction. There are no in vitro or skin testing methods available. Definitive diagnosis requires a challenge procedure, although this is only indicated if the patient has a specific need for regular NSAID therapy (ie, usually NSAIDs for rheumatologic disease or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    for cardiovascular disease).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain critical pieces of information should be obtained from the history, if possible:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Is the reaction elicited by one NSAID or multiple NSAIDs? It is important to discern if the patient took any other COX-I inhibiting NSAIDs",
"      <strong>",
"       subsequent to",
"      </strong>",
"      the first recognized reaction. If so, did this drug also cause a reaction? In contrast, NSAIDs that were ingested without problems",
"      <strong>",
"       before",
"      </strong>",
"      the first reaction are not relevant, because reactions to NSAIDs are nearly always acquired (rather than present from birth).",
"     </li>",
"     <li>",
"      Is there underlying",
"      <span class=\"nowrap\">",
"       asthma/sinusitis/nasal",
"      </span>",
"      polyposis (ie, AERD) or chronic idiopathic urticaria? Any recurrent symptoms of asthma or sinus problems or previous episodes of urticaria should be explored to discern if one of these conditions may be present but undiagnosed. These chronic conditions usually develop before the NSAID reaction, with rare exceptions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Challenge procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a definitive diagnosis is required, then a challenge procedure must be performed. This is usually only indicated if the patient has a medical need for future NSAID therapy and it is necessary to determine if the patient could tolerate NSAIDs other than the one that caused the reaction, or could be desensitized to NSAIDs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1362385\">",
"    <span class=\"h2\">",
"     Diagnostic strategy",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is sometimes difficult to determine what type of reaction has occurred if a patient has had only one event and has avoided all NSAIDs since. As an example, if a patient with asthma developed flushing and bronchospasm after taking",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/29/38352?source=see_link\">",
"     diclofenac",
"    </a>",
"    , then the reaction may have been type 1, type 4, or type 5. Without additional information, the clinician must initially advise the patient to avoid all NSAIDs. However, a challenge procedure with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    would clarify whether the patient reacts to all COX-1 inhibitors (pseudoallergic), or only to diclofenac (allergic).",
"   </p>",
"   <p>",
"    The protocols used in challenge and desensitization are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26006?source=see_link\">",
"     \"Diagnostic challenge and desensitization protocols for NSAID reactions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/54/18281?source=see_link\">",
"     \"Aspirin exacerbated respiratory disease: NSAID challenge and desensitization\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The type of NSAID reaction (ie, pseudoallergic or allergic) determines the possible management options. If the symptoms of the reaction were severe, and the type of reaction is uncertain, then the patient should avoid all NSAIDs until further evaluation can be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1362414\">",
"    <span class=\"h2\">",
"     Referral",
"    </span>",
"    &nbsp;&mdash;&nbsp;Referral to an",
"    <span class=\"nowrap\">",
"     allergist/immunologist",
"    </span>",
"    with expertise in drug allergy is recommended if the reaction was severe or life-threatening, or if avoidance of all NSAIDs is not feasible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Advice on avoidance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with allergic or pseudoallergic reactions to NSAIDs should be advised to read over-the-counter medications labels carefully:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Combination medications, such a multi-symptom cold preparations, often contain NSAIDs.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/29/35285?source=see_link\">",
"       Bismuth",
"      </a>",
"      subsalicylate is a component of over-the-counter antidiarrhea and upset stomach preparations, which is metabolized to salicylic acid and thus can precipitate symptoms.",
"     </li>",
"     <li>",
"      Dietary salicylates do not cause symptoms in NSAID-sensitive patients as they are not significant COX-1 inhibitors.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Reactions of uncertain type",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the type of NSAID reaction cannot be determined based upon the available historical information and the patient's underlying conditions, then the simplest approach is avoidance of all NSAIDs.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For treatment of minor pain, most patients can safely receive doses of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"       acetaminophen (paracetamol)",
"      </a>",
"      , up to 650 mg per dose. This includes patients with AERD and extreme sensitivity to COX-1 inhibitors. However, approximately 20 percent of patients with AERD react to",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      at a dose of 1000 mg, since acetaminophen weakly inhibits COX-1 at higher doses. Patients with AERD are usually identifiable clinically by the presence of concomitant asthma and chronic rhinosinusitis.",
"     </li>",
"     <li>",
"      Narcotic pain medications are an option for more severe pain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Types 1 to 4 - treatment options",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with pseudoallergic NSAID reactions who require subsequent antiinflammatory therapy have several options. The best option for an individual patient depends upon that patient&rsquo;s antiinflammatory and pain relief needs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Acetaminophen only",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     Acetaminophen (paracetamol)",
"    </a>",
"    is usually tolerated at doses up to 650 mg (per dose) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/22\">",
"     22",
"    </a>",
"    ]. This is the simplest option for patients with pseudoallergic reactions, provided",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    provides adequate pain relief and antiinflammatory therapy is not needed. Very sensitive patients with AERD may react with mild symptoms, as discussed previously. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Reactions of uncertain type'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Weak COX-1 inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The NSAIDs listed below are weak inhibitors of COX-1. One of these agents is a reasonable choice for patients who require some antiinflammatory effect and can obtain adequate pain relief with a relatively weak NSAID. At higher doses, these agents may inhibit COX-1 enough to cause symptoms, so we suggest limiting the dose to that specified for each drug. Even with these lower doses, highly sensitive patients may develop symptoms.",
"   </p>",
"   <p>",
"    Non-acetyl salicylates:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/14/5350?source=see_link\">",
"       Salsalate",
"      </a>",
"      (up to 2000 mg daily, divided into two or three doses)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?41/43/42677?source=see_link\">",
"       Choline magnesium trisalicylate",
"      </a>",
"      (up to 2000 mg daily, divided into two or three doses)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/41/25240?source=see_link\">",
"       Diflunisal",
"      </a>",
"      (up to 1000 mg daily, divided into two or three doses)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because not all patients will tolerate these agents, we suggest that any patient whose reaction to standard NSAIDs was severe should be in a medically supervised setting when these agents are administered for the first time. We administer the highest dose that we expect the patient to tolerate (ie, the doses specified above) and observe for three hours.",
"   </p>",
"   <p>",
"    Nimesulide (not available in the United States) and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/38/35432?source=see_link\">",
"     meloxicam",
"    </a>",
"    are agents that are weakly selective for COX-2 but also inhibit COX-1. We have found that many patients with pseudoallergy react to these, and so we avoid the use of these agents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Highly selective COX-2 inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;COX-2 inhibitors demonstrate at least a 200- to 300-fold selectivity for inhibition of COX-2 over COX-1 at the defined therapeutic doses, although not all COX-2 inhibitors are classified as highly selective (",
"    <a class=\"graphic graphic_figure graphicRef82145 \" href=\"mobipreview.htm?5/51/5950\">",
"     figure 1",
"    </a>",
"    ). Highly selective COX-2 inhibitors are tolerated by most patients with pseudoallergic reactions to NSAIDs. This option is appropriate for patients who need an antiinflammatory agent, have had gastrointestinal toxicity with NSAIDs, or are not seeking to take",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    for its cardioprotective effects. Selective COX-2 inhibitors include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/11/40120?source=see_link\">",
"     celecoxib",
"    </a>",
"    (available worldwide), etoricoxib, parecoxib, and lumiracoxib (the latter three are not available in the United States). The dosing and side effects of COX-2 inhibitors are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/48/13066?source=see_link\">",
"     \"Overview of selective COX-2 inhibitors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/27/39351?source=see_link\">",
"     \"COX-2 selective inhibitors: Adverse cardiovascular effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      -intolerant asthma and AERD (type 1) consistently tolerate",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/11/40120?source=see_link\">",
"       celecoxib",
"      </a>",
"      during placebo-controlled challenges [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/23,24\">",
"       23,24",
"      </a>",
"      ]. It is our practice simply to advise the patient with AERD that it is safe to take a highly selective COX-2 inhibitor, such as celecoxib.",
"     </li>",
"     <li>",
"      The data are not as clear regarding type 3 pseudoallergy",
"      <span class=\"nowrap\">",
"       (urticaria/angioedema",
"      </span>",
"      in otherwise asymptomatic individuals). There is one report of 252 subjects with type 3 pseudoallergy in which some patients reacted to 1000 mg",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"        acetaminophen",
"       </a>",
"       /paracetamol",
"      </span>",
"      in placebo controlled challenges, indicating sensitivity to even weak COX-1 inhibition (note that this dose is higher than that recommended in option 1 above) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/25\">",
"       25",
"      </a>",
"      ]. Among these subjects, 25 percent also demonstrated cross-reactivity with a highly selective COX-2 inhibitor, etoricoxib. The reactions were quite mild and resolved rapidly after administration of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/2/33824?source=see_link\">",
"       diphenhydramine",
"      </a>",
"      . Other case reports of apparent exceptions exist, although these are likely flawed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/26,27\">",
"       26,27",
"      </a>",
"      ]. Based on this one report [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/25\">",
"       25",
"      </a>",
"      ], some clinicians may prefer to give an initial dose of COX-2 inhibitor to highly sensitive patients with type 3 pseudoallergy in a medically supervised setting (eg, a clinic), at least until these data have been reproduced.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Desensitization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Desensitization is a technique in which the patient is given incrementally increasing doses of a medication under medical supervision, to induce a state of temporary tolerance. After a patient has been successfully desensitized to an NSAID, that agent or another equivalent NSAID",
"    <strong>",
"     must be ingested daily in order to maintain tolerance",
"    </strong>",
"    . Therefore, desensitization is appropriate in patients who require daily NSAIDs for an inflammatory disorder or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    for antiplatelet therapy.",
"   </p>",
"   <p>",
"    NSAID desensitizations are usually performed by allergy specialists. Some pulmonary specialists are also experienced in this procedure. The supervising specialist should have experience in recognizing and treating the symptoms that may arise during these procedures. Desensitizations are performed in medical settings equipped with appropriate medications, equipment, and support staff. NSAID desensitizations are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26006?source=see_link\">",
"     \"Diagnostic challenge and desensitization protocols for NSAID reactions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The different types of pseudoallergic reactions are variably amenable to desensitization. Patients with type 1 (AERD) pseudoallergic reactions can be reliably and consistently desensitized. Patients with type 2 reactions are difficult to desensitize and avoidance of NSAIDs with significant COX-1 inhibiting properties is the preferred approach to management. Desensitization can be attempted in patients with types 3 and 4 reactions, although it is not uniformly successful.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Type 1",
"      </strong>",
"      -",
"      <span class=\"nowrap\">",
"       ASA/NSAID",
"      </span>",
"      exacerbated respiratory disease (AERD): Patients with AERD can nearly always be desensitized to",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      . Once they have been successfully desensitized to aspirin, they are able to ingest other NSAIDs safely and can take different NSAIDs interchangeably. Desensitization enables AERD patients with cardiovascular disease to take prophylactic daily aspirin, or those with rheumatologic conditions to take daily NSAIDs. Furthermore, daily aspirin therapy ameliorates the inflammation underlying sinus and pulmonary disease in AERD, and can be used to treat both asthma and chronic rhinosinusitis with nasal polyposis. Aspirin desensitization and the management of AERD are reviewed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/54/18281?source=see_link\">",
"       \"Aspirin exacerbated respiratory disease: NSAID challenge and desensitization\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Type 2",
"      </strong>",
"      -",
"      <span class=\"nowrap\">",
"       ASA/NSAID-induced",
"      </span>",
"      <span class=\"nowrap\">",
"       urticaria/angioedema",
"      </span>",
"      with underlying chronic urticaria: Patients who need antiinflammatory or pain medications may tolerate a highly selective COX-2 inhibitor or an NSAID that weakly inhibits COX-1, as outlined above.",
"      <br/>",
"      <br/>",
"      Desensitization is NOT generally a useful modality in these patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/5,28\">",
"       5,28",
"      </a>",
"      ]. Although they can sometimes be successfully desensitized at first, almost all patients have recurrent reactions over time, presumably because the ongoing presence of NSAIDs aggravates the underlying chronic urticaria [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/5,28,29\">",
"       5,28,29",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Despite this, patients with type 2 reactions who need",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      for cardioprotection can sometimes tolerate 81 mg dose of aspirin daily without significant worsening of their symptoms. We usually give one-half of a tablet (40.5 mg) initially, wait approximately three hours, and then give 81 mg. If the patient reacts to either step, we repeat that step until it is tolerated. Alternatively, patients may be treated with other antiplatelet therapies. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/20/39242?source=see_link\">",
"       \"Antiplatelet agents in acute non-ST elevation acute coronary syndromes\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Type 3",
"      </strong>",
"      -",
"      <span class=\"nowrap\">",
"       ASA/NSAID-induced",
"      </span>",
"      <span class=\"nowrap\">",
"       urticaria/angioedema",
"      </span>",
"      without underlying chronic urticaria: Patients with type 3 pseudoallergic reactions can be successfully desensitized, although it may be difficult because they tend to react multiple times during the desensitization procedure. Suggestions for approaching desensitization in these patients are found separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26006?source=see_link\">",
"       \"Diagnostic challenge and desensitization protocols for NSAID reactions\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Type 4",
"      </strong>",
"      - Blended reactions in otherwise asymptomatic individuals: Desensitization can be attempted in patients with type 4 pseudoallergic reactions, but it is not uniformly successful. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26006?source=see_link\">",
"       \"Diagnostic challenge and desensitization protocols for NSAID reactions\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Types 5 and 6 - treatment options",
"    </span>",
"    &nbsp;&mdash;&nbsp;Types 5 and 6 are presumed IgE-mediated reactions to single NSAIDs. Patients with these types of reactions should avoid the causative agent.",
"   </p>",
"   <p>",
"    Patients with types 5 and 6 reactions may require diagnostic challenge with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    to confirm that they are not sensitive to all COX-1 inhibitors (ie, exclude pseudoallergy), if the history is not sufficient to make this determination. This can be safely undertaken by an allergy specialist even in patients with life-threatening anaphylaxis to an NSAID, since confirmed cases of anaphylaxis to aspirin have not been reported.",
"   </p>",
"   <p>",
"    Patients with types 5 or 6 reactions may safely take NSAIDs that are structurally dissimilar to the drug that caused the initial reaction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31672/abstract/30\">",
"     30",
"    </a>",
"    ]. Chemical groupings of NSAIDs are shown in the table (",
"    <a class=\"graphic graphic_table graphicRef70067 \" href=\"mobipreview.htm?23/54/24431\">",
"     table 2",
"    </a>",
"    ). Desensitization to the individual NSAID to which the patient is allergic is not indicated, since there is an array of alternative COX-1 inhibitors available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adverse and idiosyncratic reactions to NSAIDs (including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    ) may be classified as pseudoallergic or allergic. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H3\">",
"     'Classification of reactions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pseudoallergic reactions are related to the inhibition of COX-1 and may be triggered by",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      and all (\"cross-reacting\") COX-1 inhibiting NSAIDs (",
"      <a class=\"graphic graphic_table graphicRef62880 \" href=\"mobipreview.htm?39/38/40556\">",
"       table 1",
"      </a>",
"      ). These reactions are usually seen in patients with certain pre-existing conditions, specifically, either the combination of asthma, nasal polyps, and chronic rhinosinusitis (ie, AERD) or chronic urticaria. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pseudoallergic reactions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Allergic reactions to NSAIDs are characterized by urticaria, angioedema, or anaphylaxis in response to a single drug or a small number of structurally related drugs. These reactions are presumed to be IgE-mediated, although there are limited data about mechanism(s). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Allergic reactions (presumed IgE-mediated)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The presumptive diagnosis of an allergic or pseudoallergic reaction to an NSAID is based upon the historical details of the reaction(s) and the presence of certain underlying conditions. It is critical to determine if the patient has taken other NSAIDs since the initial reaction, and whether the other drugs also caused symptoms. There are no in vitro or skin testing methods available. Definitive diagnosis requires a challenge procedure, although this is only indicated if the patient has a specific need for subsequent NSAID therapy. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Challenge procedures have been established for the evaluation of both allergic and pseudoallergic NSAID reactions. These should be performed by allergy specialists with experience in the techniques involved. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26006?source=see_link\">",
"       \"Diagnostic challenge and desensitization protocols for NSAID reactions\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Management depends upon the type of NSAID reaction present. Patients with reactions to NSAIDs that cannot be characterized as pseudoallergic or allergic based on the available information should avoid all NSAIDs if possible. If treatment of minor pain is required, we suggest",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"       acetaminophen (paracetamol)",
"      </a>",
"      (ie, up to 650 mg per dose). Patients should be advised to use the lowest dose that effectively manages their pain. If subsequent antiinflammatory therapy is required, the patient should be referred to an allergy specialist with expertise in drug reactions for further evaluation. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Reactions of uncertain type'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with pseudoallergic reactions to NSAIDs (types 1-4) do not need to avoid dietary salicylates and have several options for future therapy:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Administration of",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"        acetaminophen",
"       </a>",
"       /paracetamol",
"      </span>",
"      at doses no higher than 650 mg per dose. This is the simplest option for patients in whom",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"       acetaminophen (paracetamol)",
"      </a>",
"      provides adequate pain relief and antiinflammatory therapy is not necessary. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Acetaminophen only'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Administration of an NSAID that weakly inhibits COX-1. This is a good option for patients who require an antiinflammatory agent and can obtain adequate relief with one of these relatively weak NSAIDs. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Weak COX-1 inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Administration of a highly selective COX-2 inhibiting NSAID, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?39/11/40120?source=see_link\">",
"       celecoxib",
"      </a>",
"      . This option is appropriate for patients who need a stronger NSAID or have gastrointestinal intolerance to standard NSAIDs, and are not specifically seeking the antiplatelet actions of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Highly selective COX-2 inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Referral to an allergy specialist for possible NSAID desensitization. Desensitization is appropriate in patients who require daily NSAIDs for an inflammatory disorder or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      for antiplatelet therapy. Desensitization is nearly always successful in patients with type 1 (AERD) pseudoallergic reactions. It is variably successful in patients with type 2, 3, and 4 reactions. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Desensitization'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with allergic reactions to a specific NSAID (Types 5 and 6) should avoid the causative agent and other NSAIDs in the same chemical grouping (",
"      <a class=\"graphic graphic_table graphicRef70067 \" href=\"mobipreview.htm?23/54/24431\">",
"       table 2",
"      </a>",
"      ). However, in many cases the history is not sufficient to make a definite diagnosis of a type 5 or 6 reaction, and patients should be referred to an allergy specialist with experience in NSAID challenges for a diagnostic challenge with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      to exclude pseudoallergy. Once a definitive diagnosis has been made, patients may safely take NSAIDS that are structurally dissimilar to the drug that caused the initial reaction. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Types 5 and 6 - treatment options'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/1\">",
"      Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001; 87:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/2\">",
"      WARIN RP. The effect of aspirin in chronic urticaria. Br J Dermatol 1960; 72:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/3\">",
"      Moore-Robinson M, Warin RP. Effect of salicylates in urticaria. Br Med J 1967; 4:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/4\">",
"      Champion RH, Roberts SO, Carpenter RG, Roger JH. Urticaria and angio-oedema. A review of 554 patients. Br J Dermatol 1969; 81:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/5\">",
"      Mathison DA, Lumry WR, Stevenson DD, et al. Aspirin in chronic urticaria and/or angioedema: Studies of sensitivity and desensitization. J Allergy Clin Immunol 1982; 69:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/6\">",
"      Stevenson DD. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 1984; 74:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/7\">",
"      Setkowicz M, Mastalerz L, Podolec-Rubis M, et al. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years. J Allergy Clin Immunol 2009; 123:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/8\">",
"      Asero R. Multiple sensitivity to NSAID. Allergy 2000; 55:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/9\">",
"      S&aacute;nchez-Borges M, Capriles-Hulett A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol 2000; 84:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/10\">",
"      Quiralte J, Blanco C, Castillo R, et al. Anaphylactoid reactions due to nonsteroidal antiinflammatory drugs: clinical and cross-reactivity studies. Ann Allergy Asthma Immunol 1997; 78:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/11\">",
"      Berkes EA. Anaphylactic and anaphylactoid reactions to aspirin and other NSAIDs. Clin Rev Allergy Immunol 2003; 24:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/12\">",
"      Blanca M, Perez E, Garcia JJ, et al. Angioedema and IgE antibodies to aspirin: a case report. Ann Allergy 1989; 62:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/13\">",
"      Szczeklik A. Adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. Ann Allergy 1987; 59:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/14\">",
"      Strom BL, Carson JL, Schinnar R, et al. The effect of indication on the risk of hypersensitivity reactions associated with tolmetin sodium vs other nonsteroidal antiinflammatory drugs. J Rheumatol 1988; 15:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/15\">",
"      van der Klauw MM, Stricker BH, Herings RM, et al. A population based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmacol 1993; 35:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/16\">",
"      Ross JE. Naproxen-induced anaphylaxis. A case report. Am J Forensic Med Pathol 1994; 15:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/17\">",
"      Alkhawajah AM, Eifawal M, Mahmoud SF. Fatal anaphylactic reaction to diclofenac. Forensic Sci Int 1993; 60:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/18\">",
"      Levy MB, Fink JN. Anaphylaxis to celecoxib. Ann Allergy Asthma Immunol 2001; 87:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/19\">",
"      Fontaine C, Bousquet PJ, Demoly P. Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole. J Allergy Clin Immunol 2005; 115:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/20\">",
"      Van Diem L, Grilliat JP. Anaphylactic shock induced by paracetamol. Eur J Clin Pharmacol 1990; 38:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/21\">",
"      Leung R, Plomley R, Czarny D. Paracetamol anaphylaxis. Clin Exp Allergy 1992; 22:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/22\">",
"      Settipane RA, Schrank PJ, Simon RA, et al. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol 1995; 96:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/23\">",
"      Gyllfors P, Bochenek G, Overholt J, et al. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. J Allergy Clin Immunol 2003; 111:1116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/24\">",
"      Woessner KM, Simon RA, Stevenson DD. The safety of celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum 2002; 46:2201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/25\">",
"      Do&ntilde;a I, Blanca-L&oacute;pez N, Jagemann LR, et al. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs. Allergy 2011; 66:1428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/26\">",
"      Umemoto J, Tsurikisawa N, Nogi S, et al. Selective cyclooxygenase-2 inhibitor cross-reactivity in aspirin-exacerbated respiratory disease. Allergy Asthma Proc 2011; 32:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/27\">",
"      Woessner KM, Simon RA, White A, Stevenson DD. Response to selective cyclooxygenase-2 inhibitor cross-reactivity in aspirin-exacerbated respiratory disease. Allergy Asthma Proc 2011.",
"     </a>",
"    </li>",
"    <li>",
"     Stevenson DD, Simon RA, Zuraw BL. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs. In: Middleton's allergy: Principles and practice, 6th ed, Adkinson NF, Yunginger JW, Busse WW, et al (Eds), Mosby, St Louis, MO 2003. p.1695.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/29\">",
"      Wong JT, Nagy CS, Krinzman SJ, et al. Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema. J Allergy Clin Immunol 2000; 105:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31672/abstract/30\">",
"      Simon RA. Prevention and treatment of reactions to NSAIDs. Clin Rev Allergy Immunol 2003; 24:189.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2082 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-16712FB15A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_59_31672=[""].join("\n");
var outline_f30_59_31672=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION OF NSAIDs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLASSIFICATION OF REACTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PSEUDOALLERGIC REACTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Type 1: NSAID-induced asthma and rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Type 2: NSAID-induced urticaria/angioedema in patients with chronic urticaria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Type 3: NSAID-induced urticaria/angioedema in otherwise asymptomatic individuals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Type 4: Blended reactions in otherwise asymptomatic individuals",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ALLERGIC REACTIONS (PRESUMED IgE-MEDIATED)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Type 5: Urticaria/angioedema to a single NSAID",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Type 6: Anaphylaxis to a single NSAID (not ASA)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Challenge procedures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1362385\">",
"      Diagnostic strategy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1362414\">",
"      Referral",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Advice on avoidance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Reactions of uncertain type",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Types 1 to 4 - treatment options",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Acetaminophen only",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Weak COX-1 inhibitors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Highly selective COX-2 inhibitors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Desensitization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Types 5 and 6 - treatment options",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/2082\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2082|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?5/51/5950\" title=\"figure 1\">",
"      COX 1 versus COX 2 inhibition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/2082|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/38/40556\" title=\"table 1\">",
"      Cross rxn among NSAIDs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/54/24431\" title=\"table 2\">",
"      Nonopioid analgesic and NSAID table",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/20/39242?source=related_link\">",
"      Antiplatelet agents in acute non-ST elevation acute coronary syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/0/39944?source=related_link\">",
"      Aspirin exacerbated respiratory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/54/18281?source=related_link\">",
"      Aspirin exacerbated respiratory disease: NSAID challenge and desensitization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/27/39351?source=related_link\">",
"      COX-2 selective inhibitors: Adverse cardiovascular effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/7/117?source=related_link\">",
"      Chronic urticaria: Standard management and patient education",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26006?source=related_link\">",
"      Diagnostic challenge and desensitization protocols for NSAID reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/17/41241?source=related_link\">",
"      Drug eruptions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/19/1336?source=related_link\">",
"      NSAIDs: Mechanism of action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/49/17177?source=related_link\">",
"      Nonselective NSAIDs: Overview of adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/48/13066?source=related_link\">",
"      Overview of selective COX-2 inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/29/17882?source=related_link\">",
"      Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_59_31673="Prevention of falls in nursing care facilities and the hospital setting";
var content_f30_59_31673=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prevention of falls in nursing care facilities and the hospital setting",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/59/31673/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/59/31673/contributors\">",
"     Sarah Berry, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/59/31673/contributors\">",
"     Douglas P Kiel, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/59/31673/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/59/31673/contributors\">",
"     Kenneth E Schmader, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/59/31673/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/59/31673/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/59/31673/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 24, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H638009032\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Falls occur commonly in older individuals, and are a major health concern. Falls usually occur in elderly persons with multiple impairments in cognitive, sensory, and gait domains [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/1\">",
"     1",
"    </a>",
"    ]. Falls are therefore very common among older adults who are cared for in institutional healthcare settings, such as nursing homes, rehabilitation facilities, or acute hospitals. &nbsp;",
"   </p>",
"   <p>",
"    Falls in institutional settings lead to functional decline, increased length of stay in acute care hospitals, and increased institutional liability. Much geriatric research has focused on strategies and interventions to prevent falling in the institutional environment.",
"   </p>",
"   <p>",
"    This topic will address risk factors and prevention strategies for older patients in nursing homes and acute care facilities. A discussion of fall risks and prevention for community dwelling older individuals is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/4/22602?source=see_link\">",
"     \"Falls in older persons: Risk factors and patient evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/12/8393?source=see_link\">",
"     \"Prevention of falls and complications of falls in community-dwelling older persons\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H638009024\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compared with community dwellers, falls occur more commonly among patients in nursing home, rehabilitation, and acute hospital settings. Data vary regarding fall rates and number of patients who fall, and depend upon the particular patient population studied. Approximately 50 percent of individuals in the long-term care setting fall each year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The average rate of falls in the nursing home is estimated to be 1.5 falls per nursing home bed annually (range, 0.2 to 3.5 falls per bed annually) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/4\">",
"     4",
"    </a>",
"    ]. In the rehabilitation setting, rates may be higher for certain groups of patients. For instance, fall rates for stroke patients have been reported as 3.4 falls per bed annually in the acute rehabilitation setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/5\">",
"     5",
"    </a>",
"    ]. Certain groups of hospitalized patients are particularly vulnerable to falls; for example, 5 percent of inpatients with a recent ischemic stroke will fall [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/6\">",
"     6",
"    </a>",
"    ], and nearly 10 percent of elderly persons admitted to a geriatric psychiatric unit will fall [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/7\">",
"     7",
"    </a>",
"    ]. Hospitalized patients with cancer are also at especially high fall risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/8\">",
"     8",
"    </a>",
"    ].",
"    <strong>",
"    </strong>",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17785891\">",
"    <span class=\"h2\">",
"     Morbidity and mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Falls that occur in nursing care facilities and acute hospital settings result in significant morbidity and mortality. As many as 5 percent of falls among nursing home residents result in a fracture, with an additional 2 percent of falls resulting in a serious injury requiring medical attention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/2\">",
"     2",
"    </a>",
"    ]. In hospitalized elderly persons, approximately 1 percent of falls result in a fracture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/9\">",
"     9",
"    </a>",
"    ] and as many as 5 percent may result in a serious injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Persons experiencing a hip fracture during hospitalization have a greater risk of institutionalization and death compared with community-dwellers experiencing a hip fracture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H727186354\">",
"    <span class=\"h2\">",
"     Institutional impact",
"    </span>",
"    &nbsp;&mdash;&nbsp;Falls are a common source of litigation and denial of insurance claims in nursing care facilities and the hospital setting. In 2001, 30 percent of lawsuits in the United States against nursing homes alleged that a potentially avoidable fall contributed to the injury under review [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Medical expenses associated with inpatient falls are a particular concern, as Medicare as of 2008 and many private payers do not reimburse institutions for complications or extended length of stay related to falls that occur in the institution. However, although a few interventions have been shown to be modestly effective in preventing falls, some falls that occur in the hospital setting are not preventable, and the wisdom of this non-reimbursement policy has been called into question [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/13\">",
"     13",
"    </a>",
"    ]. The estimated non-reimbursed hospital costs related to falls for 2008 to 2009 were 7.6 million dollars [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/14\">",
"     14",
"    </a>",
"    ]. It is important that hospitals and other institutions avoid adopting ineffective or even harmful practices, such as increased use of restraints, in an effort to decrease their revenue losses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17785898\">",
"    <span class=\"h1\">",
"     CAUSES AND RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for falls in the nursing home or hospital setting are generally similar to those in the community (",
"    <a class=\"graphic graphic_figure graphicRef63126 \" href=\"mobipreview.htm?43/9/44190\">",
"     figure 1",
"    </a>",
"    ). Risk factors include older age, history of falls, cognitive impairment, dizziness or vertigo, environmental hazards, impaired mobility, certain medication use, and visual impairment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. A combination of these factors increases the fall risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H212880639\">",
"    <span class=\"h2\">",
"     Age and health status",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased inpatient fall risk has been associated with older age and worse general health status. In a cohort of 9625 men who underwent an inpatient surgical procedure at a Veterans Affairs hospital, a post-operative fall was more likely in patients who were older, dependent in one or more activities of daily living, or had a higher American Society of Anesthesia (ASA) Score, indicating worse preoperative health [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/4/22602?source=see_link\">",
"     \"Falls in older persons: Risk factors and patient evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H212880405\">",
"    <span class=\"h2\">",
"     Cognitive impairment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delirium and dementia are both contributors to falls in the hospital or nursing home setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/16,19,20\">",
"     16,19,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H212880501\">",
"    <span class=\"h2\">",
"     Environmental hazards",
"    </span>",
"    &nbsp;&mdash;&nbsp;In one study, environmental hazards were felt to be the cause of sixteen percent of falls in the nursing home setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/4\">",
"     4",
"    </a>",
"    ]. Common environmental hazards in the institutional healthcare setting include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Wet floors",
"     </li>",
"     <li>",
"      Rooms overcrowded with furniture",
"     </li>",
"     <li>",
"      Improper toilet seat height or bed height [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Floor type, with falls more likely with carpet flooring compared to vinyl flooring [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21962697\">",
"    <span class=\"h2\">",
"     Impaired balance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several observational studies of falls in nursing home residents have found an increased risk of fall in patients with gait disorders or weakness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/4,19\">",
"     4,19",
"    </a>",
"    ]. In one review of four studies (1076 falls), gait disorders or weakness was found to be the most likely cause (25 percent) of falling; dizziness was also reported by a quarter of patients who have fallen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/4\">",
"     4",
"    </a>",
"    ]. However, a majority of falls resulted from a combination of intrinsic risk factors and situational or environmental hazards.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21962710\">",
"    <span class=\"h2\">",
"     Medication use",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medication use may be one of the most common and modifiable risk factors for falls, although it is difficult for observational studies to separate the effects of the medication from the underlying medical condition. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/0/30730?source=see_link\">",
"     \"Drug prescribing for older adults\"",
"    </a>",
"    .) Medications with activity directed at the central nervous system (CNS), such as neuroleptics, benzodiazepines, antidepressants, and other sedatives (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/48/13064?source=see_link\">",
"     zolpidem",
"    </a>",
"    ) appear to be associated with an increased risk of falls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. A meta-analysis of 70 studies evaluating the relationship between psychotropic medication use and falls includes 17 studies that were conducted in the nursing home or rehabilitation setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/25\">",
"     25",
"    </a>",
"    ]. The risk of falls was increased among users of antidepressants, antipsychotics, benzodiazepines, and other sedatives (OR 1.5 to 1.7). &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    There is no evidence that the newer psychotropic agents are less likely to cause falls. A retrospective cohort study of 2428 nursing home residents found no difference in the risk of falls among users of the newer SSRI antidepressants versus traditional tricyclic antidepressants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/26\">",
"     26",
"    </a>",
"    ]. Similarly, a prospective cohort of 2005 nursing home residents in Australia found little difference in the risk of falls among users of the newer antipsychotics versus the traditional antipsychotics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/27\">",
"     27",
"    </a>",
"    ]. Use of the newer sedatives (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/48/13064?source=see_link\">",
"     zolpidem",
"    </a>",
"    ) has also been associated with an elevated risk of falls or injurious falls in the hospital and nursing home settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/24,28\">",
"     24,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other classes of medications that have been associated with an increased risk of falls include vasodilators, diuretics, beta-blockers, and diabetic medications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/15,19,29\">",
"     15,19,29",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Recent changes in medication dosages or new medications may also be an important risk factor for falls in the nursing home [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/30-32\">",
"     30-32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17785913\">",
"    <span class=\"h1\">",
"     SCREENING FOR FALL RISK",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple falls risk screening tools have been proposed for use in the acute hospital setting including the Morse Fall Scale [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/33\">",
"     33",
"    </a>",
"    ], Hendrich II Fall Risk Model [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/34\">",
"     34",
"    </a>",
"    ], Schmid Fall Risk Assessment Tool [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/35\">",
"     35",
"    </a>",
"    ], The Johns Hopkins Hospital Fall Risk Assessment Tool [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/36\">",
"     36",
"    </a>",
"    ], and the St. Thomas&rsquo;s Risk Assessment Tool (STRATIFY) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/37\">",
"     37",
"    </a>",
"    ]. The Morse Fall Scale, one of the more commonly used scales, is comprised of six items: history of falling in past three months; presence of any secondary diagnosis; use of an ambulatory aid; receipt of intravenous therapy; abnormal gait; and impaired mental status, with composite scores ranging from 0 to 125 (",
"    <a class=\"graphic graphic_table graphicRef77876 \" href=\"mobipreview.htm?30/20/31052\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A meta-analysis comparing the sensitivity and specificity of the Morse Fall Scale and STRATIFY found that using a cutpoint of &gt;45, the Morse Fall Scale had superior sensitivity; the specificity was similar for the two scales [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/38\">",
"     38",
"    </a>",
"    ]. An inter-rater reliability study found that both the Morse Fall Scale (with a cutpoint of &gt;25) and the Hendrich II Fall Risk Model (with a cutpoint of 5) had similar sensitivity (&gt;0.70), whereas the Hendrich II exhibited superior specificity (0.62 versus 0.48) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/39\">",
"     39",
"    </a>",
"    ]. One study found that a falls risk assessment tool (STRATIFY) was not helpful in predicting fractures after falls, but that the FRAX tool was useful for that purpose [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=see_link&amp;anchor=H4#H4\">",
"     \"Osteoporotic fracture risk assessment\", section on 'Fracture risk assessment tool'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    Despite the relatively good performance of these tools in predicting falls, a systematic review and meta-analysis of prospective studies suggests that falls screening tools are comparable with nursing clinical judgment when predicting falls in the acute hospital setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/41\">",
"     41",
"    </a>",
"    ]. Screening tools may be even less useful in the nursing home setting where the majority of residents are likely to be at high fall risk. A prospective cohort study of 183 nursing home residents in Sweden found that both the staff&rsquo;s judgment of fall risk and a prior history of falls were better predictors of future falls than commonly used screening tests for falls, such as the Get Up And Go test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/42\">",
"     42",
"    </a>",
"    ]. Rather than implement falls screening, all nursing home residents should be considered at high risk for falls.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17785920\">",
"    <span class=\"h1\">",
"     PREVENTION STRATEGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two systematic reviews of studies of fall prevention in hospitals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/43,44\">",
"     43,44",
"    </a>",
"    ] and long term care facilities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/43\">",
"     43",
"    </a>",
"    ] found inconclusive evidence for the effectiveness of most approaches. Fall prevention in the setting of a long-term care facility may be particularly challenging, as most interventions have not been demonstrated to be effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. Variation in cognitive and physical impairments among patients, as well as variation in types of facilities, makes it difficult to compare and evaluate the evidence between trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17787010\">",
"    <span class=\"h2\">",
"     Exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meta-analysis of 13 randomized trials of fall prevention interventions in care facilities, comparing patients randomly assigned to supervised exercise versus usual care, found no reduction in the rate of falls (RR 1.03, 95% CI 0.81-1.31) or number of fallers (RR 1.07, 95% CI 0.94-1.23) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/46\">",
"     46",
"    </a>",
"    ]. A subgroup analysis found that the effect of exercise might differ among patient populations and suggested that exercise was beneficial in preventing falls for participants with less disability, but potentially increased falls for those requiring higher levels of nursing care.",
"   </p>",
"   <p>",
"    One randomized trial in four nursing homes evaluated the impact of an eight-month progressive walking program combined with scheduled daytime incontinence care every two hours and found a modest reduction in falls rate in the intervention group (RR .62, 95% CI 0.38-1.00) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/47\">",
"     47",
"    </a>",
"    ]. It is not clear if this effect reflects the impact of the exercise program, or the more intensive nursing care that patients received.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17785928\">",
"    <span class=\"h2\">",
"     Tai chi",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tai chi, which contains elements of both strength and balance, has been found effective in fall prevention in the community setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/48\">",
"     48",
"    </a>",
"    ]. However, randomized trials of tai chi in nursing home residents did not find statistically significant evidence of benefit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/49,50\">",
"     49,50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17785935\">",
"    <span class=\"h2\">",
"     Medication review",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medication review and adjustment of medication regimens, as part of a multifactorial intervention, is an important component of fall prevention in the community setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/45\">",
"     45",
"    </a>",
"    ]. However, there is limited evidence to suggest medication review is effective in reducing falls in institutionalized settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/46,51-54\">",
"     46,51-54",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A multifactorial falls prevention program for nursing home residents that included medication review resulted in a small reduction in fall rates that did not reach statistical significance in one randomized trial [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/53\">",
"       53",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A larger trial of 661 nursing home residents examined the effect of a comprehensive medication review by a clinical pharmacist on the risk of falls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/51\">",
"       51",
"      </a>",
"      ]. Overall 58 percent of pharmacy recommendations were implemented, and the intervention group experienced a reduction in the rate of falls (RR 0.62, 95% CI 0.53-0.72).",
"     </li>",
"     <li>",
"      In another trial that also incorporated medication review with other individualized assessments for fall prevention, there was a 20 percent reduction in the number of recurrent fallers in the intervention group, but no significant change in the number of injurious falls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17785942\">",
"    <span class=\"h2\">",
"     Behavior modification",
"    </span>",
"    &nbsp;&mdash;&nbsp;One small study of 71 elderly patients with evidence of confusion and behavioral disturbances examined the effect of individualized advice on nonpharmacological strategies to reduce agitation versus usual care in the inpatient setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/55\">",
"     55",
"    </a>",
"    ]. There was no statistically significant difference between the percentage of fallers in the intervention and control groups.",
"   </p>",
"   <p>",
"    Aromatherapy may affect the psychological status of individuals with behavioral symptoms related to dementia. The mechanism by which these agents may be effective is unclear. A randomized trial of nursing home patients in Japan found that olfactory stimulation by a lavender patch worn for a year resulted in fewer fallers and a lower incidence rate of falls for the lavender, compared to the placebo, group [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/56\">",
"     56",
"    </a>",
"    ]. These results require further confirmation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H971345\">",
"    <span class=\"h2\">",
"     Toileting interventions",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is some evidence to suggest that falls in the nursing home setting commonly occur while toileting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/57\">",
"     57",
"    </a>",
"    ], but the role of toileting interventions to reduce falls is unclear. An intervention that combined exercise with a toileting protocol for incontinence reduced falls in nursing home residents; however, it was not possible to distinguish the exercise component from that of the toileting intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For ambulatory residents with urinary symptoms, it makes sense to try and reduce urinary symptoms through medication review and control of edema. Bedside commodes and scheduled toileting may be useful for select patients, although there is no direct evidence to support this. There is evidence to suggest that nursing home residents with incontinence benefit from a multifactorial falls intervention including environmental modifications and strength and balance training, more than residents who are continent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H971378\">",
"    <span class=\"h2\">",
"     Footwear",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no studies evaluating footwear interventions to reduce falls in an institutionalized setting. However, nonskid, well-fitting footwear is likely important in an effort to reduce falls. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/12/8393?source=see_link&amp;anchor=H7#H7\">",
"     \"Prevention of falls and complications of falls in community-dwelling older persons\", section on 'Environment/assistive technology'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H638009066\">",
"    <span class=\"h2\">",
"     Education",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is limited evidence from multifactorial intervention trials that included staff education, that education is an effective strategy to reduce falls in the nursing home and rehabilitation settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. Education interventions may be more effective when they involve cognitively-intact patients.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A randomized trial found that a low-intensity intervention (use of an assessment tool to identify high-risk individuals, a \"high risk\" logo, and written prevention strategies for staff) may have actually increased falls in a residential setting [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/59\">",
"       59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A randomized trial of an intensive two-day safety training seminar for staff, involving 112 facilities and 10,558 patients with 12 month follow-up, also failed to result in fall prevention in the nursing home setting [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/60\">",
"       60",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A randomized trial compared fall rates for 1206 older patients in acute and subacute hospital units who were assigned to one of three groups: a multimedia falls education program combined with follow-up by a health professional, education program alone, or no intervention [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/61\">",
"       61",
"      </a>",
"      ]. Rates of falls did not differ between groups overall, but for cognitively intact older patients, rates of falls were decreased by half (HR 0.51, 95% CI 0.28-0.93) comparing the group assigned to education with follow-up when compared to either education alone or controls.",
"     </li>",
"     <li>",
"      Findings were similar in another trial of staff education as a component of an intervention program for residents in long-term care [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/62\">",
"       62",
"      </a>",
"      ]. A significant reduction in falls was seen in the patient group with higher cognitive function, as determined by the Mini Mental State Examination, but not in the group with lower scores.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17785949\">",
"    <span class=\"h2\">",
"     Multitargeted interdisciplinary approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most commonly, multidisciplinary strategies have been studied in the nursing home setting. Interventions may include staff training, environmental modifications, balance and strength training, medication review with discontinuation of psychotropic medications, and occupational therapy for review of assistive aids.",
"   </p>",
"   <p>",
"    A meta-analysis of seven trials for the effect of multifactorial interventions on rate of falls and seven trials on risk of falls showed a suggestive benefit (RaR 0.78, 95% CI 0.59-1.04 and RR 0.89, CI 0.77-1.02, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/46\">",
"     46",
"    </a>",
"    ]. Meta-analysis of four trials indicated a trend toward reduction in the number of people sustaining hip fracture (RR 0.56, 95% CI 0.30-1.03).",
"   </p>",
"   <p>",
"    Two trials showed a statistically significant reduction in the risk of falling in the intervention group [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. Interventions that were used in these trials included exercise programs focusing on balance and strength, environmental modifications, staff education, and medication reviews.",
"   </p>",
"   <p>",
"    In the hospital setting, analysis of four trials (6,478 participants) found that multifactorial interventions decreased the rate of falls (RaR 0.69, 95% CI 0.49-0.96) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/46\">",
"     46",
"    </a>",
"    ]. Effective interventions used in these trials included balance and strength exercises, environmental modifications, staff education, medication reviews, and a comprehensive geriatric review. Another meta-analysis of interventions in the acute hospital setting, involving six trials, found that multicomponent interventions could reduce the rate of falls (OR 0.90, 95% CI 0.83-0.99) but estimated that the number needed to treat to prevent a single inpatient fall would be 1250 patient days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/65\">",
"     65",
"    </a>",
"    ]. Given that only one-third of the inpatient falls resulted in injury, some have questioned whether an intensive multitargeted approach is cost-effective in the hospital setting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17785956\">",
"    <span class=\"h3\">",
"     Patient-tailored interventions utilizing health information technology",
"    </span>",
"    &nbsp;&mdash;&nbsp;A randomized trial in the acute hospital setting examined the effectiveness of a falls prevention kit, tailored to patient characteristics utilizing health information technology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/66\">",
"     66",
"    </a>",
"    ]. Patients (n = 10,264) were randomly assigned in clusters to usual care versus the intervention consisting of evidence-based recommendations and care plans that were automatically selected on the basis of a patient&rsquo;s profile via the electronic medical record. The fall rate and number of fallers was reduced in the intervention sites (3.15 versus 4.18",
"    <span class=\"nowrap\">",
"     falls/1000",
"    </span>",
"    patient days), with the greatest benefit observed in patients over the age of 65.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H971307\">",
"    <span class=\"h2\">",
"     Hip protectors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since hip fracture is such an important consequence of falls in older persons, methods of preventing hip fracture in patients who fall, particularly with the use of hip protectors, have been studied [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/67-69\">",
"     67-69",
"    </a>",
"    ]. Early studies of hip protectors had found benefit among groups of patients randomly assigned to an intervention based on setting (ie, by ward in a nursing home). These studies were potentially susceptible to bias with unintended \"co-interventions\" that occur when whole units participate in trials and are allocated to use hip protectors, and these co-interventions benefit other residents of these facilities. Subsequent studies have randomized individual patients.",
"   </p>",
"   <p>",
"    Findings from a variety of studies call into question the effectiveness of hip protectors:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Meta-analyses of randomized trials of hip protectors found no evidence that they were effective in reducing hip fractures in studies in which randomization was by individual patient within an institution [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/67,70\">",
"       67,70",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The apparent lack of efficacy of hip protectors may be due in part to low compliance rates [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/67\">",
"       67",
"      </a>",
"      ]. Most fractures occurred when the hip protector was not being used [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/68,69\">",
"       68,69",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study of circumstances associated with hip fracture in 300 patients presenting to an emergency room from either the community or nursing home found that hip protectors would have no potential to prevent more than half (51.8 percent) of the fractures: patients were at low risk for falls, fracture was not the result of a fall, or fracture occurred in circumstances that would have precluded use of hip protectors [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/71\">",
"       71",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study in which nursing home patients served as their own controls, wearing an undergarment designed for research purposes with a protective hip pad only on one side, found there was no difference in fracture rate between protected and unprotected hips [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/72\">",
"       72",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      One meta-analysis, however, that used a Bayesian model to address the statistical problems inherent in combining cluster-randomized and individually-randomized trials, found that use of hip protectors in nursing homes (four trials, 1922 individuals) was protective for hip fracture (OR 0.40, 95% CI 0.25-0.61) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/73\">",
"       73",
"      </a>",
"      ]. The herd effect of cluster studies, however, might still account for some of this benefit.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    At least a dozen types of hip protectors are commercially available, with most published trials using SafeHip&reg;. Many of these hip protectors have not been tested in laboratory or clinical trials. Despite concerns about effectiveness, and until results from studies with higher rates of compliance are available, it is not unreasonable for clinicians to consider the use of hip protectors in patients at high risk of hip fractures who are willing to comply with their use.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17785963\">",
"    <span class=\"h2\">",
"     Vitamin D",
"    </span>",
"    &nbsp;&mdash;&nbsp;Men and women over age 65 years with low serum 25-hydroxyvitamin D concentrations (&lt;10",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    (25",
"    <span class=\"nowrap\">",
"     nmol/L))",
"    </span>",
"    are at greater risk for loss of muscle strength and muscle mass [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/74\">",
"     74",
"    </a>",
"    ] and hip fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A systematic review of fall prevention measures in the nursing home [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/46\">",
"     46",
"    </a>",
"    ] included five randomized controlled trials that examined the effect of vitamin D on falls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/76-80\">",
"     76-80",
"    </a>",
"    ]. The authors concluded that among vitamin D users there was a statistically significant reduction in the rate of falls (RaR 0.63, 95% CI 0.46-0.86), but not the risk of falls (RR 0.99, 95% CI 0.90-1.08). The results may be affected by heterogeneity between trials including differences in comparators (usual care or placebo), doses of vitamin D, and in primary outcomes (fracture or fall). Another meta-analysis of ten randomized trials of vitamin D supplementation for fall prevention included five trials in patients in a variety of institutional settings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/81\">",
"     81",
"    </a>",
"    ]. One of the five trials (comparing vitamin D 800 IU daily plus calcium 1200 mg daily with calcium 1200 mg alone) found no difference in the number of falls or time to first fall between the two groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/82\">",
"     82",
"    </a>",
"    ]. In the overall meta-analysis, vitamin D, in varying doses between trials, reduced the relative risk of falling in hospitalized or institutionalized patients 80 years and older (RR 0.90, 95% 0.80-1.01), although the finding did not reach statistical significance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/81\">",
"     81",
"    </a>",
"    ]. The effect of vitamin D on fall prevention in community dwelling elders was more robust.",
"   </p>",
"   <p>",
"    Inconsistent results of vitamin D trials in the nursing home may relate to insufficient dosing. A randomized placebo control trial of vitamin D supplementation in nursing home residents found that only higher doses of vitamin D were associated with a decreased risk of falls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/79\">",
"     79",
"    </a>",
"    ]. In this study, 124 nursing home residents were randomly assigned to receive vitamin D (200 IU, 400 IU, 600 IU, or 800 IU) or placebo daily for five months. The rate of falls was reduced in the group taking 800 IU, with no difference in the rate of falls among the placebo group and those taking lower doses of vitamin D. &nbsp;",
"   </p>",
"   <p>",
"    Guidelines for fall prevention from the American Geriatrics Association give a strong recommendation for vitamin D supplementation of at least 800 IU per day for older persons residing in long-term care settings with proven or suspected vitamin D insufficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/45\">",
"     45",
"    </a>",
"    ]. This is the only intervention given a strong recommendation for this patient population in these fall prevention guidelines.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17785970\">",
"    <span class=\"h2\">",
"     Restraints and alarms",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no evidence to support the use of physical restraints to reduce falls in the nursing home or inpatient setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/83\">",
"     83",
"    </a>",
"    ]. One study of 263,068 nursing home residents evaluated the effect of physical restraints (full bed rails on all open sides of bed, half rail one side, trunk restraint, limb restraint, or chairs to prevent rising) on falls and other adverse health outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/84\">",
"     84",
"    </a>",
"    ]. After adjustment for factors other than restraints that might impact fall risk, a slight increased risk of falls was found among residents who were physically restrained. There was also a reduction in walking dependence, and an increase in pressure ulcers and contractures among those who were physically restrained. An increased risk of falls among nursing home residents who were physically restrained, compared with those without restraints, was also demonstrated in additional studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/85,86\">",
"     85,86",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A time series conducted in two post-stroke and brain injury rehabilitation units suggested that removal of physical restraints may be associated with a decreased rate of falls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/87\">",
"     87",
"    </a>",
"    ]. Falls were also decreased in the nursing home setting with an intervention that led to a decrease in the use of restrictive bedside rails [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The utility of bed and chair alarms in reducing falls in the nursing home setting is not established, although these devices are widely used. Alarm use leads to &ldquo;false positive&rdquo; signals that can be annoying to the resident and difficult for staff to interpret. In a cluster randomized trial in an urban community hospital involving over 27,000 patients, nursing units (matched for comparable pre-intervention fall rates) were randomly assigned to an educational intervention to increase use of bed alarms or to usual care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/88\">",
"     88",
"    </a>",
"    ]. Despite a significant increase in alarm use by the intervention groups (64.4 versus 1.8 days per 1000 patient days), there was no difference in fall rates, number of patients who fell, or fall-related injuries between groups. Authors note that the trial may have been underpowered to detect the primary end point (falls per 1000 patient-days), but a large benefit would be unlikely. Two other trials included bed alarms as part of a multifactorial fall prevention intervention, with reduction in falls found in one trial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/66\">",
"     66",
"    </a>",
"    ] but not the other [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/59/31673/abstract/89\">",
"     89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These devices may be appropriate for a select group of hospital patients or nursing home residents, but in the absence of other interventions are not likely to prevent falls for most patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17785977\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Falls are common and associated with significant morbidity and mortality in the nursing care facilities and the acute hospital setting. (See",
"      <a class=\"local\" href=\"#H638009024\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk factors for falls in the nursing home and hospital settings, similar to risk factors for falls in the community, include: older age, history of falls, cognitive impairment, impaired balance, visual impairment, certain classes of medications, medication changes, and environmental factors. Medications with central nervous system activity (neuroleptics, sedatives, antidepressants) are particularly implicated, as is change in medications. (See",
"      <a class=\"local\" href=\"#H17785898\">",
"       'Causes and risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All nursing home residents should be considered at high risk for falls. Screening tools, such as the Morse Falls Scale or the Hendrich II Fall Risk model may be useful in identifying older patients at high risk for falls in the acute hospital setting, although clinical judgment yields similar predictive accuracy. (See",
"      <a class=\"local\" href=\"#H17785913\">",
"       'Screening for fall risk'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Multifactorial interventions that address an individual resident&rsquo;s greatest risk factors for falls may be an effective strategy to reduce the rate of falls and should include exercise programs, focusing on strength and balance, as well as environmental modifications and medication review. Health information technology may be helpful to deliver personalized fall prevention strategies. (See",
"      <a class=\"local\" href=\"#H17785920\">",
"       'Prevention strategies'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17785949\">",
"       'Multitargeted interdisciplinary approach'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      We suggest vitamin D supplementation at a minimum dose of 800 IU daily for nursing home patients (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H17785963\">",
"       'Vitamin D'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend",
"      <strong>",
"       not",
"      </strong>",
"      using bedrails or physical restraints for fall protection in long-term care facilities (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H17785970\">",
"       'Restraints and alarms'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/1\">",
"      Tinetti ME, Inouye SK, Gill TM, Doucette JT. Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA 1995; 273:1348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/2\">",
"      Thapa PB, Brockman KG, Gideon P, et al. Injurious falls in nonambulatory nursing home residents: a comparative study of circumstances, incidence, and risk factors. J Am Geriatr Soc 1996; 44:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/3\">",
"      Tinetti ME, Liu WL, Ginter SF. Mechanical restraint use and fall-related injuries among residents of skilled nursing facilities. Ann Intern Med 1992; 116:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/4\">",
"      Rubenstein LZ, Josephson KR, Robbins AS. Falls in the nursing home. Ann Intern Med 1994; 121:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/5\">",
"      Nyberg L, Gustafson Y. Fall prediction index for patients in stroke rehabilitation. Stroke 1997; 28:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/6\">",
"      Schmid AA, Wells CK, Concato J, et al. Prevalence, predictors, and outcomes of poststroke falls in acute hospital setting. J Rehabil Res Dev 2010; 47:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/7\">",
"      de Carle AJ, Kohn R. Risk factors for falling in a psychogeriatric unit. Int J Geriatr Psychiatry 2001; 16:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/8\">",
"      Hendrich A, Nyhuis A, Kippenbrock T, Soja ME. Hospital falls: development of a predictive model for clinical practice. Appl Nurs Res 1995; 8:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/9\">",
"      von Renteln-Kruse W, Krause T. Incidence of in-hospital falls in geriatric patients before and after the introduction of an interdisciplinary team-based fall-prevention intervention. J Am Geriatr Soc 2007; 55:2068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/10\">",
"      Schwendimann R, B&uuml;hler H, De Geest S, Milisen K. Characteristics of hospital inpatient falls across clinical departments. Gerontology 2008; 54:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/11\">",
"      Murray GR, Cameron ID, Cumming RG. The consequences of falls in acute and subacute hospitals in Australia that cause proximal femoral fractures. J Am Geriatr Soc 2007; 55:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/12\">",
"      Stevenson DG, Studdert DM. The rise of nursing home litigation: findings from a national survey of attorneys. Health Aff (Millwood) 2003; 22:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/13\">",
"      Inouye SK, Brown CJ, Tinetti ME. Medicare nonpayment, hospital falls, and unintended consequences. N Engl J Med 2009; 360:2390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/14\">",
"      Moncada LV. Management of falls in older persons: a prescription for prevention. Am Fam Physician 2011; 84:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/15\">",
"      Myers AH, Baker SP, Van Natta ML, et al. Risk factors associated with falls and injuries among elderly institutionalized persons. Am J Epidemiol 1991; 133:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/16\">",
"      van Doorn C, Gruber-Baldini AL, Zimmerman S, et al. Dementia as a risk factor for falls and fall injuries among nursing home residents. J Am Geriatr Soc 2003; 51:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/17\">",
"      Luukinen H, Koski K, Laippala P, Kivela SL. Risk factors for recurrent falls in the elderly in long-term institutional care. Public Health 1995; 109:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/18\">",
"      Church S, Robinson TN, Angles EM, et al. Postoperative falls in the acute hospital setting: characteristics, risk factors, and outcomes in males. Am J Surg 2011; 201:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/19\">",
"      Krauss MJ, Evanoff B, Hitcho E, et al. A case-control study of patient, medication, and care-related risk factors for inpatient falls. J Gen Intern Med 2005; 20:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/20\">",
"      Lakatos BE, Capasso V, Mitchell MT, et al. Falls in the general hospital: association with delirium, advanced age, and specific surgical procedures. Psychosomatics 2009; 50:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/21\">",
"      Capezuti E, Wagner L, Brush BL, et al. Bed and toilet height as potential environmental risk factors. Clin Nurs Res 2008; 17:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/22\">",
"      Donald IP, Pitt K, Armstrong E, Shuttleworth H. Preventing falls on an elderly care rehabilitation ward. Clin Rehabil 2000; 14:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/23\">",
"      Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009; 169:1952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/24\">",
"      Kolla BP, Lovely JK, Mansukhani MP, Morgenthaler TI. Zolpidem is independently associated with increased risk of inpatient falls. J Hosp Med 2013; 8:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/25\">",
"      Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999; 47:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/26\">",
"      Thapa PB, Gideon P, Cost TW, et al. Antidepressants and the risk of falls among nursing home residents. N Engl J Med 1998; 339:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/27\">",
"      Hien le TT, Cumming RG, Cameron ID, et al. Atypical antipsychotic medications and risk of falls in residents of aged care facilities. J Am Geriatr Soc 2005; 53:1290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/28\">",
"      Wang PS, Bohn RL, Glynn RJ, et al. Zolpidem use and hip fractures in older people. J Am Geriatr Soc 2001; 49:1685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/29\">",
"      Simonson W, Han LF, Davidson HE. Hypertension treatment and outcomes in US nursing homes: results from the US National Nursing Home Survey. J Am Med Dir Assoc 2011; 12:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/30\">",
"      Sorock GS, Quigley PA, Rutledge MK, et al. Central nervous system medication changes and falls in nursing home residents. Geriatr Nurs 2009; 30:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/31\">",
"      Berry SD, Mittleman MA, Zhang Y, et al. New loop diuretic prescriptions may be an acute risk factor for falls in the nursing home. Pharmacoepidemiol Drug Saf 2012; 21:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/32\">",
"      Berry SD, Zhang Y, Lipsitz LA, et al. Antidepressant prescriptions: an acute window for falls in the nursing home. J Gerontol A Biol Sci Med Sci 2011; 66:1124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/33\">",
"      Morse JM, Black C, Oberle K, Donahue P. A prospective study to identify the fall-prone patient. Soc Sci Med 1989; 28:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/34\">",
"      Hendrich AL, Bender PS, Nyhuis A. Validation of the Hendrich II Fall Risk Model: a large concurrent case/control study of hospitalized patients. Appl Nurs Res 2003; 16:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/35\">",
"      Schmid NA. 1989 Federal Nursing Service Award Winner. Reducing patient falls: a research-based comprehensive fall prevention program. Mil Med 1990; 155:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/36\">",
"      Poe SS, Cvach MM, Gartrelu DG, et al. An evidence-based approach to fall risk assessment, prevention, and management: lessons learned. J Nurs Care Qual 2005; 20:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/37\">",
"      Oliver D, Britton M, Seed P, et al. Development and evaluation of evidence based risk assessment tool (STRATIFY) to predict which elderly inpatients will fall: case-control and cohort studies. BMJ 1997; 315:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/38\">",
"      Harrington L, Luquire R, Vish N, et al. Meta-analysis of fall-risk tools in hospitalized adults. J Nurs Adm 2010; 40:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/39\">",
"      Kim EA, Mordiffi SZ, Bee WH, et al. Evaluation of three fall-risk assessment tools in an acute care setting. J Adv Nurs 2007; 60:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/40\">",
"      Toyabe S. World Health Organization fracture risk assessment tool in the assessment of fractures after falls in hospital. BMC Health Serv Res 2010; 10:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/41\">",
"      Haines TP, Hill K, Walsh W, Osborne R. Design-related bias in hospital fall risk screening tool predictive accuracy evaluations: systematic review and meta-analysis. J Gerontol A Biol Sci Med Sci 2007; 62:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/42\">",
"      Nordin E, Lindel&ouml;f N, Rosendahl E, et al. Prognostic validity of the Timed Up-and-Go test, a modified Get-Up-and-Go test, staff's global judgement and fall history in evaluating fall risk in residential care facilities. Age Ageing 2008; 37:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/43\">",
"      Oliver D, Connelly JB, Victor CR, et al. Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses. BMJ 2007; 334:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/44\">",
"      Coussement J, De Paepe L, Schwendimann R, et al. Interventions for preventing falls in acute- and chronic-care hospitals: a systematic review and meta-analysis. J Am Geriatr Soc 2008; 56:29.",
"     </a>",
"    </li>",
"    <li>",
"     The American Geriatrics Society Clinical Practice Guideline: Prevention of falls in older person (2010) file://www.americangeriatrics.org/health_care_professionals/clinical_practice/clinical_guidelines_recommendations/2010/.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/46\">",
"      Cameron ID, Gillespie LD, Robertson MC, et al. Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database Syst Rev 2012; 12:CD005465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/47\">",
"      Schnelle JF, Kapur K, Alessi C, et al. Does an exercise and incontinence intervention save healthcare costs in a nursing home population? J Am Geriatr Soc 2003; 51:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/48\">",
"      Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009; :CD007146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/49\">",
"      Faber MJ, Bosscher RJ, Chin A Paw MJ, van Wieringen PC. Effects of exercise programs on falls and mobility in frail and pre-frail older adults: A multicenter randomized controlled trial. Arch Phys Med Rehabil 2006; 87:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/50\">",
"      Nowalk MP, Prendergast JM, Bayles CM, et al. A randomized trial of exercise programs among older individuals living in two long-term care facilities: the FallsFREE program. J Am Geriatr Soc 2001; 49:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/51\">",
"      Zermansky AG, Alldred DP, Petty DR, et al. Clinical medication review by a pharmacist of elderly people living in care homes--randomised controlled trial. Age Ageing 2006; 35:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/52\">",
"      Crotty M, Rowett D, Spurling L, et al. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2004; 2:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/53\">",
"      Dyer CA, Taylor GJ, Reed M, et al. Falls prevention in residential care homes: a randomised controlled trial. Age Ageing 2004; 33:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/54\">",
"      Ray WA, Taylor JA, Meador KG, et al. A randomized trial of a consultation service to reduce falls in nursing homes. JAMA 1997; 278:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/55\">",
"      Mador JE, Giles L, Whitehead C, Crotty M. A randomized controlled trial of a behavior advisory service for hospitalized older patients with confusion. Int J Geriatr Psychiatry 2004; 19:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/56\">",
"      Sakamoto Y, Ebihara S, Ebihara T, et al. Fall prevention using olfactory stimulation with lavender odor in elderly nursing home residents: a randomized controlled trial. J Am Geriatr Soc 2012; 60:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/57\">",
"      Jensen J, Lundin-Olsson L, Nyberg L, Gustafson Y. Falls among frail older people in residential care. Scand J Public Health 2002; 30:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/58\">",
"      Rapp K, Lamb SE, B&uuml;chele G, et al. Prevention of falls in nursing homes: subgroup analyses of a randomized fall prevention trial. J Am Geriatr Soc 2008; 56:1092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/59\">",
"      Kerse N, Butler M, Robinson E, Todd M. Fall prevention in residential care: a cluster, randomized, controlled trial. J Am Geriatr Soc 2004; 52:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/60\">",
"      Ray WA, Taylor JA, Brown AK, et al. Prevention of fall-related injuries in long-term care: a randomized controlled trial of staff education. Arch Intern Med 2005; 165:2293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/61\">",
"      Haines TP, Hill AM, Hill KD, et al. Patient education to prevent falls among older hospital inpatients: a randomized controlled trial. Arch Intern Med 2011; 171:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/62\">",
"      Jensen J, Nyberg L, Gustafson Y, Lundin-Olsson L. Fall and injury prevention in residential care--effects in residents with higher and lower levels of cognition. J Am Geriatr Soc 2003; 51:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/63\">",
"      Becker C, Kron M, Lindemann U, et al. Effectiveness of a multifaceted intervention on falls in nursing home residents. J Am Geriatr Soc 2003; 51:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/64\">",
"      Jensen J, Nyberg L, Rosendahl E, et al. Effects of a fall prevention program including exercise on mobility and falls in frail older people living in residential care facilities. Aging Clin Exp Res 2004; 16:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/65\">",
"      DiBardino D, Cohen ER, Didwania A. Meta-analysis: multidisciplinary fall prevention strategies in the acute care inpatient population. J Hosp Med 2012; 7:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/66\">",
"      Dykes PC, Carroll DL, Hurley A, et al. Fall prevention in acute care hospitals: a randomized trial. JAMA 2010; 304:1912.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/67\">",
"      Parker MJ, Gillespie LD, Gillespie WJ. Hip protectors for preventing hip fractures in the elderly. Cochrane Database Syst Rev 2003; :CD001255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/68\">",
"      Kannus P, Parkkari J, Niemi S, et al. Prevention of hip fracture in elderly people with use of a hip protector. N Engl J Med 2000; 343:1506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/69\">",
"      van Schoor NM, Smit JH, Twisk JW, et al. Prevention of hip fractures by external hip protectors: a randomized controlled trial. JAMA 2003; 289:1957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/70\">",
"      Parker MJ, Gillespie WJ, Gillespie LD. Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review. BMJ 2006; 332:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/71\">",
"      van Schoor NM, Smit JH, Bouter LM, et al. Maximum potential preventive effect of hip protectors. J Am Geriatr Soc 2007; 55:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/72\">",
"      Kiel DP, Magaziner J, Zimmerman S, et al. Efficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trial. JAMA 2007; 298:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/73\">",
"      Sawka AM, Boulos P, Beattie K, et al. Hip protectors decrease hip fracture risk in elderly nursing home residents: a Bayesian meta-analysis. J Clin Epidemiol 2007; 60:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/74\">",
"      Visser M, Deeg DJ, Lips P, Longitudinal Aging Study Amsterdam. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003; 88:5766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/75\">",
"      Cauley JA, Lacroix AZ, Wu L, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008; 149:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/76\">",
"      Bischoff HA, St&auml;helin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003; 18:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/77\">",
"      Chapuy MC, Pamphile R, Paris E, et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002; 13:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/78\">",
"      Flicker L, MacInnis RJ, Stein MS, et al. Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J Am Geriatr Soc 2005; 53:1881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/79\">",
"      Broe KE, Chen TC, Weinberg J, et al. A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007; 55:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/80\">",
"      Law M, Withers H, Morris J, Anderson F. Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. Age Ageing 2006; 35:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/81\">",
"      Kalyani RR, Stein B, Valiyil R, et al. Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis. J Am Geriatr Soc 2010; 58:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/82\">",
"      Burleigh E, McColl J, Potter J. Does vitamin D stop inpatients falling? A randomised controlled trial. Age Ageing 2007; 36:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/83\">",
"      Capezuti E, Maislin G, Strumpf N, Evans LK. Side rail use and bed-related fall outcomes among nursing home residents. J Am Geriatr Soc 2002; 50:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/84\">",
"      Castle NG, Engberg J. The health consequences of using physical restraints in nursing homes. Med Care 2009; 47:1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/85\">",
"      Capezuti E, Evans L, Strumpf N, Maislin G. Physical restraint use and falls in nursing home residents. J Am Geriatr Soc 1996; 44:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/86\">",
"      Capezuti E, Wagner LM, Brush BL, et al. Consequences of an intervention to reduce restrictive side rail use in nursing homes. J Am Geriatr Soc 2007; 55:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/87\">",
"      Amato S, Salter JP, Mion LC. Physical restraint reduction in the acute rehabilitation setting: a quality improvement study. Rehabil Nurs 2006; 31:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/88\">",
"      Shorr RI, Chandler AM, Mion LC, et al. Effects of an intervention to increase bed alarm use to prevent falls in hospitalized patients: a cluster randomized trial. Ann Intern Med 2012; 157:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/59/31673/abstract/89\">",
"      Cumming RG, Sherrington C, Lord SR, et al. Cluster randomised trial of a targeted multifactorial intervention to prevent falls among older people in hospital. BMJ 2008; 336:758.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16149 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-6CC31590FA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_59_31673=[""].join("\n");
var outline_f30_59_31673=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17785977\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H638009032\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H638009024\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17785891\">",
"      Morbidity and mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H727186354\">",
"      Institutional impact",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17785898\">",
"      CAUSES AND RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H212880639\">",
"      Age and health status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H212880405\">",
"      Cognitive impairment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H212880501\">",
"      Environmental hazards",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21962697\">",
"      Impaired balance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21962710\">",
"      Medication use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17785913\">",
"      SCREENING FOR FALL RISK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17785920\">",
"      PREVENTION STRATEGIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17787010\">",
"      Exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17785928\">",
"      Tai chi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17785935\">",
"      Medication review",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17785942\">",
"      Behavior modification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H971345\">",
"      Toileting interventions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H971378\">",
"      Footwear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H638009066\">",
"      Education",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17785949\">",
"      Multitargeted interdisciplinary approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17785956\">",
"      - Patient-tailored interventions utilizing health information technology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H971307\">",
"      Hip protectors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17785963\">",
"      Vitamin D",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17785970\">",
"      Restraints and alarms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17785977\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/16149\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/16149|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?43/9/44190\" title=\"figure 1\">",
"      Causes of falls",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/16149|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?30/20/31052\" title=\"table 1\">",
"      Morse Fall Scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/0/30730?source=related_link\">",
"      Drug prescribing for older adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/4/22602?source=related_link\">",
"      Falls in older persons: Risk factors and patient evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/42/29354?source=related_link\">",
"      Osteoporotic fracture risk assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/12/8393?source=related_link\">",
"      Prevention of falls and complications of falls in community-dwelling older persons",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_59_31674="Photomicrograph of urine sediment with white blood cells";
var content_f30_59_31674=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F75211%7ENEPH%2F54319%7ENEPH%2F68147%7ENEPH%2F59811%7ENEPH%2F65483&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F75211%7ENEPH%2F54319%7ENEPH%2F68147%7ENEPH%2F59811%7ENEPH%2F65483&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Photomicrograph of urine sediment with white blood cells",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    White blood cells in the urine sediment with nuclei and granular cytoplasm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Frances Andrus, BA, Victoria Hospital, London, Ontario.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Photomicrograph of urine sediment with white blood cell cast (I)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 247px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    White cell cast in which blue stained white cells (arrow) are contained within a granular cast.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Frances Andrus, BA, Victoria Hospital, London, Ontario.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Photomicrograph of urine sediment with white blood cell cast (II)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 236px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A white blood cell cast, three-quarters of which is filled with leukocytes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Frances Andrus, BA, Victoria Hospital, London, Ontario.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Granular and waxy casts",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 375px; height: 251px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Urine sediment showing waxy and fine and coarse (arrow) granular casts. The broader casts are thought to form when there is stasis (due to advanced renal failure) in the wider collecting tubules into which many nephrons drain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harvard Medical School.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Waxy cast",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 269px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Urine sediment showing a waxy cast (arrow) and many small fine granular casts. Note the cast outline and its amorphous appearance. The high optical density, smooth surface, and blunt ends of waxy casts, which appear to represent degenerated cellular or granular casts, allows them to be distinguished from hyaline casts. The latter are composed solely of precipitated Tamm-Horsfall mucoprotein.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Frances Andrus, BA, Victoria Hospital, London, Ontario.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_59_31674=[""].join("\n");
var outline_f30_59_31674=null;
var title_f30_59_31675="Complement receptors";
var content_f30_59_31675=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F58974&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F58974&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Complement receptors: ligands and functions",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Receptor",
"       </td>",
"       <td class=\"subtitle1\">",
"        Major ligand",
"       </td>",
"       <td class=\"subtitle1\">",
"        Functions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CR1",
"       </td>",
"       <td>",
"        C3b/C4b",
"       </td>",
"       <td>",
"        Immune adherence; immune complex clearance; regulation of C3b/C4b",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CR2",
"       </td>",
"       <td>",
"        C3dg/iC3b",
"       </td>",
"       <td>",
"        B cell coreceptor; immune complex localization; EBV receptor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CR3",
"       </td>",
"       <td>",
"        iC3b",
"       </td>",
"       <td>",
"        Phagocytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CR4",
"       </td>",
"       <td>",
"        iC3b",
"       </td>",
"       <td>",
"        Phagocytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C3aR",
"       </td>",
"       <td>",
"        C3a",
"       </td>",
"       <td>",
"        Cell activation; histamine release",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C5aR",
"       </td>",
"       <td>",
"        C5a",
"       </td>",
"       <td>",
"        Cell activation; histamine release; chemotaxis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        C1qR",
"       </td>",
"       <td>",
"        C1q",
"       </td>",
"       <td>",
"        Phagocytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CRIg",
"       </td>",
"       <td>",
"        &nbsp;C3b/iC3b",
"       </td>",
"       <td>",
"        Phagocytosis; alternative pathway inhibitor; expressed primarily in liver macrophages (Kupffer cells).&nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_59_31675=[""].join("\n");
var outline_f30_59_31675=null;
var title_f30_59_31676="Infection risk of blood products";
var content_f30_59_31676=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F69661&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F69661&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Risk of viral and bacterial infection following transfusion of blood products",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Whole blood or red blood cell products*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatitis B",
"       </td>",
"       <td>",
"        1:58,000 to 1:269,000 (see note below for 2012 estimates)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatitis C",
"       </td>",
"       <td>",
"        1:1,000,000 to 1:2,000,000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HTLV",
"       </td>",
"       <td>",
"        1:1,900,000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HIV",
"       </td>",
"       <td>",
"        1:1,500,000 to 1:2,000,000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Solvent/detergent-treated plasma products",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatitis C",
"       </td>",
"       <td>",
"        Inactivated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatitis B",
"       </td>",
"       <td>",
"        Inactivated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HIV",
"       </td>",
"       <td>",
"        Inactivated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatitis A",
"       </td>",
"       <td>",
"        Not inactivated",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Parvovirus B19",
"       </td>",
"       <td>",
"        Not inactivated",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Platelet products",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        With automated bacterial culturing methods in place, septic transfusion reactions are estimated to occur at a rate of 1:50,000 transfused platelet apheresis units. This is an underestimate, since it relies on passive surveillance data.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Cytomegalovirus (CMV) infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\">",
"        The risk of CMV infection is rare in recipients with selected conditions (eg, bone marrow or solid organ transplants) who are at risk for severe morbidity from CMV infection and who receive CMV reduced risk products. Two methods to supply CMV reduced risk products that appear to have equal efficacy are: CMV seronegative cellular components (red cells, platelets)",
"        <strong>",
"         or",
"        </strong>",
"        leukoreduced components.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Numbers reported in this table are",
"    <strong>",
"     estimates",
"    </strong>",
"    derived from multiple sources within the United States, where blood is routinely screened for infection with syphilis, hepatitis B and C, HIV-1, HIV-2, HTLV-I, HTLV-II, and West Nile Virus. CMV serotesting is not routine; only enough products are tested to provide a sufficient inventory of CMV-negative products. See relevant sections of the text for details and references.",
"    <div class=\"footnotes\">",
"     * Estimates of the risk of transmitting a viral infection by transfusion in the United States in 2010. These estimates still appear to be valid in 2012, with the exception of HBV where the risk is estimated to have diminished to one in 205,000 to one in 355,000.",
"     <br>",
"      <font class=\"bullet\">",
"       &bull;",
"      </font>",
"      Plasma products are tested for Parvovirus B19 and HAV nucleic acid before being used for further manufacturing into S/D plasma. Transmission of these agents should not occur under these conditions.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_59_31676=[""].join("\n");
var outline_f30_59_31676=null;
var title_f30_59_31677="Simvastatin heart transplant";
var content_f30_59_31677=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F60917&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F60917&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 473px\">",
"   <div class=\"ttl\">",
"    Simvastatin improves survival in cardiac transplant recipients",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 453px; height: 390px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Seventy-two heart transplant recipients were randomly assigned to simvastatin or placebo and followed for four years; then all patients were maintained on simvastatin for another four years. Survival at eight years was significantly better for those patients who were treated with simvastatin throughout the eight-year course (89 versus 60 percent).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Wenke K, Meiser B, Thiery J, et al. Circulation 2003; 107:93.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_59_31677=[""].join("\n");
var outline_f30_59_31677=null;
var title_f30_59_31678="Mycobacterium marinum osteomyelitis";
var content_f30_59_31678=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F85855&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F85855&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Osteomyelitis and septic arthritis due to Mycobacterium marinum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 194px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    65-year-old woman with history of puncture wound of distal phalanx from contact with fish spines who presented with swelling and pain at site of minor injury. Mycobacterium marinum was recovered from synovial biopsy. Frontal radiograph of digit shows soft-tissue swelling (arrowheads), marginal osseous erosion at corner of distal interphalangeal joint (curved arrow), and remarkable joint-space narrowing (straight arrows), consistent with septic arthritis and osteomyelitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Theodorou DJ, Theodorou SJ, Kakitsubata Y, et al. Imaging Characteristics and Epidemiologic Features of Atypical Mycobacterial Infections Involving the Musculoskeletal System. AJR Am J Roentgenol 2001; 176:341. Reprinted with permission from the American Journal of Roentgenology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_59_31678=[""].join("\n");
var outline_f30_59_31678=null;
var title_f30_59_31679="Bowing fracture reduction";
var content_f30_59_31679=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F75630&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F75630&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bowing fracture reduction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 418px; height: 248px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Reduction technique of bow fracture over fulcrum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sanders WE, Heckman JD. Traumatic plastic deformation of the radius and ulna: a closed method of correction of deformity. Clin Orthop 1984; 188:58. Copyright &copy; 1984 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_59_31679=[""].join("\n");
var outline_f30_59_31679=null;
